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Abstract: Alternative models of cardiac rehabilitation (CR) delivery, such as home or community-
based programs, have been developed to overcome underutilization. However, their availability and
characteristics have never been assessed globally. In this cross-sectional study, a piloted survey was
administered online to CR programs globally. CR was available in 111/203 (54.7%) countries globally;
data were collected in 93 (83.8% country response rate). 1082 surveys (32.1% program response
rate) were initiated. Globally, 85 (76.6%) countries with CR offered supervised programs, and 51
(45.9%; or 25.1% of all countries) offered some alternative model. Thirty-eight (34.2%) countries with
CR offered home-based programs, with 106 (63.9%) programs offering some form of electronic CR
(eCR). Twenty-five (22.5%) countries with CR offered community-based programs. Where available,
programs served a mean of 21.4% ± 22.8% of their patients in home-based programs. The median
dose for home-based CR was 3 sessions (Q25−Q75 = 1.0–4.0) and for community-based programs
was 20 (Q25–Q75 = 9.6–36.0). Seventy-eight (47.0%) respondents did not perceive they had sufficient
capacity to meet demand in their home-based program, for reasons including funding and insufficient
staff. Where alternative CR models are offered, capacity is insufficient half the time. Home-based CR
dose is insufficient to achieve health benefits. Allocation to program model should be evidence-based.
Keywords: cardiac rehabilitation; surveys and questionnaires; international health; patient education
as topic
1. Introduction
Cardiac rehabilitation (CR) is an outpatient model of secondary preventive care primarily
delivered in clinical settings. Given participation is associated with a 26% reduction in cardiovascular
mortality and 18% reductions in re-hospitalization compared with controls [1]; it is a Class I Level A
recommendation in clinical practice guidelines [2,3]. However, CR remains grossly under-utilized,
particularly when juxtaposed against other guideline recommendations for cardiovascular disease
(CVD) patients [4]. The reasons include patient-related factors such as geographic access, cost
(including for transportation to sessions), and time conflicts due to return-to-work and family
obligations [5,6], as well as health system-related factors such as insufficient capacity (i.e., 18,936,405
more CR “spots” needed to treat incident ischemic heart patients globally annually) [7]. To mitigate
these barriers, alternative models have been developed, where CR is delivered in non-clinical settings,
such as the home or community.
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While there is no universally-agreed upon definition of home or community-based CR, CR
guidelines recommend delivery of the same established core CR components in these programs,
including structured exercise, patient education and counseling. For example, in home-based CR,
a patient would come in to the CR center for an initial assessment, during which patient safety for
independent exercise would be established and an exercise prescription developed. Then, exercise
training is performed without formal supervision, and regular contacts via phone or other technology
(i.e., eCR) [8] are made to deliver the other components and review exercise. In community-based
CR, local community exercise facilities are exploited, and CR staff go to these centers to deliver
comprehensive services.
A series of Cochrane reviews have established the equivalent benefits of home and supervised
CR [9], and there have also been reviews on the benefits of eCR (including greater patient adherence,
suggesting they indeed mitigate patient barriers) [10–12]. There have been a few studies demonstrating
the benefits of community-based CR as well [13–15]. While home-based CR may not be more
cost-effective than supervised programs [9] (which indeed are very cost-effective and affordable) [16],
eCR and community-based programs may well be. Moreover, recent data by our group demonstrate
programs offering alternative models that treat a higher volume of patients [7], and this could
be particularly true for eCR. Therefore, it is clear that delivery of alternative models should be
optimized globally.
It is then surprising that there is little information in the literature regarding the proportion of
programs offering these models, how they allocate patients to model (e.g., based on geography, risk
of an adverse event) and the proportion treated in the various models, whether alternate models
are reimbursed (among other potential barriers to delivery), and the degree of exploitation of new
eCR possibilities, among other considerations. Studies in Canada suggest only approximately 10%
of patients receive home-based CR, and unfortunately use was not associated with distance from
centre, but was associated with disease severity [17,18]. Other studies around the world suggest
that 15% of patients in Australia [19], 12% in New Zealand [20], 28% in Europe [21], and 38% in
Mexico [22] participate in alternative models. Our recent literature review of national CR program
surveys summarizes the proportion of programs delivering alternative models in countries where
assessed [23].
Therefore, the objective of this study was to ascertain the models of CR delivered in countries
around the globe (i.e., home [including eCR] and community-based), describe the nature of these
models (e.g., dose, proportion of patients served, healthcare provider types delivering, basis for
offering) and their barriers to delivery.
2. Experimental Section
This research was observational and cross-sectional in design. Protocol details are provided
elsewhere [7]. Countries in the world where CR services were available were identified through
reviews [24,25] as well as key informants, and identified leaders in these countries were sent an e-mail
requesting their assistance administering the survey to each program therein.
Each program identified was emailed requesting their completion of the survey. Informed consent
was secured through an online form. Data were collected confidentially through REDCap from June
2016 to July 2017. Contacts were sent two e-mail reminders, at 2-week intervals.
The study was reviewed by York University’s Office of Research Ethics (Toronto, Canada) and
Mayo Clinic’s Institutional Review Board (Rochester, United States); both institutions provided an
ethics approval exemption given the study methods. Informed consent was sought through an online
consent form. Respondents were required to click a box to consent and proceed to complete the survey.
The sample consisted of all CR programs identified in the world, that offered services to patients
following an acute cardiac event or hospitalization (i.e., Phase II). The inclusion criteria were CR
programs that offered: (a) initial assessment, (b) structured exercise, and (c) at least one other strategy
to control cardiovascular (CV) risk factors. All programs were contacted in countries known to
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have ≤250 CR programs. Where more existed (only the United States), a random sub-sample of 250
were contacted.
Development of the survey is described in detail elsewhere [26]. In short, items were based
on previous national/regional CR program surveys [27–29]. Most items had forced-choice response
options, and skip-logic was used to get more detail where applicable. This was pilot-tested in the Arab
world and Canada [26], and is available elsewhere [30].
Specific survey items were the focus of this paper, namely regarding availability and the
nature of alternative models. Alternative models comprised home-based (eCR where information
and communications technology were used), community-based and hybrid programs. In regards
to home-based programs, 13 questions were posed including a proportion of program patients
served, forms of communication between patients and the program, and barriers. In regards to
community-based programs, 12 questions similar to the home-based items were posed.
SPSS version 24 was used for analysis [31]. All initiated surveys were included. The number of
responses for each question varied due to missing data (e.g., respondent did not answer a question due
to lack of willingness or potential inapplicability, use of skip logic); for descriptive analyses, percentages
were computed with the denominator being the number of programs offering a given model.
The proportion of countries offering each model type (i.e., by at least one program) was computed.
To characterize model delivery by programs within countries, descriptive statistics were applied for all
closed-ended items in the survey (e.g., frequencies with percentages, as well as means and standard
deviations or medians with quartiles (Q25–Q75)). All open-ended responses were coded/categorized
using an interpretive-descriptive approach by the first author and reviewed by the last [32]. Responses
were then compared by country and World Health Organization (WHO) region; inferential comparisons
were not undertaken due to small cell sizes.
3. Results
There were 111/203 (54.7%) countries in the world with CR, of which data were collected in
93 (83.8%). Figure 1 displays the 92 countries without CR. Response rate by country is reported
elsewhere [30].
Figure 1. Countries That Offer Any Alternative Models of Cardiac Rehabilitation around the Globe.
CR = cardiac rehabilitation.
Globally, 85 (76.6%) countries with CR (or 41.9% of all the countries in the world) offered
supervised CR (n = 630 programs, 68.9%), and 51 (45.9%) countries with CR (or 25.1% of all the
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countries in the world) offered some alternative model (Figure 1; n = 285 programs, 31.1%). Twelve
(1.1%) programs offered only alternative models (n = 8, 7.2% countries). This was significantly more
common in high versus low and middle-income countries (see [33]). The proportion of responding
programs offering home and community-based CR specifically is shown by country and WHO region
in Supplemental Table S1.
Ninety-two (8.5%) programs (from 24 countries) reported delivering some form of hybrid model
(where patients had some supervised CR and then transitioned to another setting). By WHO region this
was: 1 (5.6%) in the African region, 25 (9.6%) in the Americas, 3 (12.5%) in the Eastern Mediterranean
region, 43 (8.9%) in Europe, 1 (3.1%) in the South-East Asian region, and 19 (7.2%) in the Western Pacific
region. Twenty-nine (4.3%) programs reported delivering some “other” form of CR, which included
(n = 1 for each) rural satellites, shorter or longer programs, heart clubs/peer programs, and programs
offered in primary care, among other responses. Whether alternative models were reimbursed by
government or private healthcare insurance is displayed by country and WHO region in Supplemental
Table S1. Finally, while maintenance program delivery was beyond the scope of the study, 256 (23.7%)
respondents reported offering some form of patient follow-up post-program.
3.1. Supervised CR
Year first offered (1944), capacity of supervised CR programs (3373 programs in the world that
can serve 1,675,270 patients/year) [7], healthcare provider types delivering (on average 5/program;
most-commonly nurses, exercise specialists/physiotherapists), core components offered (most
commonly exercise training and patient education) [30], are reported elsewhere, by country and
WHO region.
With regard to the provision of resistance training (90.8% globally) is reported elsewhere [30].
Patient education was one of the most commonly offered components. Number of sessions provided
to patients per complete program and duration of education sessions is shown by country and WHO
region in Supplemental Table S2. Delivery of non-traditional forms of exercise (e.g., yoga, dance) and
of women-only classes is also reported elsewhere [31].
3.2. Home-Based CR
Information about home-based CR in the 38 countries where it is offered is shown by WHO region
in Table 1 and by country in Supplemental Table S1. Median dose globally was three sessions for a full
program (Q25–Q75 = 1.0–4.0).
Patients were most often offered a home-based program on the basis of choice or transportation
barriers/distance (Table 1), with “other” responses including research (n = 4; 2.4%), and mobility
(n = 2, 1.2%). Materials provided to patients (i.e., education) are also shown, with “other” responses
including psychosocial/ stress management materials, and remote cardiac monitoring (n = 1 for
each). Provider types interacting with patients in home-based programs were most often exercise
physiologists/physiotherapists or nurses (Table 2), with “other” provider types including dietitians
(n = 7; 4.2%), kinesiologists (n = 5; 3.0%), occupational therapists (n = 4; 2.4%), social workers (n = 1;
0.6%), and pharmacists (n = 1; 0.6%).
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Table 1. Characteristics of Home-Based Programs by World Health Organization Region.
n (%)/Mean± Standard
Deviation African (n = 2) Americas (n = 41) EMR (n = 5) Europe (n = 62) SEAR (n = 2)
Western Pacific
(n = 54)
Global (n = 166;
15.3% Total)
Year 1st program opened 2014 1979 2010 1986 2005 1980 1979
% pts served
20.0 ± 0.0
J. Clin. Med. 2018, 7, x FOR PEER REVIEW  5 of 13 
 
Table 1. Characteristics of Home-Based Programs by World Health Organization Region. 
n (%)/  
Mean ± Standard Deviation 
African  
(n = 2) 
Americas  
(n = 41) 
EMR  
(n = 5) 
Europe  
(n = 62) 
SEAR  
(n = 2) 
Western Pacific  
(n = 54) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 2014 1979 2010 1986 2005 1980 1979 
% pts served 
20.0 ± 0.0  
x ̃ = 20.0  
Q25–Q75 = 20.0–20.0 
18.7 ± 18.3  
x ̃ = 10.0  
Q25–Q75 = 5.0–34.8 
12.5 ± 15.7  
x ̃ = 7.5  
Q25–Q75 = 2.5–25.0 
12.9 ± 11.8  
x ̃ = 10.0  
Q25–Q75 = 5.0–25.0 
55.0 ± 35.4  
x ̃ = 55.0  
Q25–Q75 = 30.0–55.0 
35.6 ± 30.8  
x ̃ = 22.5  
Q25–Q75 = 10.0–60.0 
21.4 ± 22.8 
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (50.0%) 19 (46.3%) 3 (60.0%) 36 (58.1%) 1 (50.0%) 28 (51.9%) 88 (53.0%) 
Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 15 (24.3%) 1 (50.0%) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (40.0%) 13 (21.0%) 1 (50.0%) 8 (14.8%) 31 (18.7%) 
Pts too high-risk 0 (0.0%) 2 (4.9%) 1 (20.0%) 0 (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8.0 ± 0.0  
x ̃ = 8.0  
Q25–Q75 = 8.0–8.0 
3.2 ± 2.7  
x ̃ = 3.0  
Q25–Q75 = 1.0–4.0 
6.2 ± 4.6  
x ̃ = 5.0  
Q25–Q75 = 2.0–11.0 
4.9 ± 7.1  
x ̃ = 3.0  
Q25–Q75 = 2.0–4.0 
6.5 ± 7.8  
x ̃ = 6.5  
Q25–Q75 = 1.0–6.5 
3.9 ± 4.2  
x ̃ = 2.0  
Q25–Q75 = 1.0–4.0 
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4.0–4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = 3.0–6.5 
2.5 ± 0.8 
x ̃ = 3.0  
Q25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (100.0%) 32 (72.0%) 0 (0.0%) 44 (72.1%) 2 (100.0%) 21 (38.9%) 101 (60.8%) 
Nurse 0 (0.0%) 12 (29.3%) 3 (60.0%) 31 (50.0%) 0 (0.0%) 32 (59.3%) 78 (47.0%) 
Physician 0 (0.0%) 10 (24.4%) 5 (100.0%) 14 (22.6%) 0 (0.0%) 14 (25.9%) 43 (25.9%) 
Basis for Offering 
Patient choice 0 (0.0%) 36 (87.8%) 3 (60.0%) 45 (72.6%) 2 (100.0%) 35 (64.8%) 121 (72.9%) 
Transportation barriers 1 (50.0%) 34 (82.9%) 5 (100.0%) 39 (62.9%) 2 (100.0%) 29 (53.7%) 110 (66.3%) 
Distance 1 (50.0%) 35 (85.4%) 5 (100.0%) 33 (53.2%) 2 (100.0%) 32 (59.3%) 108 (65.1%) 
Time or work constraints 0 (0.0%) 29 (70.7%) 2 (40.0%) 26 (41.9%) 2 (100.0%) 25 (46.3%) 84 (50.6%) 
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 25 (40.3%) 1 (50.0%) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0%) 20 (48.8%) 1 (20.0%) 22 (35.5%) 1 (50.0%) 23 (42.6%) 67 (40.4%) 
Cost 1 (50.0%) 9 (22.0%) 3 (60.0%) 6 (9.7%) 2 (100.0%) 17 (31.5%) 38 (22.9%) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 (100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 22 (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0%) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 (0.0%) 1 (20.0%) 6 (9.7%) 0 (0.0%) 9 (16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 38 (61.3%) 1 (50.0%) 37 (68.5%) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0%) 12 (22.2%) 58 (34.9%) 
= 20.0
Q25– 2 .0–20.0
18.7 ± 18.3
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Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (1 0.0%) 32 (72.0%) 0 (0.0%) 44 (72.1%) 2 (100.0%) 21 (38.9%) 101 (60.8%) 
Nurse  (0.0%) 12 (29.3%) 3 (60.0%) 31 (50.0%) 0 ( .0 ) 32 (59.3%) 78 (47.0%) 
Physician 0 (0.0%)  (24.4%) 5 (100.0%) 14 (22.6%) 0 (0.0 ) 14 (25.9%) 43 (25.9%) 
Basis for Offering 
Patient choice  (0.0%) 36 (87.8%) 3 (60.0%) 45 (72.6%) 2 (100.0%) 35 (64.8%) 121 (72.9%) 
Transportation barriers 1 (50.0%) 34 (82.9%) 5 (100.0%) 39 (62.9%) 2 (100.0%) 29 (53.7%) 110 (66.3%) 
Distance 1 (50.0%) 5 (85.4%) 5 (100.0%) 33 (53.2%) 2 (100.0%) 32 ( 9.3%) 108 (65.1%) 
Time or work constraints  (0.0%) 29 (70.7%) 2 (40.0%) 2  (41.9%) 2 (100.0%) 25 (4 .3%) 84 (50.6%) 
Risk stratification  (0.0%) 4 (58.5%) 1 (20.0%) 25 (40.3%) 1 (50.0%) 25 (46.3%) 76 (45.8%) 
Patient indication  (0.0%)  (48.8%) 1 (20.0%) 2  (35.5%) 1 (50.0%) 23 (42.6%) 67 (40.4%) 
Cost 1 (50.0%) 9 (22.0%) 3 (60.0%) 6 (9.7%) 2 (100.0%) 17 (31.5%) 38 (22.9%) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0%) 2  (48.8%) 2 (40.0%) 28 (45.2%) 2 (100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 2 (53.7%) 1 (20.0%) 6 (41.9%) 1 ( 0.0%) 14 (25.9%) 65 (39.2%) 
Telemetry  (0.0%)  (0.0%) 1 (20.0%) 6 (9.7%) 0 (0.0%) 9 (1 .7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 3  (61.3%) 1 (50.0%) 37 (68.5%) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
 (0.0%) 4 (58.5%) 1 (20.0%)  (32.3%) 1 (50.0%) 12 (22.2%) 58 (34.9%) 
= 7.5
Q25– 2.5–2 .0
12.9 ± 11.8
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Table 1. Charact ristics of Home-Bas d Programs by W rld Health Organization Region. 
n (%)/  
Mean ± Standard Deviation 
Af n  
(n = 2) 
Americas  
(n = 41) 
EMR
(n = 5) 
Europe 
(n = 62) 
SEAR  
(n = 2
Western Pacific  
(n = 54)
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 2014 1979 2010 1986 2005 1980 1979 
% pts served 
20.0 ± 0.0  
x ̃ = 2 .0  
Q25–Q75 = . –20.0 
18 7 ± 18.3  
x ̃ = 10.0  
Q25–Q75 = .0–34.8 
12. ± 5.7  
x ̃ = 7.5  
2 –Q75 = 2. –25.0 
12.9 ± 11.8  
x ̃ = 1 .0  
Q25–Q75 = 5.0–25.0 
55.0 ± 35.4  
x ̃ = 55.0  
25– 75 = 30.0–55.0 
35.6 ± 30.8  
x ̃ = 22.5  
10.0–60.0 
21.4 ± 22.8 
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (50.0%) 19 (46.3%) 3 (60.0%) 36 (58.1%) 1 0 28 (51.9 ) 88 (53.0%) 
Not enough staff 0 (0.0 ) 11 (26.9%) 1 (20.0%) 15 (24.3%) 1 50 0 14 (25.9 ) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (40.0%) 3 (21.0%) 1 (50.0 ) 8 4 8 31 (18.7%) 
Pts too high-risk 0 (0.0%) 2 (4.9%) 1 (2 .0%) 0 ( .0%) 0 (0.0 ) 3 (5.6 ) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8.0 ± 0.0  
x ̃ = 8.0  
25–Q75 = 8. –8.0 
3.2 ± 2.7  
x ̃ = 3.0  
Q25–Q75 = 1. –4.0 
6. ± 4.6  
x ̃ = 5.0  
25–Q75 = 2.0–11.0 
4.9 ± 7.1  
x ̃ = 3.0  
Q25–Q75 = 2. –4.0 
6.5 ± 7.8  
x ̃ = 6.5  
25– 75 = 1.0–6.5 
3.9 ± 4.2  
x ̃ = 2.0  
25– 75 = 1.0–4.0 
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4. –4.0 
.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = . –6.5 
2.5 ± .8 
x ̃ = 3.0  
2 –Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2. –3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
25– 75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
roviders Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
 (10 .0%) 32 (72.0%) 0 (0.0 ) 44 (72.1%) 2 (100.0 ) 2 38 9 101 (60.8%) 
Nurse 0 (0.0 ) 12 (29.3%) 3 (60.0%) 31 (50.0%) 0 (0.0%) 32 (59.3 ) 78 (47.0%) 
Physician 0 (0.0 ) 10 (24.4%) 5 (100.0%) 14 (22.6%) 0 (0.0%) 14 (25.9 ) 43 (25.9%) 
Basis for Offering 
Patient choice 0 (0.0 ) 36 (87.8%) 3 (60.0%) 45 (72.6%) 2 (100.0 ) 35 64 8 121 (72.9%) 
Transportation barriers 1 (50.0%) 34 (82.9%) 5 (100.0%) 39 (62.9%) 2 (100.0 ) 29 53 7 110 (66.3%) 
Distance 1 ( 0.0%) 35 (85.4%) 5 (100.0%) 33 (53.2%) 2 (100.0 ) 32 59 3 108 (65.1%) 
Time or work constraints 0 (0.0 ) 29 (7 .7%) 2 (40.0%) 26 (41.9%) 2 (100.0 ) 25 (46.3 ) 84 (50.6%) 
Risk stratification 0 (0.0 ) 24 (58.5%) 1 (20.0%) 25 (40.3%) 1 50 0 25 (46.3 ) 76 (45.8%) 
Patient indication 0 (0.0 ) 20 (48.8%) 1 (20.0%) 22 (35.5%) 1 50 0 23 (42.6 ) 67 (40.4%) 
Cost 1 (5 .0%) 9 (22.0%) 3 (60.0%) 6 (9.7 ) 2 (100.0 ) 17 (31.5 ) 38 (22.9%) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 (100.0 ) 17 (31.5 ) 70 (42.2%) 
Heart rate 1 (50.0%) 22 (53.7%) 1 (20.0%) 26 (41.9%) 1 50 0 14 (25.9 ) 65 (39.2%) 
Telemetry 0 ( .0%) 0 (0.0%) 1 (20.0%)  (9.7%) 0 (0 0 9 (16.7 ) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 3  (61.3%) 1 50 0 37 5 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0 ) 24 (58.5%) 1 ( 0.0%) 20 (32.3%) 1 50 0 12 (22.2 ) 58 (34.9%) 
= 10.0
5.0–25.0
55.0 ± 35.4
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Table 1. Ch racteristics of Home-Based Programs by W rld Health Organization Region. 
n (%)/  
Mean ± Standard Deviation 
African  
(n = 2) 
Am ricas  
(n = 41) 
EMR
(n = 5) 
urope  
(n = 62) 
SEAR  
(n = 2) 
Western Pacific  
(n = 54) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 2014 979 2010 1986 20 5 1980 1979 
% pts served
20.0 ± 0.0  
x ̃ = 20.0  
Q25–Q7 = 2 .0–20.0 
18 7 ± 18.3  
x ̃ = 10.0  
Q25–Q7  = 5.0–34.8 
1 5 ± 15.7  
x ̃ = 7.5  
Q25–Q75 = 2. –25.0 
12.9 ± 11.8  
x ̃ = 10.0  
Q25–Q75 = 5.0–25.0 
5.0 ± 35.4  
x ̃ = 55.0  
Q25–Q75 = 3 .0–55.0 
35.6 ± 30.8  
x ̃ = 22.5  
25– 75 = 1 .0–6 .0 
21.4 ± 22.8 
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (50.0%) 19 (46.3%) 3 (60.0%) 36 (58.1%) 1 (50.0%) 28 (51.9%) 88 (53.0%) 
Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 1  (24.3%) 1 ( 0.0%) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (4 .0%) 13 (21.0%) 1 (50.0%) 8 (14.8 ) 31 (18.7%) 
Pts too high-risk 0 (0.0%)  (4.9%) 1 (20.0%)  (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8.0 ± 0.0  
x ̃ = 8.0  
Q25–Q75 = 8.0–8.0 
3.2 ± 2.7  
x ̃ = 3.0  
Q25–Q75 = 1 –4.0 
6.  ± 4.6  
x ̃ = 5.0  
25–Q75 = 2.0–11.0 
4.9 ± 7.1  
x ̃ = 3   
Q25–Q75 = 2. –4.0 
6.5 ± 7.8  
x ̃ = 6.5  
Q25–Q75 = 1.0–6.5 
3.9 ± 4.2  
x ̃ = 2.0  
Q25–Q75 = 1.0–4.0 
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.  ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4. –4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = . –6.5 
2.5 ± 0.8 
x ̃ = 3.0  
2 –Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2. –3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (100.0%) 3  (72.0%)  (0.0%) 44 (72.1%) 2 1 0.0%) 21 (38.9 ) 101 (60.8%) 
Nurse 0 (0.0%) 12 (29.3%) 3 (6 .0%) 31 (50.0%) 0 (0 0 32 (59.3%) 78 (47.0%) 
Physician  (0.0%)  (24.4%) 5 (100.0%) 14 (22.6%) 0 (0 0 14 (25.9%) 43 (25.9%) 
Basis for Offering 
Patient choice 0 (0.0%) 3  (87.8%) 3 (60.0%) 45 (72.6%) 2 100.0%) 35 (64.8 ) 121 (72.9%) 
Transportation barriers 1 (50.0%) 34 (82.9%) 5 (100.0%) 39 (62.9%) 2 100.0%) 29 (53.7 ) 110 (66.3%) 
Distance 1 (50.0%) 35 (85.4%) 5 (100.0%) 33 (53.2%)  100.0%) 32 (59.3 ) 108 (65.1%) 
Time or work constraints 0 (0.0%) 29 (70.7%) 2 (40.0%) 26 (41.9%) 2 1 0.0%) 25 (46.3%) 84 (50.6%) 
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 2  (40.3%) 1 ( 0.0%) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0%) 20 (48.8%) 1 (20.0%) 22 (35.5%) 1 (50.0%) 23 (42.6%) 67 (40.4%) 
Cost 1 (50.0%) 9 (22.0%) 3 (60.0%) 6 (9.7%) 2 100.0%) 17 (31.5%) 38 (22.9%) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 2  (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0%) 14 (25.9%) 65 (39.2%) 
Telemetry  (0.0%) 0 ( .0%) 1 (20.0%) 6 (9.7%) 0 (0.0%) 9 16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 3  (61.3%) 1 (50.0 ) 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0%) 12 (22.2%) 58 (34.9%) 
= 55.0
3 .0– 5.0
5.6 ± 30.8
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Table 1. Ch ract ristics of Home-Bas d Programs by W rld Health Organization Region. 
n (%)/  
Mean ± Sta dard Deviation 
African  
(n = 2) 
Americas  
(n = 41) 
EMR  
(n = 5) 
urope 
(n = 62) 
SEAR  
(n = 2) 
Western Pacific  
(n = 54) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 2014 979 2010 1986 20 5 1980 1979 
% pts served 
20 0 ± 0.0  
x ̃ = 20.0  
2 –Q7 = 0. –20.0 
18.7 ± 18.3  
x ̃ = 10.0  
Q2 –Q75 = –34.8 
1 ± 15.7  
x ̃ = 7.5  
2 –Q75 = 2. –25.0 
12.9 ± 11.8  
x ̃ = 10.0  
Q25–Q7  = 5. –25.0 
5.0 ± 35.4  
x ̃ = 55.0  
Q25–Q75 = 30.0–55.0 
35.6 ± 30.8  
x ̃ = 22.5  
25– 75 = 1 .0–6 .0 
21.4 ± 22.8 
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity §  (50.0%) 19 (46.3%) 3 (60.0%) 36 (58.1%) 1 (5 .0 ) 28 (51.9%) 88 (53.0%) 
Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 1  (24.3%) 1 (50.0 ) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (4 .0%) 3 (21.0%) 1 (50.0%) 8 (14.8 ) 31 (18.7%) 
Pts too high-risk 0 (0.0%)  (4.9%) 1 (20.0%)  (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8.0 ± 0.0  
x ̃ = 8.0  
25–Q75 = . –8.0 
3.2 ± 2.7  
x ̃ = 3.0  
25–Q7  = 1 –4.0 
6.2 ± 4.6  
x ̃ = 5.0  
Q25–Q75 = 2 –11.0 
4.9 ± 7.1  
x ̃ = 3   
Q25–Q75 = 2. –4.0 
6.5 ± 7.8  
x ̃ = 6.5  
Q25–Q75 = 1.0–6.5 
3.9 ± 4.2  
x ̃ = 2.0  
Q25–Q75 = 1.0–4.0 
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
25–Q75 = 4. –4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = . –6.5 
2.5 ± 0.8 
x ̃ = 3.0  
25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2. –3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (100.0%) 32 (72.0%) 0 (0.0%) 44 (72.1%) 2 100.0%) 21 (38.9 ) 101 (60.8%) 
Nurse 0 (0.0%) 12 (29.3%) 3 (6 .0%) 31 (50.0%) 0 (0 0 32 (59.3%) 78 (47.0%) 
Physician 0 (0.0%)  (24.4%)  (100.0%) 14 (22.6%) 0 (0 0 14 (25.9%) 43 (25.9%) 
Basis for Offering 
Patient choice 0 (0.0%) 3 (87.8%) 3 (60.0%) 45 (72.6%) 2 100.0%) 35 (64.8 ) 121 (72.9%) 
Transportation barriers 1 (50.0%) 34 (82.9%) 5 (100.0%) 39 (62.9%) 2 100.0%) 29 (53.7 ) 110 (66.3%) 
Distance 1 (50.0%) 35 (85.4%) 5 (100.0%) 33 (53.2%) 100.0%) 32 (59.3 ) 108 (65.1%) 
Time or work constraints 0 (0.0%) 29 (70.7%) 2 (40.0%) 26 (41.9%) 2 100.0%) 25 (46.3%) 84 (50.6%) 
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 2  (40.3%) 1 (50.0 ) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0%) 20 (48.8%) 1 (20.0%) 22 (35.5%) 1 (50.0 ) 23 (42.6%) 67 (40.4%) 
Cost 1 (50.0%) 9 (22.0%) 3 (60.0%) 6 (9.7%) 2 100.0%) 17 (31.5%) 38 (22.9%) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 2  (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0 ) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 ( .0%) 1 (20.0%)  (9.7%) 0 (0.0 ) 9 16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 38 (61.3%) 1 (50.0%) 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0 ) 12 (22.2%) 58 (34.9%) 
= 22.5
. –60.0
21.4 ± 2.8
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Table 1. Characteris ics of Home-Based Programs by World Health Organization Region. 
n (%)/  
Mean ± Sta dard Deviation
Af n
(n = 2) 
Americas  
(n = 41) 
EMR
(n = 5) 
Europe  
(n = 62) 
SEAR  
(n = 2)
Western Pacific  
(n = 54) 
Global  
(n = 166; 15.3% Total) 
Year st program opened 2014 1979 2010 1986 2005 80 1979 
% pts served 
20.0 ± 0.0  
x ̃ = 20.0  
2 – 75 = 2 .0–20.0 
18.7 ± 18.3  
x ̃ = 10.0  
Q25–Q7  = –34.8 
1 .5 ± 5.7  
x ̃ = 7.5  
25–Q75 = 2.5–25.0 
12.9 ± 11.8  
x ̃ = 10.0  
Q25–Q7 = 5. –25.0 
5 0 5 4
̃ 55 0
3 55
35 6 30  
̃ 22 5  
25– 75 = 10.0–60.0 
21.4 ± 22.8 
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (50.0 ) 19 (46.3%) 3 (60.0 ) 36 (58.1%) 1 (50.0 ) 2 1 9 88 (53.0%) 
Not enough staff  (0 0 11 (26.9%) 1 (20.0 ) 1  (24.3%) 1 (50.0 ) 14 9 42 (25.3%) 
Not enough funding  (0.0 ) 7 (17.1%) 2 (40.0 ) 3 (21.0%) 1 50 0 8 (14.8 ) 31 (18.7%) 
Pts too high-risk (0.0%) 2 (4.9 ) 1 (2 .0%) 0 (0.0%) 0 0 0 3 6 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
.0 ± 0.0  
x ̃ = 8.0  
2 –Q75 = 8.0–8.0 
3.2 ± 2.7  
x ̃ = 3.0  
Q2 –Q75 = 1.0–4.0 
6.2 ± 4.6  
x ̃ = 5.0  
25– 75 = 2. –11.0 
4.9 ± 7.1  
x ̃ = 3.0  
Q25–Q75 = 2.0–4.  
6 5 7 8
̃ 6 5
6 5
3 9 4 2  
̃ 2  
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.  ± 0.0  
x ̃ = 4.0  
–Q75 = 4.0–4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = 3.0–6.5 
2.5 ± 0.8
x ̃ = 3.0  
25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2 3 1 8  
̃ 1 5  
0 9 3
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
roviders Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
100.0%) 3  (72.0%)  (0 0 44 (72.1%)  (100 0 21 (38.9 ) 101 (60.8%) 
Nurse (0 0 12 (29.3%) 3 (60.0 ) 31 (50.0%) 0 0 32 59 3 78 (47.0%) 
Physician (0 0 10 (24.4%) 100.0%) 14 (22.6%) 0 0 0 14 43 (25.9%) 
Basis for Offering 
Patient choice  (0 0 36 (87.8%) 3 (60.0 ) 45 (72.6%) 2 (100 0 35 (64.8 ) 121 (72.9%) 
Transportation barriers 1 (50.0 ) 34 (82.9%) 5 100.0%) 39 (62.9%)  (100 0 29 (53.7 ) 110 (66.3%) 
Distance 1 (50.0 ) 35 (85.4%) 5 00.0%) 33 (53.2%) 2 (100 0 32 (59.3 ) 108 (65.1%) 
Time or work constraints  ( 0 29 (7 .7%) 2 (40.0 ) 26 (41.9%) 1 0 0 25 46 3 84 (50.6%) 
Risk stratification  (0 0 24 (58.5%) 1 (20.0 ) 2  (4 .3%) 1 (50.0 ) 25 6 3 76 (45.8%) 
Patient indication  (0 0 20 (48.8%) 1 (20.0 ) 22 (35.5%) 1 (50.0 ) 23 2 6 67 (40.4%) 
Cost 1 (50.0%)  (22.0%) 3 (60.0%) 6 (9 7 2 100 0 17 31 5 38 (22.9%) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0 ) 2  (48.8%) 2 (40.0 ) 28 (45.2%) 2 100 0 17 31 5 70 (42.2%) 
Heart rate 1 (50.0 ) 22 (53.7%) 1 (20.0 ) 26 (41.9%) 1 (50.0 ) 14 25 9 65 (39.2%) 
Telemetry (0.0%) 0 (0.0 ) 1 (20.0%) 6 (9.7%) 0 (0.0 ) 9 (16 7 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0 ) 34 (82.9%) 3 (60.0 ) 38 (61.3%) 1 50 0 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
 (0 0 24 (58.5%) 1 (20.0 ) 20 (32.3%) 1 (50.0 ) 12 22 2 58 (34.9%) 
= 10.0
= 5.0–30.0
% perceive sufficient capacity § 1 (50.0%) 19 (46.3%) 3 (60 0%) 36 (58 1%) 1 (50 0%) 28 (5 .9%) 88 (53.0%)
Not enou h staff 0 (0.0%) 11 (26.9%) 1 (2 .0%) 15 (24.3%) 1 (5 .0%) 14 (2 .9%) 42 (25.3%)
Not enough funding 0 (0.0%) 7 (17.1%) 2 (40 %) 13 (21.0%) 1 (50.0%) 8 (14 8%) 31 (18.7%)
Pts too high-risk 0 (0.0%) 2 (4.9%) 1 (20.0%) 0 (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%)
Dose
Number sessions pts prescribed
per month a
8.0 ± 0.0
J. Clin. Med. 2018, 7, x FOR PEER REVIEW  5 of 1  
 
Table 1. Characteristics of Home-Based Programs by W rld Health Organization Re ion. 
n (%)/  
Mean ± Standard Deviation 
African  
(n = 2) 
Americas  
(n = 41) 
EMR  
(n = 5) 
Europe  
(n = 62) 
SEAR  
(n = 2) 
Western Pacific  
(n = 54) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 2014 1979 2010 1986 2005 1980 1979 
% pts served 
20.0 ± 0.0  
x ̃ = 20.0  
Q25–Q75 = 20.0–20.0 
18.7 ± 18.3  
x ̃ = 10.0  
Q25–Q75 = 5.0–34.8 
12.5 ± 15.7  
x ̃ = 7.5  
Q25–Q75 = 2.5–25.0 
12.9 ± 11.8  
x ̃ = 10.0  
Q25–Q75 = 5.0–25.0 
55.0 ± 35.4  
x ̃ = 55.0  
Q25–Q75 = 30.0–55.0 
35.6 ± 30.8  
x ̃ = 22.5  
Q25–Q75 = 10.0–60.0 
21.4 ± 22.8 
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (50.0%) 19 (46.3%) 3 (60.0%) 36 (58.1%) 1 (50.0%) 28 (51.9%) 88 (53.0%) 
Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 15 (24.3%) 1 (50.0%) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (40.0%) 13 (21.0%) 1 (50.0%) 8 (14.8%) 31 (18.7%) 
Pts too high-risk 0 (0.0%) 2 (4.9%) 1 (20.0%) 0 (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8.0 ± 0.0  
x ̃ = 8.0  
Q25–Q75 = 8.0–8.0 
3.2 ± 2.7  
x ̃ = 3.0  
Q25–Q75 = 1.0–4.0 
6.2 ± 4.6  
x ̃ = 5.0  
Q25–Q75 = 2.0–11.0 
4.9 ± 7.1  
x ̃ = 3.0  
Q25–Q75 = 2.0–4.0 
6.5  7.8  
x ̃ = 6.5  
Q25–Q75 = 1.0–6.5 
3.9 ± 4.2  
x ̃ = 2.0  
Q25–Q75 = 1.0–4.0 
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4.0–4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = 3.0–6.5 
2.5 ± 0.8 
x ̃ = 3.0  
Q25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (100.0%) 32 (72.0 ) 0 (0.0 ) 44 (72.1 ) 2 (100.0%) 21 (38.9 ) 101 (60.8 ) 
Nurse 0 (0.0%) 12 (29.3%) 3 (60.0%) 31 (50.0%) 0 (0.0%) 32 (59.3%) 78 (47.0%) 
Physician 0 (0.0%) 10 (24.4%) 5 (100.0%) 14 (22.6%) 0 (0.0%) 14 (25.9%) 43 (25.9%) 
Basis for Offering 
Patient choice 0 (0.0%) 36 (87.8%) 3 (60.0%) 45 (72.6%) 2 (100.0%) 35 (64.8%) 121 (72.9%) 
Transportation barriers 1 (50.0%) 34 (82.9%) 5 (100.0%) 39 (62.9%) 2 (100.0%) 29 (53.7%) 110 (66.3%) 
Distance 1 (50.0%) 35 (85.4%) 5 (100.0%) 33 (53.2%) 2 (100.0%) 32 (59.3%) 108 (65.1%) 
Time or work constraints 0 (0.0%) 29 (70.7%) 2 (40.0%) 26 (41.9%) 2 (100.0%) 25 (46.3%) 84 (50.6%) 
Risk stratification 0 ( . ) 24 (58.5 ) 1 (20.0 ) 25 (40.3 ) 1 (50.0 ) 25 (46. ) 76 (45.8 ) 
Patient indication 0 (0.0%) 20 (48.8%) 1 (20.0%) 22 (35.5%) 1 (50.0%) 23 (42.6%) 67 (40.4%) 
Cost 1 (50.0%) 9 (22.0 ) 3 (60.0%) 6 (9.7 ) 2 (1 0.0%) 17 (31.5 ) 38 ( 2.9 ) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 (100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 22 (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0%) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 (0.0%) 1 (20.0%) 6 (9.7%) 0 (0.0%) 9 (16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 38 (61.3%) 1 (50.0%) 37 (68.5%) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0%) 12 (22.2%) 58 (34.9%) 
= 8.0
8.0–8.0
3.2 ± 2.7
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Western Pacific  
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Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 1  (24.3%) 1 (50.0 ) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (4 .0%) 13 (21.0%) 1 (50.0%) 8 (14.8 ) 31 (18.7%) 
Pts too high-risk 0 (0.0%)  (4.9%) 1 (20.0%)  (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8.0 ± 0.0  
x ̃ = 8.0  
Q25–Q75 = 8.0–8.0 
3.2 ± 2.7  
x ̃ = 3.0  
Q25–Q75 = 1.0–4.0 
6.2 ± 4.6  
x ̃ = 5.0  
Q25–Q75 = 2.0–11.0 
4.9 ± 7.1  
x ̃ = 3.0  
Q25–Q75 = 2.0–4.0 
6.5  7.8  
x ̃ = 6.5  
Q25–Q75 = 1.0–6.5 
3.9 ± 4.2  
x ̃ = 2.0  
Q25–Q75 = 1.0–4.0 
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
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x ̃ = 4.0  
Q25–Q75 = 4.0–4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = 3.0–6.5 
2.5 ± 0.8 
x ̃ = 3.0  
Q25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (100.0%) 32 (72.0 ) 0 (0.0 ) 44 (72.1 ) 2 100.0%) 21 (38.9 ) 101 (60.8 ) 
Nurse 0 (0.0%) 12 (29.3%) 3 (6 .0%) 31 (50.0%) 0 (0 0 32 (59.3%) 78 (47.0%) 
Physician 0 (0.0%)  (24.4%) 5 (100.0%) 14 (22.6%) 0 (0 0 14 (25.9%) 43 (25.9%) 
Basis for Offering 
Patient choice 0 (0.0%) 3  (87.8%) 3 (60.0%) 45 (72.6%) 2 100.0%) 35 (64.8 ) 121 (72.9%) 
Transportation barriers 1 (50.0%) 34 (82.9%) 5 (100.0%) 39 (62.9%) 2 100.0%) 29 (53.7 ) 110 (66.3%) 
Distance 1 (50.0%) 35 (85.4%) 5 (100.0%) 33 (53.2%) 100.0%) 32 (59.3 ) 108 (65.1%) 
Time or work constraints 0 (0.0%) 29 (70.7%) 2 (40.0%) 26 (41.9%) 2 100.0%) 25 (46.3%) 84 (50.6%) 
Risk stratification 0 ( . ) 24 (58.5 ) 1 (20.0 ) 2  (40.3 ) 1 (50.0%) 25 (46. ) 76 (4 .8 ) 
Patient indication 0 (0.0%) 20 (48.8%) 1 (20.0%) 22 (35.5%) 1 (50.0 ) 23 (42.6%) 67 (40.4%) 
Cost 1 (50.0%) 9 (22. )  (60.0%) 6 (9.7 ) 2 1 0.0%) 17 (31.5 ) 38 ( .9 ) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 2  (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0 ) 14 (25.9%) 65 (39.2%) 
Telemetry  (0.0%) 0 ( .0%) 1 (20.0%) 6 (9.7%) 0 (0.0 ) 9 16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 38 (61.3%) 1 (50.0 ) 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0 ) 12 (22.2%) 58 (34.9%) 
= 3.0
1.0–4.0
6.2 ± 4.6
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35.6 ± 30.8  
x ̃ = 22.5  
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% perceive sufficient capacity § 1 (50.0%) 19 (46.3%) 3 (60.0%) 36 (58.1%) 1 (5 .0 ) 28 (51.9%) 88 (53.0%) 
Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 1  (24.3%) 1 (50.0 ) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (4 .0%) 3 (21.0%) 1 (50.0%) 8 (14.8 ) 31 (18.7%) 
Pts too high-risk 0 (0.0%)  (4.9%) 1 (20.0%)  (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8.0 ± 0.0  
x ̃ = 8.0  
25–Q75 = 8. –8.0 
3.2 ± 2.7  
x ̃ = 3.0  
Q25–Q75 = 1. –4.0 
6.2 ± 4.6  
x ̃ = 5.0  
Q25–Q75 = 2.0–11.0 
4.9 ± 7.1  
x ̃ = 3.0  
Q25–Q75 = 2.0–4.0 
.5  7.8  
x ̃ = 6.5  
Q25–Q75 = 1.0–6.5 
3.9 ± 4.2  
x ̃ = 2.0  
Q25–Q75 = 1.0–4.0 
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4. –4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = . –6.5 
2.5 ± 0.8 
x ̃ = 3.0  
Q25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (100.0%) 32 (72.0 ) 0 (0.0 ) 44 (72.1 ) 2 100.0 ) 21 (38.9 ) 101 (60.8 ) 
Nurse 0 (0.0%) 12 (29.3%) 3 (6 .0%) 31 (50.0%) 0 (0 0 32 (59.3%) 78 (47.0%) 
Physician 0 (0.0%)  (24.4%) 5 (100.0%) 14 (22.6%) 0 (0 0 14 (25.9%) 43 (25.9%) 
Basis for Offering 
Patient choice 0 (0.0%) 3  (87.8%) 3 (60.0%) 45 (72.6%) 2 100.0%) 35 (64.8 ) 121 (72.9%) 
Transportation barriers 1 (50.0%) 34 (82.9%) 5 (100.0%) 39 (62.9%) 2 100.0%) 29 (53.7 ) 110 (66.3%) 
Distance 1 (50.0%) 35 (85.4%) 5 (100.0%) 33 (53.2%) 100.0%) 32 (59.3 ) 108 (65.1%) 
Time or work constraints 0 (0.0%) 29 (70.7%) 2 (40.0%) 26 (41.9%) 2 100.0%) 25 (46.3%) 84 (50.6%) 
Risk stratification  (0.0 ) 2  (58.5 ) 1 (2 . ) 2  (40. )  ( . ) 25 (46.3 ) 76 (4 .8 ) 
Patient indication 0 (0.0%) 20 (48.8%) 1 (20.0%) 22 (35.5%) 1 (50.0 ) 23 (42.6%) 67 (40.4%) 
Cost 1 (50.0 ) 9 (22.0 )  (6 . ) 6 (9.7%) 2 100.0 ) 7 (31.5 ) 3  ( 2. ) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 2  (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0 ) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 ( .0%) 1 (20.0%)  (9.7%) 0 (0.0 ) 9 16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 38 (61.3%) 1 (50.0%) 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0 ) 12 (22.2%) 58 (34.9%) 
= 5.0
2.0–11.0
4.9 ± 7.1
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Activity tracker (accelerometer, 
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Pts too high-risk 0 (0.0%)  (4.9%) 1 (20.0%)  (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8.0 ± 0.0  
x ̃ = 8.0  
25–Q75 = 8. –8.0 
3.2 ± 2.7  
x ̃ = 3.0  
Q25–Q75 = 1. –4.0 
6.  ± 4.6  
x ̃ = 5.0  
25–Q75 = 2.0–11.0 
4.9 ± 7.1  
x ̃ = 3.0  
Q25–Q75 = 2. –4.0 
.   7.8  
x ̃ = 6.5  
Q25–Q75 = 1.0–6.5 
3.9 ± 4.2  
x ̃ = 2.0  
Q25–Q75 = 1.0–4.0 
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4. –4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = . –6.5 
2.5 ± 0.8 
x ̃ = 3.0  
2 –Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2. –3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (100.0%) 32 (72.0 ) 0 (0.0 ) 44 (72.1 ) 2 100.0%) 21 (38.9 ) 101 (60.8 ) 
Nurse 0 (0.0%) 12 (29.3%) 3 (6 .0%) 31 (50.0%) 0 (0 0 32 (59.3%) 78 (47.0%) 
Physician 0 (0.0%)  (24.4%) 5 (100.0%) 14 (22.6%) 0 (0 0 14 (25.9%) 43 (25.9%) 
Basis for Offering 
Patient choice 0 (0.0%) 3  (87.8%) 3 (60.0%) 45 (72.6%) 2 100.0%) 35 (64.8 ) 121 (72.9%) 
Transportation barriers 1 (50.0%) 34 (82.9%) 5 (100.0%) 39 (62.9%) 2 100.0%) 29 (53.7 ) 110 (66.3%) 
Distance 1 (50.0%) 35 (85.4%) 5 (100.0%) 33 (53.2%) 100.0%) 32 (59.3 ) 108 (65.1%) 
Time or work constraints 0 (0.0%) 29 (70.7%) 2 (40.0%) 26 (41.9%) 2 100.0%) 25 (46.3%) 84 (50.6%) 
Risk stratification 0 ( . ) 24 (58.5 ) 1 (20.0 ) 2  ( 0.3 ) 1 (50.0%) 25 (46.3 ) 76 (45.8 ) 
Patient indication 0 (0.0%) 20 (48.8%) 1 (20.0%) 22 (35.5%) 1 (50.0 ) 23 (42.6%) 67 (40.4%) 
Cost 1 (50.0%) 9 (22.0 )  (60. %) 6 (9.7 ) 2 1 0. %) 17 (31.5 ) 38 (22.9 ) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 2  (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0 ) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 ( .0%) 1 (20.0%)  (9.7%) 0 (0.0 ) 9 16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 3  (61.3%) 1 (50.0%) 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0 ) 12 (22.2%) 58 (34.9%) 
= 6.5
1.0–6.5
3.9 ± 4.2
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Table 1. Ch ract ristics of Home-Bas d Programs by W rld Health Organization Region. 
n (%)/  
Mean ± Standard Deviation 
African  
(n = 2) 
Americas  
(n = 41) 
EMR
(n = 5) 
urope 
(n = 62) 
SEAR  
(n = 2) 
Western Pacific  
(n = 54) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 2014 979 2010 1986 20 5 1980 1979 
% pts served 
20.0 ± 0.0  
x ̃ = 20.0  
Q25–Q7 = . –20.0 
18 7 ± 18.3  
x ̃ = 10.0  
Q2 –Q75 = 5.0–34.8 
1 ± 15.7  
x ̃ = 7.5  
2 –Q75 = 2. –25.0 
12.9 ± 11.8  
x ̃ = 10.0  
Q25–Q75 = 5.0–25.0 
5.0 ± 35.4  
x ̃ = 55.0  
Q25–Q75 = 30.0–55.0 
35.6 ± 30.8  
x ̃ = 22.5  
25– 75 = 1 .0–6 .0 
21.4 ± 22.8 
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (50.0%) 19 (46.3%) 3 (60.0%) 36 (58.1%) 1 (5 .0 ) 28 (51.9%) 88 (53.0%) 
Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 1  (24.3%) 1 (50.0 ) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (4 .0%) 3 (21.0%) 1 (50.0%) 8 (14.8 ) 31 (18.7%) 
Pts too high-risk 0 (0.0%)  (4.9%) 1 (20.0%)  (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8.0 ± 0.0  
x ̃ = 8.0  
25–Q75 = 8. –8.0 
3.2 ± 2.7  
x ̃ = 3.0  
Q25–Q75 = 1.0–4.0 
6.  ± 4.6  
x ̃ = 5.0  
25–Q75 = 2.0–11.0 
4.9 ± 7.1  
x ̃ = 3.0  
Q25–Q75 = 2. –4.0 
6.5  7.8  
x ̃ = 6.5  
Q25–Q75 = 1.0–6.5 
3.9 ± 4.2  
x ̃ = 2.0  
Q25–Q75 = 1.0–4.0 
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4. –4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = . –6.5 
2.5 ± 0.8 
x ̃ = 3.0  
2 –Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2. –3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (100.0%) 32 (72.0 ) 0 (0.0 ) 44 (72.1 ) 2 100.0 ) 21 (38.9 ) 101 (60.8%) 
Nurse 0 (0.0%) 12 (29.3%) 3 (6 .0%) 31 (50.0%) 0 (0 0 32 (59.3%) 78 (47.0%) 
Physician 0 (0.0%)  (24.4%) 5 (100.0%) 14 (22.6%) 0 (0 0 14 (25.9%) 43 (25.9%) 
Basis for Offering 
Patient choice 0 (0.0%) 3 (87.8%) 3 (60.0%) 45 (72.6%) 2 100.0%) 35 (64.8 ) 121 (72.9%) 
Transportation barriers 1 (50.0%) 34 (82.9%) 5 (100.0%) 39 (62.9%) 2 100.0%) 29 (53.7 ) 110 (66.3%) 
Distance 1 (50.0%) 35 (85.4%) 5 (100.0%) 33 (53.2%) 100.0%) 32 (59.3 ) 108 (65.1%) 
Time or work constraints 0 (0.0%) 29 (70.7%) 2 (40.0%) 26 (41.9%) 2 100.0%) 25 (46.3%) 84 (50.6%) 
Risk stratification  ( . ) 24 ( 8.5 ) 1 (20.0 ) 2  (4 .3 ) 1 (50.0 ) 25 (46.3%) 76 (45.8 ) 
Patient indication 0 (0.0%) 20 (48.8%) 1 (20.0%) 22 (35.5%) 1 (50.0 ) 23 (42.6%) 67 (40.4%) 
Cost 1 (50.0%) 9 (22. )  (60.0%) 6 (9.7 ) 2 1 0.0 ) 7 (31.5 ) 38 (22.9 ) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 2  (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0 ) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 ( .0%) 1 (20.0%)  (9.7%) 0 (0.0 ) 9 16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 3  (61.3%) 1 (50.0%) 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0 ) 12 (22.2%) 58 (34.9%) 
= 2.0
1.0–4.0
4.2 5.3
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Table . Characteris ics of Home-Based Programs by World Health Organization Region. 
n (%)/  
Mean ± Sta dard Deviation
Af n
(n = 2) 
Americas  
(n = 41) 
EMR
(n = 5) 
Europe  
(n = 62) 
SEAR  
(n = 2)
Western Pacific  
(n = 54) 
Global  
(n = 166; 15.3% Total) 
Year st program opened 2014 1979 2010 1986 2005 80 1979 
% pts served 
20.0 ± 0.0  
x ̃ = 20.0  
2 – 75 = 2 .0–20.0 
18.7 ± 18.3  
x ̃ = 10.0  
Q25–Q7  = . –34.8 
1 .5 ± 5.7  
x ̃ = 7.5  
2 –Q75 = 2.5–25.0 
12.9 ± 11.8  
x ̃ = 10.0  
Q25–Q7 = 5. –25.0 
5 0 5 4
̃ 55 0
3 55
35 6 30  
̃ 22 5  
25– 75 = 10.0–60.0 
21.4 ± 22.8 
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (50.0 ) 19 (46.3%) 3 (60.0 ) 36 (58.1%) 1 (50.0 ) 2 1 9 88 (53.0%) 
Not enough staff (0 0 11 (26.9%) 1 (20.0 ) 1  (24.3%) 1 (50.0 ) 14 9 42 (25.3%) 
Not enough funding (0.0 ) 7 (17.1%) 2 (40.0 ) 3 (21.0%) 1 50 0 8 (14.8 ) 31 (18.7%) 
Pts too high-risk  (0.0%) 2 (4.9 ) 1 (2 .0%) 0 (0.0%) 0 0 0 3 6 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8.0 ± 0.0  
x ̃ = 8.0  
2 –Q75 = 8.0–8.0 
3.2 ± 2.7  
x ̃ = 3.0  
2 –Q75 = 1 –4.0 
6.2 ± 4.6  
x ̃ = 5.0  
2 – 75 = 2. –11.0 
4.9 ± 7.1  
x ̃ = 3  
Q25–Q75 = 2 .  
6 5 7 8
̃ 6 5
6 5
3 9 4 2  
̃ 2  
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.  ± 0.0  
x ̃ = 4.0  
–Q75 = 4.0–4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = 3.0–6.5 
2.5 ± 0.8
x ̃ = 3.0  
2 –Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2 3 1 8  
̃ 1 5  
0 9 3
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
roviders Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
100.0%) 3  (72.0 )  (0 0 44 (72.1 )  (100 0% 21 (38.9 ) 101 (60.8%) 
Nurse  (0 0 12 (29.3%) 3 (60.0 ) 31 (50.0%) 0 0 32 59 3 78 (47.0%) 
Physician  (0 0 10 (24.4%) 5 100.0%) 14 (22.6%) 0 0 0 14 43 (25.9%) 
Basis for Offering 
Patient choice  (0 0 36 (87.8%) 3 (60.0 ) 45 (72.6%) 2 (100 0 35 (64.8 ) 121 (72.9%) 
Transportation barriers 1 (50.0 ) 34 (82.9%) 5 100.0%) 39 (62.9%)  (100 0 29 (53.7 ) 110 (66.3%) 
Distance 1 (50.0 ) 5 (85.4%) 100.0%) 33 (53.2%) 2 (100 0 32 (59.3 ) 108 (65.1%) 
Time or work constraints  ( 0 29 (7 .7%) 2 (40.0 ) 26 (41.9%) 1 0 0 25 46 3 84 (50.6%) 
Risk stratification ( % 24 (58.5 ) 1 (20.0%) 2  (4 .3 ) 1 (50.0 ) 25 6 3 76 (45.8 ) 
Patient indication (0 0 20 (48.8%) 1 (20.0 ) 22 (35.5%) 1 (50.0 ) 23 2 6 67 (40.4%) 
Cost 1 (50.0%)  (22.0 ) 3 (60.0%) 6 (9 7 2 1 0 0% 17 31 5% 38 (22.9 ) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0 ) 2  (48.8%) 2 (40.0 ) 28 (45.2%) 2 100 0 17 31 5 70 (42.2%) 
Heart rate 1 (50.0 ) 22 (53.7%) 1 (20.0 ) 26 (41.9%) 1 (50.0 ) 14 25 9 65 (39.2%) 
Telemetry  (0.0%) 0 (0.0 ) 1 (20.0%) 6 (9.7%) 0 (0.0 ) 9 (16 7 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0 ) 34 (82.9%) 3 (60.0 ) 38 (61.3%) 1 50 0 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
(0 0 4 (58.5%) 1 (20.0 ) 20 (32.3%) 1 (50.0 ) 12 22 2 58 (34.9%) 
= 3.0
= 1.0–4.0
Program duration (months)
4.0 ± 0 0
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Table 1. Characteristics of Home-Based Programs by World Health Organization Region. 
n (%)/  
Mean ± Standard Deviation 
African  
(  = 2) 
Americas  
(n = 41) 
EMR  
(n = 5) 
Eur pe  
(n = 62) 
SEAR  
(n = 2) 
Western Pacific  
(n  4) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 2014 1979 2010 1986 200  1980 1979 
% pts served 
20.0 ± 0.0  
x ̃ = 20.0  
Q25–Q75 = 20.0–20.0 
8.7 ± 18.3  
x ̃ = 1 .   
Q25–Q75 = 5.0–34.8 
12.5 ± 1 .7  
x ̃ = 7.5 
Q25–Q 5 = 2.5–25.0 
12.9 ± 1.8  
x ̃ = 1 .  
Q25–Q75 = 5.0–25.0 
55.0 ± 35.4  
x ̃ = 55.0
Q25–Q7  = 30.0–55.0 
35.6 ± 0.8
x ̃ = 22.5 
Q25–Q75 = 10.0–60.0 
21.4 ± 22.
x ̃ = 1 .  
Q25–Q75 = 5.0–3 .0 
% perceive sufficient capacity § 1 (50.0 ) 19 6.3%) 3 6 36 58.1%) 1 (50. ) 28 1 9 88 3 0
Not enough staff 0 (0.0 ) 11 (26.9 ) 1 20.0%) 15 (24.3 ) 1 (5 14 (25.9 ) 42 25 3
Not enough funding 0 (0.0%) 7 (17.1%) 2 (40.0%) 13 (21.0%) 1 (50.0%) 8 (14.8%) 31 (18.7%) 
Pts too high-risk 0 (0.0%) 2 (4.9%) 1 (20.0%) 0 (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per m th a 
8
̃ 8
8 8
3 2 2 7
̃ 3
1 4 0
6 2 4 6
̃ 5
25– 75 = 2.0–11.0 
4 9 7 1
̃ 3
4
6.5  7.8 
x ̃ = 6.5 
Q25–Q75 = 1.0–6.5 
3 9 4 2
̃ 2 0
1 0 4
4 2 5 3
̃
1
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4.0–4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = 3.0–6.5 
2.5 ± 0.8 
x ̃ = 3.0  
Q25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise phys ologist or 
physiotherapist 
2 (100.0%) 32 (72.0%) 0 (0.0%) 44 (72.1%) 2 (100.0%) 21 (38.9%) 101 (60.8%) 
Nurse 0 (0.0 ) 12 (29.3 ) 3 (60.0 ) 31 (50.0 ) 0 (0.0%) 32 (59.3 ) 78 (47.0 ) 
Physician 0 (0.0 ) 10 (24.4 ) 5 (100.0 ) 14 (22.6 ) 0 (0.0%) 14 (25.9 ) 43 (25.9 ) 
Basis for Offering 
Patient ch ice 36 87 8 3 6 45 72 6 3 64 8 121 (72.9 )
Tran portation barriers 1 (50.0 ) 3 82 9 5 1 0.0%) 39 62 9 2 1 0.0%) 9 3 7 110 6 3
Distance 1 (50.0 ) 35 85 4 5 (1 0.0 ) 33 53 2 2 (100.0 ) 32 59 108 (6 . )
Time or work constraints 0 (0.0 ) 29 (7 .7 ) 2 4 2 41.9%) 25 46 84 5 6
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 25 (40.3%) 1 (50.0%) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0 ) 20 (48.8 ) 1 (20.0 ) 22 (35.5 ) 1 (50.0 ) 23 (42.6 ) 67 (40.4 ) 
Cost 1 (50.0 ) 9 (22.0 ) 3 (60.0 ) 6 (9.7%) 2 (100.0 ) 17 (31.5 ) 38 (22.9 ) 
Exercise Monitoring 
Bo g percei ed exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 (100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 22 (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0%) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 (0.0%) 1 (20.0%) 6 (9.7%) 0 (0.0%) 9 (16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 38 (61.3%) 1 (50.0%) 37 (68.5%) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0%) 12 (22.2%) 58 (34.9%) 
= 4.0
4.0–4.0
5.8 ± 3 9
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Table 1. Ch racteristics of Home-Based Programs by W rld Health Organization Region. 
n (%)/  
Mean ± Standard Deviation 
African  
(  = 2) 
Americas  
(n = 41) 
EMR  
(n = 5) 
ur pe  
(n = 62) 
SEAR  
(n = 2) 
Western Pacific  
(n  4) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 2014 979 201  1986 20  1980 1979 
% pts served 
20.0 ± 0.0  
x ̃ = 20.0  
Q25–Q 5 = 20.0–20.0 
8.7 ± 18.3  
x ̃ = 1 .   
Q25–Q75 = 5.0–34.8 
12.5 ± 1 .7  
x ̃ = 7.5
Q25–Q 5 = 2.5–25.0 
12.9 ± 1.8  
x ̃ = 1 .  
Q25–Q75 = 5.0–25.0 
5.0 ± 35.4  
x ̃ = 55.0
Q25–Q7  = 30.0–55.0 
35.6 ± 0.8  
x ̃ = 22.5 
25– 75 = 1 .0–6 .0 
21.4 ± 22.
x ̃ = 1 .  
Q25–Q75 = 5.0–3 .0 
% perceive sufficient capacity § 1 (50.0 ) 19 6.3%) 3 6 36 58.1%) 1 (50. ) 28 1 9 88 3 0
Not enough staff 0 ( .0 ) 11 (26.9 ) 1 0.0%)  (24.3 ) 1 (5 4 25.9%) 4 25 3
Not enough funding 0 (0.0%) 7 (17.1%) 2 (4 .0%) 13 (21.0%) 1 (50.0%) 8 (14.8 ) 31 (18.7%) 
Pts too high-risk 0 (0.0%)  (4.9%) 1 (20.0%)  (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per m th a 
8
̃ 8
8 8
3 2 2 7
̃ 3
1 4 0
6 2 4 6
̃ 5
25– 75 = 2.0–11.0 
4 9 7 1
̃ 3
4
6.5  7.8
x ̃ = 6.5
Q25–Q75 = 1.0–6.5 
3 9 4 2
̃ 2 0
1 0 4
4 2 5 3
̃
1
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4.0–4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = 3.0–6.5 
2.5 ± 0.8 
x ̃ = 3.0  
Q25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise phys ologist or 
physiotherapist 
2 (100.0%) 32 (72.0%) 0 (0.0%) 44 (72.1%) 2 100.0%) 21 (38.9 ) 101 (60.8%) 
Nurse 0 (0.0 ) 12 (29.3 ) 3 (6 .0 ) 31 (50.0 ) 0 (0 0 32 (59.3 ) 78 (47.0 ) 
Physician 0 (0.0 )  (24.4 ) 5 (100.0 ) 14 (22.6 ) 0 (0 0 14 (25.9 ) 43 (25.9 ) 
Basis for Offering 
Patient ch ice 3 87 8 3 6 45 72 6 3 64 8 121 (72.9 ) 
Tran portation barriers 1 (50.0 ) 3 82 9 5 1 0.0%) 39 62 9 2 1 0.0 ) 9 3 7 110 (66. ) 
Distance 1 (50.0 ) 35 85 4 5 (1 0.0 ) 33 53 2 100.0%) 32 59 108 (6 . ) 
Time or work constraints 0 ( .0 ) 9 (70.7%) 2 2 41.9%) 25 46 84 5 6
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 2  (40.3%) 1 (50.0 ) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0 ) 20 (48.8 ) 1 (20.0 ) 22 (35.5 ) 1 (50.0 ) 23 (42.6 ) 67 (40.4 ) 
Cost 1 (50.0 ) 9 (22.0 ) 3 (60.0 ) 6 (9.7%) 2 100.0%) 17 (31.5 ) 38 (22.9 ) 
Exercise Monitoring 
Bo g percei ed exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 2  (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0 ) 14 (25.9%) 65 (39.2%) 
Telemetry  (0.0%) 0 ( .0%) 1 (20.0%) 6 (9.7%) 0 (0.0 ) 9 16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 38 (61.3%) 1 (50.0 ) 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0 ) 12 (22.2%) 58 (34.9%) 
= 4.0
3.0–6.5
.5 ± 0
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Table 1. Ch ract ristics of Home-Bas d Programs by W rld Health Organization Region. 
n (%)/  
Mean ± Standard Deviation 
African  
( = 2) 
Americas  
(n = 41) 
EMR  
(n = 5) 
urope 
(n = 62) 
SEAR  
(n = 2) 
Western Pacific  
(n  4) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 014 979 201  986 20 5 1980 1979 
% pts served 
2 .0 ± 0.0  
x ̃ = 20.0  
Q 5–Q 5 = 0. –20.0 
8.7 ± 18.3  
x ̃ = 1 .   
Q25–Q75 = 5.0–34.8 
12.  ± 1 .7  
x ̃ = 7.5
25–Q 5 = 2. –25.0 
12.9 ± 1.8  
x ̃ = 1 .  
Q25–Q75 = 5.0–25.0 
.0 ± 35.4  
x ̃ = 55.0
Q25–Q7  = 30.0–55.0 
35.6 ± 0.8  
x ̃ = 22.5  
25– 75 = 1 .0–6 .0 
21.4 ± 22.
x ̃ = 1 .  
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (50.0 ) 19 6.3%) 3 6 36 58.1%) 1 (5 . ) 28 1 9 88 3 0
Not enough staff 0 ( .0%) 11 26 9 1 (20.0 ) 24 3 1 (50.0 ) 4 25 4  (25.3 ) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (4 .0%) 3 (21.0%) 1 (50.0%) 8 (14.8 ) 31 (18.7%) 
Pts too high-risk 0 (0.0%)  (4.9%) 1 (20.0%)  (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
e month a 
8
̃ 8
8 8
3 2 2 7
̃ 3
1 4 0
6 2 4 6
̃ 5
25– 75 = 2.0–11.0 
4 9 7 1
̃ 3
4
6.   7.8
x ̃ = 6.5
Q25–Q75 = 1.0–6.5
3 9 4 2
̃ 2 0
1 0 4
4 2 5 3
̃
1
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4. –4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = . –6.5 
2.5 ± 0.8 
x ̃ = 3.0  
Q25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise phys ologist or 
physiotherapist 
2 (100.0%) 32 (72.0%) 0 (0.0%) 44 (72.1%) 2 100.0%) 21 (38.9 ) 101 (60.8%) 
Nurse 0 (0.0 ) 12 (29.3 ) 3 (6 .0 ) 31 (50.0 ) 0 (0 0 32 (59.3 ) 78 (47.0 ) 
Physician 0 (0.0 )  (24.4 ) 5 (100.0 ) 14 (22.6 ) 0 (0 0 14 (25.9 ) 43 (25.9 ) 
Basis for Offering 
Patient ch ice 3 87 8 3 6 45 72 6 3 64 8 121 (72.9 ) 
Tran portation barriers 5 (100.0 ) 9 2 9 2 100.0 ) 9 3 7 0 6 3
Distance 1 (50.0 ) 35 85 4 5 (1 0.0 ) 33 53 2 100.0%) 32 59 108 (6 .1 ) 
Time or work constraints 9 7 7 2 4 41 9 25 46 84 5 6
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 2  (40.3%) 1 (50.0 ) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0 ) 20 (48.8 ) 1 (20.0 ) 22 (35.5 ) 1 (50.0 ) 23 (42.6 ) 67 (40.4 ) 
Cost 1 (50.0 ) 9 (22.0 ) 3 (60.0 ) 6 (9.7%) 2 100.0%) 17 (31.5 ) 38 (22.9 ) 
Exercise Monitoring 
Bo g percei ed exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 2  (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0 ) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 ( .0%) 1 (20.0%)  (9.7%) 0 (0.0 ) 9 16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 38 (61.3%) 1 (50.0%) 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0 ) 12 (22.2%) 58 (34.9%) 
= 3.0
1.6–3.0
.7 ± 2.0
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35.6 ± 30.8  
x ̃ = 22.5  
25– 75 = 1 .0–6 .0 
21.4 ± 22.8
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Pts too high-risk 0 (0.0%)  (4.9%) 1 (20.0%)  (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
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8
̃ 8
8 8
3 2 2 7
̃ 3
1 4 0
6 4 6
̃ 5
25– 75 = 2.0–11.0 
4 9 7 1
̃ 3
4
6.5  7.
x ̃ = 6.5
Q25– 7  = 1.0–6.5 
3 9 4 2
̃ 2 0
1 0 4
4 2 5 3
̃
1
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4. –4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = . –6.5 
2.5 ± 0.8 
x ̃ = 3.0  
2 –Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2. –3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise phys ologist or 
physiotherapist 
2 (100.0%) 32 (72.0%) 0 (0.0%) 44 (72.1%) 2 100.0%) 21 (38.9 ) 101 (60.8%) 
Nurse 0 (0.0 ) 12 (29.3 ) 3 (6 .0 ) 31 (50.0 ) 0 (0 0 32 (59.3 ) 78 (47.0 ) 
Physician 0 (0.0 )  (24.4 ) 5 (100.0 ) 14 (22.6 ) 0 (0 0 14 (25.9 ) 43 (25.9 ) 
Basis for Offering 
Patient ch ice 3 87 8 3 6 45 72 6 3 64 8 121 (72.9 ) 
Tran portation barriers 1 (50.0 ) 3 82 9 5 0.0%) 39 62 9 2 1 0.0%) 9 3 7 110 6 3
Distance 1 (50.0 ) 35 85 4 5 (1 0.0 ) 33 53 2 100. %) 32 59 108 (6 .1 ) 
Time or work constraints  ( .0 ) 9 (7 .7 ) 4 41.9%) 25 6 84 50 6
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 2  (40.3%) 1 (50.0 ) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0 ) 20 (48.8 ) 1 (20.0 ) 22 (35.5 ) 1 (50.0 ) 23 (42.6 ) 67 (40.4 ) 
Cost 1 (50.0 ) 9 (22.0 ) 3 (60.0 ) 6 (9.7%) 2 100.0%) 17 (31.5 ) 38 (22.9 ) 
Exercise Monitoring 
Bo g percei ed exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 2  (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0 ) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 ( .0%) 1 (20.0%)  (9.7%) 0 (0.0 ) 9 16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 3  (61.3%) 1 (50.0%) 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0 ) 12 (22.2%) 58 (34.9%) 
= 2.0
2.0–
-
.3 ± 1 8
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Table 1. Charact ristics of Home-Bas d Programs by World Health Organization Region. 
n (%)/  
Mean ± Standard Deviation 
African  
(n = 2) 
Americas  
(n  41) 
EMR
(n  5) 
Europe 
(n = 62) 
SEAR  
(n  2) 
Western Pacific  
(n = 4) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 014 1979 2 1 986 2005 1980 1979 
% pts served 
2 .0 ± 0.0  
x ̃ = 20.0  
Q 5–Q  = . –20.0 
8 7 ± 18.3  
x ̃ = 10.0  
Q2 –Q75 = 5.0–34.8 
1 ± 15.7 
x ̃ = 7.5  
25–Q75 = 2. –25.0 
12.9 ± 1.8  
x ̃ = 10.0  
Q25–Q 5 = 5.0–25.0 
5 .0 ± 35.4 
x ̃ = 55 0 
Q25–Q7 = 3 .0–55.0 
35.6 ± 30.8  
x ̃ = 22.5 
Q25–Q7  = 10.0–60.0 
1.4 ± 22.8
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (50.0 ) 19 6 3 3 6 36 58.1 ) 1 (5 .0 ) 28 1.9%) 88 3.0%) 
Not enough staff 0 ( .0 ) 11 (26.9 ) 1 20.0%) 5 (24.3 ) 1 (5 4 (25.9%) 42 25 3
Not enough funding 0 (0.0%) 7 (17.1%) 2 (40.0%) 3 (21.0%) 1 (50.0%) 8 (14.8%) 31 (18.7%) 
Pts too high-risk 0 (0.0%) 2 (4.9%) 1 (20.0%) 0 (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per m th a 
8
̃ 8
8 8
3 2 2 7
̃ 3
1 4 0
6 4 6
̃ 5
25– 75 = 2.0–11.0 
4 9 7 1
̃ 3
4
6.5  7.8
x ̃ = 6.5
Q25–Q75 = 1.0–6.5 
3 9 4 2
̃ 2 0
1 0 4
4 2 5 3
̃
1
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4. –4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = . –6.5 
2.5 ± 0.8 
x ̃ = 3.0  
2 –Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2. –3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise phys ologist or 
physiotherapist 
2 (100.0%) 32 (72.0%) 0 (0.0%) 44 (72.1%) 2 (100.0%) 21 (38.9%) 101 (60.8%) 
Nurse 0 (0.0 ) 12 (29.3 ) 3 (60.0 ) 31 (50.0 ) 0 (0.0 ) 32 (59.3 ) 78 (47.0 ) 
Physician 0 (0.0 ) 10 (24.4 ) 5 (100.0 ) 14 (22.6 ) 0 (0.0 ) 14 (25.9 ) 43 (25.9 ) 
Basis for Offering 
Patient ch ice 36 87 8 3 6 45 72 6 3 64 8 121 (72.9 ) 
Tran portation barriers 1 (50.0 ) 3 82 9 5 1 0.0 ) 39 2 9 2 1 0.0 ) 9 3 7 110 (66.3 ) 
Distance 1 (50.0 ) 35 85 4 5 (100.0 ) 33 53 2 2 100.0%) 32 59 3 108 (65.1 ) 
Time or work constraints  ( .0 ) 9 (70.7 ) 4 41 9 5 46 3 84 50 6
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 25 (40.3%) 1 (50.0%) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0 ) 20 (48.8 ) 1 (20.0 ) 22 (35.5 ) 1 (50.0 ) 23 (42.6 ) 67 (40.4 ) 
Cost 1 (50.0 ) 9 (22.0 ) 3 (60.0 ) 6 (9.7%) 2 (100.0%) 17 (31.5 ) 38 (22.9 ) 
Exercise Monitoring 
Bo g percei ed exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 (100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 22 (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0%) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 (0.0%) 1 (20.0%)  (9.7%) 0 (0.0%) 9 (16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 3  (61.3%) 1 (50.0%) 37 (68.5%) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0%) 12 (22.2%) 58 (34.9%) 
= 1 5
0 9
6 3.1
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Table 1. Characteristics of Home-Based Programs by World Health Organization Region. 
n (%)/  
Mean ± Sta dard Deviation
Af n
(n = 2) 
Americas  
(n = 41) 
EMR
(n = 5) 
Europe  
(n = 62) 
SEAR  
(n = 2) 
Western Pacific  
(n = 54) 
Global  
(n = 166; 15.3% Total) 
Year st program opened 2 14 1979 2 1  1986 2005 80 1979 
% pts served 
20.0 ± 0.0  
x ̃ = 20.0  
2 – 75 = 2 .0–20.0 
.7 ± 18.3  
x ̃ = 10.0  
Q25–Q75 = . –34.8 
1 .5 ± 5.7  
x ̃ = 7.5 
2 –Q75 = 2.5–25.0 
12.9 ± 1.8  
x ̃ = 10.0  
Q25–Q7 = 5. –25.0 
5 0 5 4
̃ 5 0
3 55
35 6 30  
̃ 22 5  
25– 75 = 10.0–60.0 
21.4 ± 22.8
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (50.0 ) 19 6.3%) 3 6 36 58.1%) 1 (50.0 ) 2 1 9 88 3.0%) 
Not enough staff (0 0 11 (26.9 ) 1 0.0%) 1  (24.3 ) 5 14 9 42 25 3
Not enough funding (0.0 ) 7 (17.1%) 2 (40.0 ) 3 (21.0%) 1 50 0 8 (14.8 ) 31 (18.7%) 
Pts too high-risk 0 (0.0%) 2 (4.9 ) 1 (2 .0%) 0 (0.0%) 0 0 0 3 6 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per m th a 
8
̃ 8
8 8
3 2 7
̃ 3
1 4 0
6 2 4 6  
̃ 5
2 – 75 = 2. –11.0 
4 9 7 1
̃ 3
4
6 5 7
̃ 6
6 5
9 4 2
̃ 2
4 2 5 3
̃
1
Program duration (months) 
4.  ± 0.0  
x ̃ = 4.0  
–Q75 = 4.0–4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = 3.0–6.5 
2.5 ± 0.8
x ̃ = 3.0  
2 –Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2 3 1 8  
̃ 1 5  
0 9 3
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
roviders Interacting with Pts ‖ 
Exercise phys ologist or 
physiotherapist 
100.0%) 32 (72.0%) 0 (0 0 44 (72.1%)  (100 0 21 (38.9 ) 101 (60.8%) 
Nurse  (0 0 12 (29.3 ) 3 (60.0 ) 31 (50.0 ) 0 0.0 ) 32 59 3 78 (47.0 ) 
Physician 0 (0 0 10 (24.4 ) 5 100.0 ) 14 (22.6 ) 0 0.0 ) 14 43 (25.9 ) 
Basis for Offering 
Patient ch ice 6 87 8 3 6 45 72 6 3 64 8 121 (72.9 ) 
Tran portation barriers 1 (50.0 ) 82 9 1 0.0 ) 39 62 9 1 0 0 9 53 110 (66.3 ) 
Distance 1 (50.0 ) 85 4 100.0%) 33 53 2 1 0 0 32 59 3 108 (65.1 ) 
Time or work constraints ( 0 9 (7 .7%) 2 4 41.9%) 25 46 3 84 50 6
Risk stratification 0 (0 0 24 (58.5%) 1 (20.0 ) 2  (4 .3%) 1 (50.0 ) 25 6 3 76 (45.8%) 
Patient indication 0 (0 0 20 (48.8 ) 1 (20.0 ) 22 (35.5 ) 1 (50.0 ) 23 2 6 67 (40.4 ) 
Cost 1 (50.0 ) 9 (22.0 ) 3 (60.0 ) 6 (9 7 2 (100 0 17 31 5 38 (22.9 ) 
Exercise Monitoring 
Bo g percei ed exertion [34] 1 (50.0 ) 2  (48.8%) 2 (40.0 ) 28 (45.2%) 2 (100 0 17 31 5 70 (42.2%) 
Heart rate 1 (50.0 ) 22 (53.7%) 1 (20.0 ) 26 (41.9%) 1 (50.0 ) 14 25 9 65 (39.2%) 
Telemetry 0 (0.0%) 0 (0.0 ) 1 (20.0%) 6 (9.7%) 0 (0.0 ) 9 (16 7 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0 ) 34 (82.9%) 3 (60.0 ) 38 (61.3%) 1 (50.0 ) 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0 0 4 (58.5%) 1 (20.0 ) 20 (32.3%) 1 (50.0 ) 12 22 2 58 (34.9%) 
= 3.0
= 2.0–4.0
P oviders I eracting with Pts ||
Exercise physiologist or
p ysiotherapist 2 (10 . %) 32 (72. %) 0 ( 44 (72.1%) 2 (10 . %) 1 8 9 ) 101 (60.8%)
Nurse 0 (0.0%) 12 (29.3%) 3 (60.0%) 31 (50.0%) 0 (0.0%) 32 (59.3%) 78 (47.0%)
Physician 0 (0.0%) 10 (24.4%) 5 (100.0%) 14 (22.6%) 0 (0.0%) 14 (25.9%) 43 (25.9%)
Basis for Offering
Patient choice 0 (0.0%) 36 (87.8 ) 3 (60.0 ) 45 (72.6 ) 2 (100.0 ) 35 (64.8%) 121 (72.9%)
Transportation barriers 1 (50.0%) 34 (82.9%) 5 (100.0%) 39 (62.9%) 2 (100.0%) 29 (53.7%) 110 (66.3%)
Dist nce 1 (50.0%) 35 (85.4%) 5 (100.0%) 33 (53.2%) 2 (100.0%) 32 (59.3%) 108 (65.1%)
T me or work constraints 0 (0.0%) 29 (70.7%) 2 (40.0%) 26 (41.9%) 2 (100.0%) 25 (46.3%) 84 (50.6%)
Risk st at fication 0 (0.0%) 24 (58.5%) 1 (20.0%) 25 (40.3%) 1 (50.0%) 25 (46.3%) 76 (45.8%)
Patient indication 0 (0.0%) 20 (48.8%) 1 (20.0%) 22 (35.5%) 1 (50.0%) 23 (42.6%) 67 (40.4%)
Cost 1 (50.0%) 9 (22.0%) 3 (60.0%) 6 (9.7%) 2 (100.0%) 17 (31.5%) 38 (22.9%)
Exercise Monitoring
Borg perceived exertion [34] 1 (50.0%) 20 (48.8 ) 2 (40.0%) 28 (45.2 ) 2 (100.0 ) 17 (31.5%) 70 (42.2%)
He rt rate 1 (50.0 ) 22 (53.7%) 1 (20.0 ) 26 (41.9%) 1 (50.0%) 14 (25.9 ) 65 (39.2%)
Telemetry 0 (0.0 ) 0 (0.0 ) 1 (20.0%) 6 (9.7 ) 0 (0.0 ) 9 (16.7 ) 16 (9.6 )
Materials Provided
Educati n materials (workbook,
DVD, website) ( 0.0%) 34 ( 2.9%) 3 (60.0%) 38 (61.3%) 1 (50.0%) 37 (68.5 1 4 (68.7%)
Activity tracker (accelerometer,
pedometer) 0 ( . ) 4 (58.5%) ( 0.0%) 0 (3 .3%) 1 (50.0%) 1 (22.2 ) 58 (34.9%)
Resistance training materials (e.g.,
therabands) 1 (50.0%) 11 (26.8%) 1 (20.0%) 6 (9.7%) 1 (50.0%) 7 (13.0%) 27 (16.3%)
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Table 1. Cont.
n (%)/Mean± Standard
Deviation African (n = 2) Americas (n = 41) EMR (n = 5) Europe (n = 62) SEAR (n = 2)
Western Pacific
(n = 54)
Global (n = 166;
15.3% Total)
Level of Risk Accepted
High 0 (0.0%) 12 (29.3%) 1 (20.0%) 18 (29.0%) 1 (50.0%) 8 (14.8%) 40 (24.1%)
Moderate 1 (50.0%) 27 (65.9%) 4 (80.0%) 42 (67.7%) 2 (100.0%) 23 (42.6%) 99 (59.6%)
Low 1 (50.0%) 36 (87.8%) 4 (80.0%) 48 (77.4%) 2 (100.0%) 30 (55.6%) 121 (72.9%)
Do not risk stratify 1 (50.0%) 2 (4.9%) 0 (0.0%) 1 (1.6%) 0 (0.0%) 10 (18.5%) 13 (7.8%)
Barriers to Communication with pts (% yes)
Lack of pt access (e.g., no
computer) - 13 (31.7%) 5 (100.0%) 12 (19.4%) 1 (50.0%) 13 (24.1%) 44 (26.5%)
Logistical problems (e.g., internet
connection) - 16 (39.0%) 3 (60.0%) 7 (11.3%) 1 (50.0%) 11 (20.4%) 38 (22.9%)
Difficulty for staff - 4 (9.8%) 2 (40.0%) 5 (8.7%) 0 (0.0%) 8 (14.8%) 19 (11.4%)
a formal contact with cardiac rehabilitation staff. § Respondents responding ‘yes’ perceived their program to have sufficient capacity to meet need/demand in the home-base model
reported in this row; respondents responding ‘no’ were asked to specify why they do not have sufficient capacity. These are shown in the subsequent three rows (italics). || Total number of
providers on staff reported elsewhere [30];
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n (%)/  
Mean ± Standard Deviation 
African  
(n = 2) 
Americas  
(n = 41) 
EMR  
(n = 5) 
Europe  
(n = 62) 
SEAR  
(n = 2) 
Western Pacific  
(n = 54) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 2014 1979 2010 1986 2005 1980 1979 
% pts served 
20.0 ± 0.0  
x ̃ = 20.0  
Q25–Q75 = 20.0–20.0 
18.7 ± 18.3  
x ̃ = 10.0  
Q25–Q75 = 5.0–34.8 
12.5 ± 15.7  
x ̃ = 7.5  
Q25–Q75 = 2.5–25.0 
12.9 ± 11.8  
x ̃ = 10.0  
Q25–Q75 = 5.0–25.0 
55.0 ± 35.4  
x ̃ = 55.0  
Q25–Q75 = 30.0–55.0 
35.6 ± 30.8  
x ̃ = 22.5  
Q25–Q75 = 10.0–60.0 
21.4 ± 22.8 
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (50.0%) 19 (46.3%) 3 (60.0%) 36 (58.1%) 1 (50.0%) 28 (51.9%) 88 (53.0%) 
Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 15 (24.3%) 1 (50.0%) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (40.0%) 13 (21.0%) 1 (50.0%) 8 (14.8%) 31 (18.7%) 
Pts too high-risk 0 (0.0%) 2 (4.9%) 1 (20.0%) 0 (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8.0 ± 0.0  
x ̃ = 8.0  
Q25–Q75 = 8.0–8.0 
3.2 ± 2.7  
x ̃ = 3.0  
Q25–Q75 = 1.0–4.0 
6.2 ± 4.6  
x ̃ = 5.0  
Q25–Q75 = 2.0–11.0 
4.9 ± 7.1  
x ̃ = 3.0  
Q25–Q75 = 2.0–4.0 
6.5 ± 7.8  
x ̃ = 6.5  
Q25–Q75 = 1.0–6.5 
3.9 ± 4.2  
x ̃ = 2.0  
Q25–Q75 = 1.0–4.0 
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4.0–4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = 3.0–6.5 
2.5 ± 0.8 
x ̃ = 3.0  
Q25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (100.0%) 32 (72.0%) 0 (0.0%) 44 (72.1%) 2 (100.0%) 21 (38.9%) 101 (60.8%) 
Nurse 0 (0.0%) 12 (29.3%) 3 (60.0%) 31 (50.0%) 0 (0.0%) 32 (59.3%) 78 (47.0%) 
Physician 0 (0.0%) 10 (24.4%) 5 (100.0%) 14 (22.6%) 0 (0.0%) 14 (25.9%) 43 (25.9%) 
Basis for Offering 
Patient choice 0 (0.0%) 36 (87.8%) 3 (60.0%) 45 (72.6%) 2 (100.0%) 35 (64.8%) 121 (72.9%) 
Transportation barriers 1 (50.0%) 34 (82.9%) 5 (100.0%) 39 (62.9%) 2 (100.0%) 29 (53.7%) 110 (66.3%) 
Distance 1 (50.0%) 35 (85.4%) 5 (100.0%) 33 (53.2%) 2 (100.0%) 32 (59.3%) 108 (65.1%) 
Time or work constraints 0 (0.0%) 29 (70.7%) 2 (40.0%) 26 (41.9%) 2 (100.0%) 25 (46.3%) 84 (50.6%) 
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 25 (40.3%) 1 (50.0%) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0%) 20 (48.8%) 1 (20.0%) 22 (35.5%) 1 (50.0%) 23 (42.6%) 67 (40.4%) 
Cost 1 (50.0%) 9 (22.0%) 3 (60.0%) 6 (9.7%) 2 (100.0%) 17 (31.5%) 38 (22.9%) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 (100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 22 (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0%) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 (0.0%) 1 (20.0%) 6 (9.7%) 0 (0.0%) 9 (16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 38 (61.3%) 1 (50.0%) 37 (68.5%) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0%) 12 (22.2%) 58 (34.9%) 
median; - no response; Abbreviations: pts = patients; Acronyms: SEAR = South-East Asia region; EMR = Eastern Mediterranean region.
Table 2. Characteristics of Community-Based Programs by World Health Organization Region.
n (%)/Mean± Standard Deviation African (n = 1) Americas (n = 21) EMR (n = 1) European (n = 54) SEAR (n = 1) Western Pacific(n = 31)
Global (n = 109;
10.1% of Total)
Year the 1st program opened - 1982 2012 1979 - 1968 1968
% pts served -
28.5 ± 27.0
J. Clin. Med. 2018, 7, x FOR PEER REVIEW  5 of 13 
 
Table 1. Characteristics of Home-Based Programs by World Health Organization Region. 
n (%)/  
Mean ± Standard Deviation 
African  
(n = 2) 
Americas  
(n = 41) 
EMR  
(n = 5) 
Europe  
(n = 62) 
SEAR  
(n = 2) 
Western Pacific  
(n = 54) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 2014 1979 2010 1986 2005 1980 1979 
% pts served 
20.0 ± 0.0  
x ̃ = 20.0  
Q25–Q75 = 20.0–20.0 
18.7 ± 18.3  
x ̃ = 10.0  
Q25–Q75 = 5.0–34.8 
12.5 ± 15.7  
x ̃ = 7.5 
Q25–Q75 = 2.5–25.0 
12.9 ± 11.8  
x ̃ = 10.0  
Q25–Q75 = 5.0–25.0 
55.0 ± 35.4  
x ̃ = 55.0  
Q25–Q75 = 30.0–55.0 
35.6 ± 30.8  
x ̃ = 22.5  
Q25–Q75 = 10.0–60.0 
21.4 ± 22.8 
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (50.0%) 19 (46.3%) 3 (60.0%) 36 (58.1%) 1 (50.0%) 28 (51.9%) 88 (53.0%) 
Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 15 (24.3%) 1 (50.0%) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (40.0%) 13 (21.0%) 1 (50.0%) 8 (14.8%) 31 (18.7%) 
Pts too high-risk 0 (0.0%) 2 (4.9%) 1 (20.0%) 0 (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8.0 ± 0.0  
x ̃ = 8.0  
Q25–Q75 = 8.0–8.0 
3.2 ± 2.7  
x ̃ = 3.0  
Q25–Q75 = 1.0–4.0 
6.2 ± 4.6  
x ̃ = 5.0  
Q25–Q75 = 2.0–11.0 
4.9 ± 7.1  
x ̃ = 3.0  
Q25–Q75 = 2.0–4.0 
6.5 ± 7.8  
x ̃ = 6.5  
Q25–Q75 = 1.0–6.5 
3.9 ± 4.2  
x ̃ = 2.0  
Q25–Q75 = 1.0–4.0 
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4.0–4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = 3.0–6.5 
2.5 ± 0.8 
x ̃ = 3.0  
Q25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (100.0%) 32 (72.0%) 0 (0.0%) 44 (72.1%) 2 (100.0%) 21 (38.9%) 101 (60.8%) 
Nurse 0 (0.0%) 12 (29.3%) 3 (60.0%) 31 (50.0%) 0 (0.0%) 32 (59.3%) 78 (47.0%) 
Physician 0 (0.0%) 10 (24.4%) 5 (100.0%) 14 (22.6%) 0 (0.0%) 14 (25.9%) 43 (25.9%) 
Basis for Offering 
Patient choice 0 (0.0%) 36 (87.8%) 3 (60.0%) 45 (72.6 ) 2 (100.0%) 35 (64.8%) 121 (72.9%) 
Transportation barriers 1 (50.0%) 34 (82.9%) 5 (100.0%) 39 (62.9%) 2 (100.0%) 29 (53.7%) 110 (66.3%) 
Distance 1 (50.0%) 35 (85.4%) 5 (100.0%) 33 (53.2%) 2 (100.0%) 32 (59.3%) 108 (65.1%) 
Time or work constraints 0 (0.0%) 29 (70.7%) 2 (40.0%) 26 (41.9%) 2 (100.0%) 25 (46.3%) 84 (50.6%) 
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 25 (40.3 ) 1 (50.0%) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0%) 20 (48.8%) 1 (20.0%) 22 (35.5%) 1 (50.0%) 23 (42.6%) 67 (40.4%) 
Cost 1 (50.0%) 9 (22.0%) 3 (60.0%) 6 (9.7%) 2 (100.0%) 17 (31.5%) 38 (22.9%) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 (100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 22 (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0%) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 (0.0%) 1 (20.0%) 6 (9.7%) 0 (0.0%) 9 (16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 38 (61.3 ) 1 (50.0%) 37 (68.5%) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0%) 12 (22.2%) 58 (34.9%) 
= 20.0
5.0–42.5
10.0 ± 0.0
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Table 1. Ch racteristics of Home-Based Programs by W rld Health Organization Region. 
n (%)/  
Mean ± Standard Deviation 
African  
(n = 2) 
Americas  
(n = 41) 
EMR  
(n = 5) 
urope  
(n = 62) 
SEAR  
(n = 2) 
Western Pacific  
(n = 54) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 2014 979 2010 1986 20 5 1980 1979 
% pts served 
20.0 ± 0.0  
x ̃ = 20.0  
Q25–Q75 = 20.0–20.0 
18.7 ± 18.3  
x ̃ = 1 .0  
Q25–Q75 = 5.0–34.8 
12.5 ± 15.7  
x ̃ 7.5  
Q25–Q75 = 2.5–25.0 
12.9 ± 11.8  
x ̃ = 10.0  
Q25–Q75 = 5.0–25.0 
5.0 ± 35.4  
x ̃ = 55.0  
Q25–Q75 = 30.0–55.0 
35.6 ± 30.8  
x ̃ = 22.5  
25– 75 = 1 .0–6 .0 
21.4 ± 22.8 
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (50.0%) 19 (46.3%) 3 (60.0%) 36 (58.1%) 1 (50.0 ) 28 (51.9%) 88 (53.0%) 
Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 1  (24.3%) 1 (50.0 ) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (4 .0%) 13 (21.0%) 1 (50.0%) 8 (14.8 ) 31 (18.7%) 
Pts too high-risk 0 (0.0%)  (4.9%) 1 (20.0%)  (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8.0 ± 0.0  
x ̃ = 8.0  
Q25–Q75 = 8.0–8.0 
3.2 ± 2.7  
x ̃ = 3.0  
Q25–Q75 = 1.0–4.0 
6.2 ± 4.6  
x ̃ = 5.0  
Q25–Q75 = 2.0–11.0 
4.9 ± 7.1  
x ̃ = 3   
Q25–Q75 = 2.0–4.0 
6.5 ± 7.8  
x ̃ = 6.5  
Q25–Q75 = 1.0–6.5 
3.9 ± 4.2  
x ̃ = 2.0  
Q25–Q75 = 1.0–4.0 
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4.0–4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = 3.0–6.5 
2.5 ± 0.8 
x ̃ = 3.0  
Q25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (100.0%) 32 (72.0%) 0 (0.0%) 44 (72.1%) 2 100.0%) 21 (38.9 ) 101 (60.8%) 
Nurse 0 (0.0%) 12 (29.3%) 3 (6 .0%) 31 (50.0%) 0 (0 0 32 (59.3%) 78 (47.0%) 
Physician 0 (0.0%)  (24.4%) 5 (100.0%) 14 (22.6%) 0 (0 0 14 (25.9%) 43 (25.9%) 
Basis for Offering 
Patient choice 0 (0.0%) 3  (87.8%) 3 (60.0%) 45 (72.6%) 2 100.0%) 35 (64.8 ) 121 (72.9%) 
Transportation barriers 1 (50.0%) 34 (82.9%) 5 (100.0%) 39 (62.9%) 2 100.0%) 29 (53.7 ) 110 (66.3%) 
Distance 1 (50.0%) 35 (85.4%) 5 (100.0%) 33 (53.2%) 100.0%) 32 (59.3 ) 108 (65.1%) 
Time or work constraints 0 (0.0%) 29 (70.7%) 2 (40.0%) 26 (41.9%) 2 100.0%) 25 (46.3%) 84 (50.6%) 
Risk stratification 0 (0.0%) 24 (58.5%) 1 (2 .0%) 2  (40.3%) 1 (50.0 ) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0%) 20 (48.8%) 1 (20.0%) 22 (35.5%) 1 (50.0 ) 23 (42.6%) 67 (40.4%) 
Cost 1 (50.0%) 9 (22.0%) 3 (60.0%) 6 (9.7%) 2 100.0%) 17 (31.5%) 38 (22.9%) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 2  (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0 ) 14 (25.9%) 65 (39.2%) 
Telemetry  (0.0%) 0 ( .0%) 1 (20.0%) 6 (9.7%) 0 (0.0 ) 9 16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 38 (61.3%) 1 (50.0 ) 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0 ) 12 (22.2%) 58 (34.9%) 
= 10.0
.0–10.0
43.7 ± 30.6
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Table 1. Ch ract ristics of Home-Bas d Programs by W rld Health Organization Region. 
n (%)/  
Mean ± Standard Deviation 
African  
(n = 2) 
Americas  
(n = 41) 
EMR  
(n = 5) 
urope 
(n = 62) 
SEAR  
(n = 2) 
Western Pacific  
(n = 54) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 2014 979 2010 1986 20 5 1980 1979 
% pts served 
20.0 ± 0.0  
x ̃ = 20.0  
Q25–Q75 = 0. –20.0 
18.7 ± 18.3  
x ̃ = 1 .0  
Q25–Q75 = 5.0–34.8 
12.  ± 15.7  
x ̃ = 7.5 
2 –Q75 = 2. –25.0 
12.9 ± 11.8  
x ̃ = 10.0  
Q25–Q75 = 5.0–25.0 
5.0 ± 35.4  
x ̃ = 55.0  
Q25–Q75 = 30.0–55.0 
35.6 ± 30.8  
x ̃ = 22.5  
25– 75 = 1 .0–6 .0 
21.4 ± 22.8 
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (50.0%) 19 (46.3%) 3 (60.0%) 36 (58.1%) 1 (5 .0 ) 28 (51.9%) 88 (53.0%) 
Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 1  (24.3%) 1 (50.0 ) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (4 .0%) 3 (21.0%) 1 (50.0%) 8 (14.8 ) 31 (18.7%) 
Pts too high-risk 0 (0.0%)  (4.9%) 1 (20.0%)  (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8.0 ± 0.0  
x ̃ = 8.0  
25–Q75 = 8. –8.0 
3.2 ± 2.7  
x ̃ = 3.0  
Q25–Q75 = 1. –4.0 
6.  ± 4.6  
x ̃ = 5.0  
Q25–Q75 = 2.0–11.0 
4.9 ± 7.1  
x ̃ = 3   
Q25–Q75 = 2.0 4.0 
6.5 ± 7.8  
x ̃ = 6.5  
Q25–Q75 = 1.0–6.5 
3.9 ± 4.2  
x ̃ = 2.0  
Q25–Q75 = 1.0–4.0 
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4. –4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = . –6.5 
2.5 ± 0.8 
x ̃ = 3.0  
Q25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (100.0%) 32 (72.0%) 0 (0.0%) 44 (72.1%) 2 100.0%) 21 (38.9 ) 101 (60.8%) 
Nurse 0 (0.0%) 12 (29.3%) 3 (6 .0%) 31 (50.0%) 0 (0 0 32 (59.3%) 78 (47.0%) 
Physician 0 (0.0%)  (24.4%) 5 (100.0%) 14 (22.6%) 0 (0 0 14 (25.9%) 43 (25.9%) 
Basis for Offering 
Patient choice 0 (0.0%) 3  (87.8%) 3 (60.0%) 45 (72.6%) 2 100.0%) 35 (64.8 ) 121 (72.9%) 
Transportation barriers 1 (50.0%) 34 (82.9%) 5 (100.0%) 39 (62.9%) 2 100.0%) 29 (53.7 ) 110 (66.3%) 
Distance 1 (50.0%) 35 (85.4%) 5 (100.0%) 33 (53.2%) 100.0%) 32 (59.3 ) 108 (65.1%) 
Time or work constraints 0 (0.0%) 29 (70.7%) 2 (40.0%) 26 (41.9%) 2 100.0%) 25 (46.3%) 84 (50.6%) 
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 2  (40.3%) 1 (50.0 ) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0%) 20 (48.8%) 1 (20.0%) 22 (35.5%) 1 (50.0 ) 23 (42.6%) 67 (40.4%) 
Cost 1 (50.0%) 9 (22.0%) 3 (60.0%) 6 (9.7%) 2 100.0%) 17 (31.5%) 38 (22.9%) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 2  (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0 ) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%)  ( .0%) 1 (20.0%)  (9.7%) 0 (0.0 ) 9 16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 38 (61.3%) 1 (50.0%) 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0 ) 12 (22.2%) 58 (34.9%) 
= 40.0
2 . –69.0
50.0 ± 0.0
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Table 1. Ch ract ristics of Home-Bas d Programs by W rld Health Organization Region. 
n (%)/  
Mean ± Standard Deviation 
African  
(n = 2) 
Americas  
(n = 41) 
EMR
(n = 5) 
urope 
(n = 62) 
SEAR  
(n = 2) 
Western Pacific  
(n = 54) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 2014 979 2010 1986 20 5 1980 1979 
% pts served 
20.0 ± 0.0  
x ̃ = 20.0  
Q25–Q75 = . –20.0 
18 7 ± 18.3  
x ̃ = 10.0  
Q25–Q75 = 5.0–34.8 
12.  ± 15.7  
x ̃ = 7.   
2 –Q75 = 2. –25.0 
12.9 ± 11.8  
x ̃ = 10.0  
Q25–Q75 = 5.0–25.0 
5.0 ± 35.4  
x ̃ = 55.0  
Q25–Q75 = 30.0–55.0 
35.6 ± 30.8  
x ̃ = 22.5  
25– 75 = 1 .0–6 .0 
21.4 ± 22.8 
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (50.0%) 19 (46.3%) 3 (60.0%) 36 (58.1%) 1 (5 .0 ) 28 (51.9%) 88 (53.0%) 
Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 1  (24.3%) 1 (50.0 ) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (4 .0%) 3 (21.0%) 1 (50.0%) 8 (14.8 ) 31 (18.7%) 
Pts too high-risk 0 (0.0%)  (4.9%) 1 (20.0%)  (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8.0 ± 0.0  
x ̃ = 8.0  
25–Q75 = 8. –8.0 
3.2 ± 2.7  
x ̃ = 3.0  
Q25–Q75 = 1 –4.0 
6.  ± 4.6  
x ̃ = 5.0  
25–Q75 = 2.0–11.0 
4.9 ± 7.1  
x ̃ = 3   
Q25–Q75 = 2. 4.0 
6.5 ± 7.8  
x ̃ = 6.5  
Q25–Q75 = 1.0–6.5 
3.9 ± 4.2  
x ̃ = 2.0  
Q25–Q75 = 1.0–4.0 
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4. –4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = . –6.5 
2.5 ± 0.8 
x ̃ = 3.0  
2 –Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2. –3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (100.0%) 32 (72.0%) 0 (0.0%) 44 (72.1%) 2 100.0%) 21 (38.9 ) 101 (60.8%) 
Nurse 0 (0.0%) 12 (29.3%) 3 (6 .0%) 31 (50.0%) 0 (0 0 32 (59.3%) 78 (47.0%) 
Physician 0 (0.0%)  (24.4%) 5 (100.0%) 14 (22.6%) 0 (0 0 14 (25.9%) 43 (25.9%) 
Basis for Offering 
Patient choice 0 (0.0%) 3  (87.8%) 3 (60.0%) 45 (72.6%) 2 100.0%) 35 (64.8 ) 121 (72.9%) 
Transportation barriers 1 (50.0%) 34 (82.9%) 5 (100.0%) 39 (62.9%) 2 100.0%) 29 (53.7 ) 110 (66.3%) 
Distance 1 (50.0%) 35 (85.4%) 5 (100.0%) 33 (53.2%) 100.0%) 32 (59.3 ) 108 (65.1%) 
Time or work constraints 0 (0.0%) 29 (70.7%) 2 (40.0%) 26 (41.9%) 2 100.0%) 25 (46.3%) 84 (50.6%) 
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 2  (40.3%) 1 (50.0 ) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0%) 20 (48.8%) 1 (20.0%) 22 (35.5%) 1 (50.0 ) 23 (42.6%) 67 (40.4%) 
Cost 1 (50.0%) 9 (22.0%) 3 (60.0%) 6 (9.7%) 2 100.0%) 17 (31.5%) 38 (22.9%) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 2  (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0 ) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 ( .0%) 1 (20.0%)  (9.7%) 0 (0.0 ) 9 16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 3  (61.3%) 1 (50.0%) 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0 ) 12 (22.2%) 58 (34.9%) 
= 50.0
5 . – 0.0
8.5 ± 38.6
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Table 1. Ch ract ristics of Home-Bas d Programs by W rld Health Organization Region. 
n (%)/  
Mean ± Standard Deviation 
African  
(n = 2) 
Americas  
(n = 41) 
EMR
(n = 5) 
urope 
(n = 62) 
SEAR  
(n = 2) 
Western Pacific  
(n = 54) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 2014 979 2010 1986 20 5 1980 1979 
% pts served 
20.0 ± 0.0  
x ̃ = 20.0  
Q25–Q7 = . –20.0 
18 7 ± 18.3  
x ̃ = 10.0  
Q25–Q75 = 5.0–34.8 
1 ± 15.7  
x ̃ = 7.5  
2 –Q75 = 2. –25.0 
12.9 ± 11.8  
x ̃ = 10.0  
Q25–Q75 = 5.0–25.0 
5.0 ± 35.4  
x ̃ = 55.0  
Q25–Q75 = 30.0–55.0 
35.6 ± 30.8  
x ̃ = 22.5  
25– 75 = 1 .0–6 .0 
21.4 ± 22.8 
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (50.0%) 19 (46.3%) 3 (60.0%) 36 (58.1%) 1 (5 .0 ) 28 (51.9%) 88 (53.0%) 
Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 1  (24.3%) 1 (50.0 ) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (4 .0%) 3 (21.0%) 1 (50.0%) 8 (14.8 ) 31 (18.7%) 
Pts too high-risk 0 (0.0%)  (4.9%) 1 (20.0%)  (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8.  ± 0.0  
x ̃ = 8.0  
25–Q75 = 8. –8.0 
3.2 ± 2.7  
x ̃ = 3.0  
Q25–Q75 = 1. – .0 
6.  ± 4.6  
x ̃ = 5.0  
25–Q75 = 2.0–11.0 
4.9 ± 7.1  
x ̃ = 3   
Q25–Q75 = 2. 4.0 
6.5 ± 7.8  
x ̃ = 6.5  
Q25–Q75 = 1.0–6.5 
3.9 ± 4.2  
x ̃ = 2.0  
Q25–Q75 = 1.0–4.0 
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4. –4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = . –6.5 
2.5 ± 0.8 
x ̃ = 3.0  
2 –Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2. –3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (100.0%) 32 (72.0%) 0 (0.0%) 44 (72.1%) 2 100.0%) 21 (38.9 ) 101 (60.8%) 
Nurse 0 (0.0%) 12 (29.3%) 3 (6 .0%) 31 (50.0%) 0 (0 0 32 (59.3%) 78 (47.0%) 
Physician 0 (0.0%)  (24.4%) 5 (100.0%) 14 (22.6%) 0 (0 0 14 (25.9%) 43 (25.9%) 
Basis for Offering 
Patient choice 0 (0.0%) 3  (87.8%) 3 (60.0%) 45 (72.6%) 2 100.0%) 35 (64.8 ) 121 (72.9%) 
Transportation barriers 1 (50.0%) 34 (82.9%) 5 (100.0%) 39 (62.9%) 2 100.0%) 29 (53.7 ) 110 (66.3%) 
Distance 1 (50.0%) 35 (85.4%) 5 (100.0%) 33 (53.2%) 100.0%) 32 (59.3 ) 108 (65.1%) 
Time or work constraints 0 (0.0%) 29 (70.7%) 2 (40.0%) 26 (41.9%) 2 100.0%) 25 (46.3%) 84 (50.6%) 
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 2  (40.3%) 1 (50.0 ) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0%) 20 (48.8%) 1 (20.0%) 22 (35.5%) 1 (50.0 ) 23 (42.6%) 67 (40.4%) 
Cost 1 (50.0%) 9 (22.0%) 3 (60.0%) 6 (9.7%) 2 100.0%) 17 (31.5%) 38 (22.9%) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 2  (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0 ) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 ( .0%) 1 (20.0%)  (9.7%) 0 (0.0 ) 9 16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 3  (61.3%) 1 (50.0%) 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0 ) 12 (22.2%) 58 (34.9%) 
= 20.0
5.0–83.8
38.1 ± 32.3
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Table 1. Characteris ics of Home-Based Programs by World Health Organization Region. 
n (%)/  
Mean ± Sta dard Deviation 
Af n
(n = 2) 
Americas  
(n = 41) 
EMR
(n = 5) 
Europe  
(n = 62) 
SEAR  
(n = 2)
Western Pacific  
(n = 54) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 2014 1979 2010 1986 2005 80 1979 
% pts served 
20.0 ± 0.0  
x ̃ = 20.0  
2 – 75 = 2 .0–20.0 
18.7 ± 18.3  
x ̃ = 10.0  
Q25–Q7  = . –34.8 
1 .5 ± 5.7  
x ̃ = 7.5  
2 –Q75 = 2.5–25.0 
12.9 ± 11.8  
x ̃ = 10.0  
Q25–Q7 = 5. –25.0 
5 0 5 4
̃ 55 0
3 55
35 6 30  
̃ 22 5  
25– 75 = 10.0–60.0 
21.4 ± 22.8 
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (50.0 ) 19 (46.3%) 3 (60.0 ) 36 (58.1%) 1 (50.0 ) 2 1 9 88 (53.0%) 
Not enough staff (0 0 11 (26.9%) 1 (20.0 ) 1  (24.3%) 1 (50.0 ) 14 9 42 (25.3%) 
Not enough funding (0.0 ) 7 (17.1%) 2 (40.0 ) 3 (21.0%) 1 50 0 8 (14.8 ) 31 (18.7%) 
Pts too high-risk  (0.0%) 2 (4.9 ) 1 (2 .0%) 0 (0.0%) 0 0 0 3 6 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8.  ± .0  
x ̃ = 8.0  
2 –Q75 = . –8.0 
3.2 ± 2.7  
x ̃ = 3.0  
2 –Q75 = 1.0–4.0 
6.2 ± 4.6  
x ̃ = 5.0  
2 – 75 = 2. –11.0 
4.9 ± 7.1  
x ̃ = 3.0  
Q25–Q75 = 2 4.0 
6 5 7 8
̃ 6 5
6 5
3 9 4 2  
̃ 2  
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.  ± 0.0  
x ̃ = 4.0  
2 –Q75 = 4.0–4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = 3.0–6.5 
2.5 ± 0.8
x ̃ = 3.0  
2 –Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2 3 1 8  
̃ 1 5  
0 9 3
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
roviders Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
100.0%) 3  (72.0%)  (0 0 44 (72.1%)  (100 0 21 (38.9 ) 101 (60.8%) 
Nurse  (0 0 12 (29.3%) 3 (60.0 ) 31 (50.0%) 0 0 32 59 3 78 (47.0%) 
Physician  (0 0 10 (24.4%) 5 100.0%) 14 (22.6%) 0 0 0 14 43 (25.9%) 
Basis for Offering 
Patient choice  (0 0 36 (87.8%) 3 (60.0 ) 45 (72.6%) 2 (100 0 35 (64.8 ) 121 (72.9%) 
Transportation barriers 1 (50.0 ) 34 (82.9%) 5 100.0%) 39 (62.9%)  (100 0 29 (53.7 ) 110 (66.3%) 
Distance 1 (50.0 ) 5 (85.4%) 100.0%) 33 (53.2%) 2 (100 0 32 (59.3 ) 108 (65.1%) 
Time or work constraints  ( 0 29 (7 .7%) 2 (40.0 ) 26 (41.9%) 1 0 0 25 46 3 84 (50.6%) 
Risk stratification (0 0 24 (58.5%) 1 (20.0 ) 2  (4 .3%) 1 (50.0 ) 25 6 3 76 (45.8%) 
Patient indication (0 0 20 (48.8%) 1 (20.0 ) 22 (35.5%) 1 (50.0 ) 23 2 6 67 (40.4%) 
Cost 1 (50.0%)  (22.0%) 3 (60.0%) 6 (9 7 2 100 0 17 31 5 38 (22.9%) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0 ) 2  (48.8%) 2 (40.0 ) 28 (45.2%) 2 100 0 17 31 5 70 (42.2%) 
Heart rate 1 (50.0 ) 22 (53.7%) 1 (20.0 ) 26 (41.9%) 1 (50.0 ) 14 25 9 65 (39.2%) 
Telemetry  (0.0%) 0 (0.0 ) 1 (20.0%) 6 (9.7%) 0 (0.0 ) 9 (16 7 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0 ) 34 (82.9%) 3 (60.0 ) 38 (61.3%) 1 50 0 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
(0 0 4 (58.5%) 1 (20.0 ) 20 (32.3%) 1 (50.0 ) 12 22 2 58 (34.9%) 
= 27.5
–25– 5 0.0–61.3
Where provided
Public centre - 15 (71.4%) 1 (100.0%) 2 (46.3%) 0 (0. %) 21 (67.7%) 62 (56.9%)
Private centre - 2 (9.5%) 0 (0.0%) 17 (31.5%) 0 (0.0%) 4 (12.9%) 23 (21.1%)
Semi-private centre - 0 (0.0%) 0 (0.0%) 6 (11.1%) 1 (100.0%) 1 (3.2%) 8 (7.3%)
Dose
Sessions pts prescribed/month -
9.1 ± 4.5
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Table 1. Characteristics of Home-Based Programs by World Health Organizatio  Region. 
n (%)/  
Mean ± Standard Deviation 
African  
(n = 2) 
Americas  
(n = 41) 
EMR  
(n = 5) 
Europe  
(n = 62) 
SEAR  
(n = 2) 
Western Pacific  
(n = 54) 
Global  
(n = 166; 15.3% Total) 
Yea 1st program opened 2014 1979 2010 1986 2005 1980 1979 
% pts served 
20.0 ± 0.0  
x ̃ = 20.0  
Q25–Q75 = 20.0–20.0 
18.7 ± 18.3  
x ̃ = 10.0  
Q25–Q75 = 5.0–34.8 
12.5 ± 15.7  
x ̃ = 7.5  
Q25–Q75 = 2.5–25.0 
12.9 ± 11.8  
x ̃ = 10.0  
Q25–Q75 = 5.0–25.0 
55.0 ± 35.4  
x ̃ = 55.0  
Q25–Q75 = 30.0–55.0 
35.6 ± 30.8  
x ̃ = 22.5  
Q25–Q75 = 10.0–60.0 
21.4 ± 22.8 
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (50.0%) 19 (46.3%) 3 (60.0%) 36 (58.1%) 1 (50.0%) 28 (51.9%) 88 (53.0%) 
Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 15 (24.3%) 1 (50.0%) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (40.0%) 13 (21.0%) 1 (50.0%) 8 (14.8%) 31 (18.7%) 
Pts too high-risk 0 (0.0 )  (4.9 ) 1 20.0%) 0 (0. ) 0 (0.0 ) 3 (5.6 ) 6 5.2%) 
Dose 
Number sessions pts prescribed 
p  month a 
8.0 ± 0.0  
x ̃ = 8.0  
Q25–Q75 = 8.0–8.0 
3.2 ± 2.7  
x ̃ = 3.0  
Q25–Q75 = 1.0–4.0 
6.2 ± 4.6  
x ̃ = 5.0  
Q25–Q75 = 2.0–11.0 
4.9 ± 7.1  
x ̃ = 3.0  
Q25–Q75 = 2.0–4.0 
6.5  7.8  
x ̃ = 6.5  
Q25–Q75 = 1.0–6.5 
3.9 ± 4.2  
x ̃ = 2.0  
Q25–Q75 = 1.0–4.0 
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration months  
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4.0–4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = 3.0–6.5 
2.5 ± 0.8 
x ̃ = 3.0  
Q25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (10 .0%) 32 (72.0 ) 0 ( 44 (7 .1 ) 2 1 0.0%) 2 38 9 10 6 8
Nurse 0 (0.0%) 12 (29.3%) 3 (60.0%) 31 (50.0%) 0 (0.0%) 32 (59.3%) 78 (47.0%) 
Physician 0 (0.0%) 10 (24.4%) 5 (100.0%) 14 (22.6%) 0 (0.0%) 14 (25.9%) 43 (25.9%) 
Basis for Offering 
Patient choice 0 (0.0%) 36 (87.8%) 3 (60.0%) 45 (72.6%) 2 (100.0%) 35 (64.8%) 121 (72.9%) 
Transportation barriers 1 (50.0%) 34 (82.9%) 5 (100.0%) 39 (62.9%) 2 (100.0%) 29 (53.7%) 110 (66.3%) 
Distance 1 (50.0%) 35 (85.4%) 5 (100.0%) 33 (53.2%) 2 (100.0%) 32 (59.3%) 108 (65.1%) 
Time or work constraints 0 ( .  29 (70.7%) 2 (40.0%) 26 (41.9%) 2 1 0.0%) 25 46.  8  50.6  
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 25 (40.3%) 1 (50.0%) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0 ) 20 (48.8 ) 1 (20.0 ) 22 (35.5 ) 1 (50.0 ) 23 42.6  67 (4 .4 ) 
Cost 1 (50.0%) 9 (22.0%) 3 (60.0%) 6 (9.7%) 2 (100.0%) 17 (31.5%) 38 (22.9%) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 (100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 22 (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0%) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 (0.0%) 1 (20.0%) 6 (9.7%) 0 (0.0%) 9 (16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 38 (61.3%) 1 (50.0%) 37 (68.5%) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0%) 12 (22.2%) 58 (34.9%) 
= 9.0
Q25– 4.0–12.0
-
9.0 ± 9.1
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Table 1. Charact ristics of Home-Bas d Programs by World Health Organization Region. 
n (%)/  
Mean ± Standard Deviation 
African  
(n = 2) 
Americas  
(n = 41) 
EMR  
(n = 5) 
Europe 
(n = 62) 
SEAR  
(n = 2) 
Western Pacific  
(n = 54) 
Global  
(n = 166; 15.3% Total) 
Yea 1st program opened 2014 1979 2010 1986 2005 1980 1979 
% pts served 
20.0 ± 0.0  
x ̃ = 20.0  
Q25–Q75 = 0. –20.0 
18.7 ± 18.3  
x ̃ = 10.0  
Q25–Q75 = 5.0–34.8 
12.  ± 15.7  
x ̃ = 7.5  
2 –Q75 = 2. –25.0 
12.9 ± 11.8  
x ̃ = 10.0  
Q25–Q75 = 5.0–25.0 
55.0 ± 35.4  
x ̃ = 55.0  
Q25–Q75 = 30.0–55.0 
35.6 ± 30.8  
x ̃ = 22.5  
Q25–Q75 = 10.0–60.0 
21.4 ± 22.8 
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (50.0%) 19 (46.3%) 3 (60.0%) 36 (58.1%) 1 (5 .0%) 28 (51.9%) 88 (53.0%) 
Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 15 (24.3%) 1 (50.0%) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (40.0%) 3 (21.0%) 1 (50.0%) 8 (14.8%) 31 (18.7%) 
Pts too high-risk 0 ( .0 )  (4.9 ) 1 20.0%)  ( . ) 0 (0.0 ) 3 (5.6  6 5.2%) 
Dose 
Number sessions pts prescribed 
p  month a 
8.0 ± 0.0  
x ̃ = 8.0  
25–Q75 = 8. –8.0 
3.2 ± 2.7  
x ̃ = 3.0  
Q25–Q75 = 1. –4.0 
6.2 ± 4.6  
x ̃ = 5.0  
Q25–Q75 = 2.0–11.0 
4.9 ± 7.1  
x ̃ = 3.0  
Q25–Q75 = 2.0–4.0 
6.5  7.8  
x ̃ = 6.5  
Q25–Q75 = 1.0–6.5 
3.9 ± 4.2  
x ̃ = 2.0  
Q25–Q75 = 1.0–4.0 
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4. –4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = . –6.5 
2.5 ± 0.8 
x ̃ = 3.0  
Q25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (10 .0%) 32 (72.0 )  ( 4 (7 .1 ) 2 1 0.0%) 2 38 9 10 6 8
Nurse 0 (0.0%) 12 (29.3%) 3 (60.0%) 31 (50.0%) 0 (0.0%) 32 (59.3%) 78 (47.0%) 
Physician 0 (0.0%) 10 (24.4%) 5 (100.0%) 14 (22.6%) 0 (0.0%) 14 (25.9%) 43 (25.9%) 
Basis for Offering 
Patient choice 0 (0.0%) 36 (87.8%) 3 (60.0%) 45 (72.6%) 2 (100.0%) 35 (64.8%) 121 (72.9%) 
Transportation barriers 1 (50.0%) 34 (82.9%) 5 (100.0%) 39 (62.9%) 2 (100.0%) 29 (53.7%) 110 (66.3%) 
Distance 1 (50.0%) 35 (85.4%) 5 (100.0%) 33 (53.2%) 2 (100.0%) 32 (59.3%) 108 (65.1%) 
Time or work constraints  ( .  29 (70.7%) 2 (40.0%) 26 (41.9%) 2 1 0.0%) 25 46.3  8  50.  
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 25 (40.3%) 1 (50.0%) 25 (46.3%) 76 (45.8%) 
Patient indication  (0.0 )  (48.8 ) 1 (20.0 )  (35.5 ) 1 (50.0%) 23 42.6  67 (40.4 ) 
Cost 1 (50.0%) 9 (22.0%) 3 (60.0%) 6 (9.7%) 2 (100.0%) 17 (31.5%) 38 (22.9%) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 (100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 22 (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0%) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 (0.0%) 1 (20.0%)  (9.7%) 0 (0.0%) 9 (16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 38 (61.3%) 1 (50.0%) 37 (68.5%) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0%) 12 (22.2%) 58 (34.9%) 
= 8.0
Q25– 4.0–10.0
2.0 ± 0.0
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Table 1. Ch racteristics of Home-Based Programs by W rld Health Organization Region. 
n (%)/  
Mean ± Standard Deviation 
African  
(n = 2) 
Americas  
(n = 41) 
EMR
(n = 5) 
urope  
(n = 62) 
SEAR  
(n = 2) 
Western Pacific  
(n = 54) 
Global  
(n = 166; 15.3% Total) 
Yea 1st program opened 2014 979 2010 1986 20 5 1980 1979 
% pts served 
20.0 ± 0.0  
x ̃ = 20.0  
Q25–Q75 = 2 .0–20.0 
18 7 ± 18.3  
x ̃ = 10.0  
Q25–Q75 = 5.0–34.8 
12.5 ± 15.7  
x ̃ = 7.5  
Q25–Q75 = 2.5–25.0 
12.9 ± 11.8  
x ̃ = 10.0  
Q25–Q75 = 5.0–25.0 
5.0 ± 35.4  
x ̃ = 55.0  
Q25–Q75 = 30.0–55.0 
35.6 ± 30.8  
x ̃ = 22.5  
25– 75 = 1 .0–6 .0 
21.4 ± 22.8 
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (50.0%) 19 (46.3%) 3 (60.0%) 36 (58.1%) 1 (50.0 ) 28 (51.9%) 88 (53.0%) 
Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 1  (24.3%) 1 (50.0 ) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (4 .0%) 13 (21.0%) 1 (50.0%) 8 (14.8 ) 31 (18.7%) 
Pts too high-risk 0 ( .0 )  (4.9 ) 1 20. %)  ( . ) 0 (0.0 ) 3 (5.6  6 5.2%) 
Dose 
Number sessions pts prescribed 
p  month a 
8.0 ± 0.0  
x ̃ = 8.0  
Q25–Q75 = 8.0–8.0 
3.2 ± 2.7  
x ̃ = 3.0  
Q25–Q75 = 1.0–4.0 
6.  ± 4.6  
x ̃ = 5.0  
25–Q75 = 2.0–11.0 
4.9 ± 7.1  
x ̃ = 3.0  
Q25–Q75 = 2. –4  
6.5  7.8  
x ̃ = 6.5  
Q25–Q75 = 1.0–6.5 
3.9 ± 4.2  
x ̃ = 2.0  
Q25–Q75 = 1.0–4.0 
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4.0–4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = 3.0–6.5 
2.5 ± 0.8 
x ̃ = 3.0  
2 –Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2. –3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (10 .0%) 32 (72.0 )  ( 4 (7 .1 ) 2 1 0. %) 2 38 9 101 60 8
Nurse 0 (0.0%) 12 (29.3%) 3 (6 .0%) 31 (50.0%) 0 (0 0 32 (59.3%) 78 (47.0%) 
Physician 0 (0.0%)  (24.4%) 5 (100.0%) 14 (22.6%) 0 (0 0 14 (25.9%) 43 (25.9%) 
Basis for Offering 
Patient choice 0 (0.0%) 3  (87.8%) 3 (60.0%) 45 (72.6%) 2 100.0%) 35 (64.8 ) 121 (72.9%) 
Transportation barriers 1 (50.0%) 34 (82.9%) 5 (100.0%) 39 (62.9%) 2 100.0%) 29 (53.7 ) 110 (66.3%) 
Distance 1 (50.0%) 35 (85.4%) 5 (100.0%) 33 (53.2%) 100.0%) 32 (59.3 ) 108 (65.1%) 
Time or work constraints  ( .  29 (70.7%) 2 (40.0%) 26 ( 1.9%) 2 1 0. %) 25 46.3  8  .6  
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 2  (40.3%) 1 (50.0 ) 25 (46.3%) 76 (45.8%) 
Patient indication  (0.0 )  (48.8 ) 1 (20.0 )  (35. ) 1 (50.0%) 23 42.6  67 4 .4  
Cost 1 (50.0%) 9 (22.0%) 3 (60.0%) 6 (9.7%) 2 100.0%) 17 (31.5%) 38 (22.9%) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 2  (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0 ) 14 (25.9%) 65 (39.2%) 
Telemetry  (0.0%) 0 ( .0%) 1 (20.0%) 6 (9.7%) 0 (0.0 ) 9 16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 3  (61.3%) 1 (50.0 ) 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0 ) 12 (22.2%) 58 (34.9%) 
= 2.0
2.0–2.0
6.6 ± 5.3
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Table 1. Ch ract ristics of Home-Bas d Programs by W rld Health Organiza io  Region. 
n (%)/  
Mean ± Standard Deviation 
African  
(n = 2) 
Americas  
(n = 41) 
EMR  
(n = 5) 
urope 
(n = 62) 
SEAR  
(n = 2) 
Western Pacific  
(n = 54) 
Global  
(n = 166; 15.3% Total) 
Yea 1st program opened 2014 979 2010 1986 20 5 1980 1979 
% pts served 
20.0 ± 0.0  
x ̃ = 20.0  
Q25–Q7 = 0. –20.0 
18.7 ± 18.3  
x ̃ = 10.0  
Q25–Q75 = 5.0–34.8 
1 ± 15.7  
x ̃ = 7.5  
2 –Q75 = 2. –25.0 
12.9 ± 11.8  
x ̃ = 10.0  
Q25–Q75 = 5.0–25.0 
5.0 ± 35.4  
x ̃ = 55.0  
Q25–Q75 = 30.0–55.0 
35.6 ± 30.8  
x ̃ = 22.5  
25– 75 = 1 .0–6 .0 
21.4 ± 22.8 
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (50.0%) 19 (46.3%) 3 (60.0%) 36 (58.1%) 1 (5 .0 ) 28 (51.9%) 88 (53.0%) 
Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 1  (24.3%) 1 (50.0 ) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (4 .0%) 3 (21.0%) 1 (50.0%) 8 (14.8 ) 31 (18.7%) 
Pts too high-risk 0 ( .0 )  (4.9 ) 1 20.0%)  ( .0 ) 0 (0.0 ) 3 (5.6  6 5.2%) 
Dose 
Number sessions pts prescribed 
p  month a 
8.0 ± 0.0  
x ̃ = 8.0  
25–Q75 = 8. –8.0 
3.2 ± 2.7  
x ̃ = 3.0  
Q25–Q75 = 1. –4.0 
6.2 ± 4.6  
x ̃ = 5.0  
Q25–Q75 = 2.0–11.0 
4.9 ± 7.1  
x ̃ = 3.0  
Q25–Q75 = 2.0–4.0 
.5  7.8  
x ̃ = 6.5  
Q25–Q75 = 1.0–6.5 
3.9 ± 4.2  
x ̃ = 2.0  
Q25–Q75 = 1.0–4.0 
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4. –4.0 
5.8 ± 3.9  
x ̃ = 4.0 
Q25–Q75 = . –6.5 
2.5 ± 0.8 
x ̃ = 3.0  
Q25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (10 .0%) 32 (72.0 )  ( 4 72 1 2 1 0.0 ) 21 (38.9 ) 101 (60.8%) 
Nurse 0 (0.0 ) 12 (29.3%) 3 (6 .0%) 31 (50.0%) 0 (0 0 32 (59.3%) 78 (47.0%) 
Physician 0 (0.0%)  (24.4%) 5 (100.0%) 14 (22.6%) 0 (0 0 14 (25.9%) 43 (25.9%) 
Basis for Offering 
Patient choice 0 (0.0%) 3  (87.8%) 3 (60.0%) 45 (72.6%) 2 100.0%) 35 (64.8 ) 121 (72.9%) 
Transportation barriers 1 (50.0%) 34 (82.9%) 5 (100.0%) 39 (62.9%) 2 100.0%) 29 (53.7 ) 110 (66.3%) 
Distance 1 (50.0%) 35 (85.4%) 5 (100.0%) 33 (53.2%) 100.0%) 32 (59.3 ) 108 (65.1%) 
Time or work constraints  ( .  29 7 .7%  2 (40.0%) 26 41.9%  2 1 0.0 ) 25 (46.3%) 8  50.6  
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 2  (40.3%) 1 (50.0 ) 25 (46.3%) 76 (45.8%) 
Patient indication  (0.0 )  (48.8 ) 1 (20.0 )  35.5  1 (50.0%) 23 (42.6 ) 67 (40.4 ) 
Cost 1 (50.0%) 9 (22.0%) 3 (60.0%) 6 (9.7%) 2 100.0%) 17 (31.5%) 38 (22.9%) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 2  (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0 ) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 ( .0%) 1 (20.0%)  (9.7%) 0 (0.0 ) 9 16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 38 (61.3%) 1 (50.0%) 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0 ) 12 (22.2%) 58 (34.9%) 
= 5.0
2.0–11.0
8.3 7.3
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Table 1. Characteris ics of Home-Based Programs by Wo ld Health Organization Region. 
n (%)/  
Mean ± Sta dard Deviation 
Af n
(n = 2) 
Americas  
(n = 41) 
EMR
(n = 5) 
Europe  
(n = 62) 
SEAR  
(n = 2)
Western Pacific  
(n = 54) 
Global  
(n = 166; 15.3% Total) 
Yea 1st program opened 2014 1979 2010 1986 2005 80 1979 
% pts served 
20.0 ± 0.0  
x ̃ = 20.0  
2 – 75 = 2 .0–20.0 
18.7 ± 18.3  
x ̃ = 10.0  
Q25–Q7  = . –34.8 
12.5 ± 5.7  
x ̃ = 7.5  
2 –Q75 = 2.5–25.0 
12.9 ± 11.8  
x ̃ = 10.0  
Q25–Q7 = 5. –25.0 
5 0 5 4
̃ 55 0
3 55
35 6 30  
̃ 22 5  
25– 75 = 10.0–60.0 
21.4 ± 22.8 
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (50.0 ) 19 (46.3%) 3 (60.0 ) 36 (58.1%) 1 (50.0 ) 2 1 9 88 (53.0%) 
Not enough staff  (0 0 11 (26.9%) 1 (20.0 ) 1  (24.3%) 1 (50.0 ) 14 9 42 (25.3%) 
Not enough funding  (0.0 ) 7 (17.1%) 2 (40.0 ) 3 (21.0%) 1 50 0 8 (14.8 ) 31 (18.7%) 
Pts too high-risk  (0.0 )  (4.9 ) 1 .0%)  (0.0 ) 0 0 3 6 6 5.2%) 
Dose 
Number sessions pts prescribed 
p  month a 
8.0 ± 0.0  
x ̃ = 8.0  
2 –Q75 = 8.0–8.0 
3.2 ± 2.7  
x ̃ = 3.0  
2 –Q75 = 1.0–4.0 
6.2 ± 4.6  
x ̃ = 5.0  
25– 75 = 2. –11.0 
4.9 ± 7.1  
x ̃ = 3  
Q25–Q75 = 2.0–4.0 
6 5 7 8
̃ 6 5
6 5
3 9 4 2  
̃ 2  
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.  ± 0.0  
x ̃ = 4.0  
2 –Q75 = 4.0–4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = 3.0–6.5 
2.5 ± 0.8
x ̃ = 3.0  
Q25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2 3 1 8  
̃ 1 5  
0 9 3
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
roviders Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
10 .0%)  (72.0 )  ( %  (72.1 ) 1 0 0% 21 (38.9 ) 101 (60.8%) 
Nurse  (0 0 12 (29.3%) 3 (60.0 ) 31 (50.0%) 0 0 32 59 3 78 (47.0%) 
Physician  (0 0 10 (24.4%) 5 100.0%) 14 (22.6%) 0 0 0 14 43 (25.9%) 
Basis for Offering 
Patient choice  (0 0 36 (87.8%) 3 (60.0 ) 45 (72.6%) 2 (100 0 35 (64.8 ) 121 (72.9%) 
Transportation barriers 1 (50.0 ) 34 (82.9%) 5 100.0%) 39 (62.9%)  (100 0 29 (53.7 ) 110 (66.3%) 
Distance 1 (50.0 ) 35 (85.4%) 5 100.0%) 33 (53.2%) 2 (100 0 32 (59.3 ) 108 (65.1%) 
Time or work constraints  ( 29 (7 .7%) 2 (40.0 ) 2  (41.9%) 1 0 0 25 46 3 8  50.6  
Risk stratification  (0 0 24 (58.5%) 1 (20.0 ) 2  (4 .3%) 1 (50.0 ) 25 6 3 76 (45.8%) 
Patient indication  (0 0 20 (48.8 ) 1 ( 0.0%) 2  (35.5 ) 1 50.0  23 2 6% 67 (40.4 ) 
Cost 1 (50.0%)  (22.0%) 3 (60.0%) 6 (9 7 2 100 0 17 31 5 38 (22.9%) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0 ) 2  (48.8%) 2 (40.0 ) 28 (45.2%) 2 100 0 17 31 5 70 (42.2%) 
Heart rate 1 (50.0 ) 22 (53.7%) 1 (20.0 ) 26 (41.9%) 1 (50.0 ) 14 25 9 65 (39.2%) 
Telemetry  (0.0%) 0 (0.0 ) 1 (20.0%) 6 (9.7%) 0 (0.0 ) 9 (16 7 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0 ) 34 (82.9%) 3 (60.0 ) 38 (61.3%) 1 50 0 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
 (0 0 24 (58.5%) 1 (20.0 ) 20 (32.3%) 1 (50.0 ) 12 22 2 58 (34.9%) 
= 8.0
– 4.0–12.0
Duration (months) -
5.5 ± 1 5
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Table 1. Characteristics of Home-Based Programs by World Health Organization Region. 
n (%)/  
Mean ± Standard Deviation 
Afric n  
(n = 2) 
A ericas  
(n = 41) 
EMR  
(n = 5) 
Eu ope  
(n = 62) 
SEAR  
(n = 2) 
Western Pacific  
(n = 54) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 2014 1979 2010 1986 200  1980 1979 
% pts served 
20.0 ± 0.0  
x ̃ = 20.0  
Q25–Q75 = 20.0–20.0 
8.7 ± 18.3  
x ̃ = 10.0  
Q25–Q75 = 5.0–34.8 
12.5 ± 1 .7  
x ̃ = 7.5 
Q25–Q75 = 2.5–25.0 
12.9 ± 1.8  
x ̃ = 10.  
Q25–Q75 = 5.0–25.0 
55.0 ± 35.4  
x ̃ = 55.0
Q25–Q7  = 30.0–55.0 
35.6 ± 0.8  
x ̃ = 22.5 
Q25–Q75 = 10.0–60.0 
21.4 ± 22.
x ̃ = 1 .  
Q25–Q75 = 5.0–3 .0 
% perceive sufficient capacity § 1 (5 . ) 19 6.3 ) 3 (6 36 58.1 ) 1 (5 . ) 28 1.9 ) 88 ( 3. ) 
Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 15 (24.3  1 (50.0%) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (40.0%) 13 (21.0%) 1 (50.0%) 8 (14.8%) 31 (18.7%) 
Pts too high-risk 0 (0.0%) 2 (4.9%) 1 (20.0%) 0 (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8
̃ 8
8 8
3 2 2 7
̃ 3
1 4 0
6 2 4 6
̃ 5
25– 75 = 2.0–11.0 
4 9 7 1
̃ 3
4
6.   7.8 
x ̃ = 6.5 
Q25–Q75 = 1.0–6.5 
3 9 4 2
̃ 2 0
1 0 4
4 2 5 3
̃
1
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4.0–4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = 3.0–6.5 
2.5 ± 0.8 
x ̃ = 3.0  
Q25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise phys ologist or 
physiotherapist 
2 (1 0.0%) 32 (72.0 ) 0 ( . ) 44 (72. ) 2 (100.0 ) 21 (38.9 ) 1 1 (6 .8 ) 
Nurse 0 (0.0 ) 12 (29.3 ) 3 (60.0 ) 31 (50.0 ) 0 (0.0%) 32 (59.3 ) 78 (47.0 ) 
Physician 0 (0.0 ) 10 (24.4 ) 5 (100.0 ) 14 (22.6 ) 0 (0.0%) 14 (25.9 ) 43 (25.9 ) 
Basis for Offering 
Patient ch ice ) 36 87 8 3 6 4 72 6 ( 3 (64 8 ) 12  (72.9 ) 
Tran portation barriers 1 (50.0 ) 3 82 9 5 (100.0 ) 39 62 9 2 (100.0 ) 9 53 7 110 (66.3 ) 
Distance 1 (50.0%) 35 85 4 5 (1 .0%) 33 53 2 2 (1 0.0%) 32 ( 9 ) 108 (6 . ) 
Time or work constraints 0 (0.0 ) 29 (70.7 ) 2 4 2 41.9%) 25 46 3 84 50 6
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 25 (40.3%) 1 (50.0%) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0 ) 20 (48.8 ) 1 (20.0 ) 22 (35.5 ) 1 (50.0 ) 23 (42.6 ) 67 (40.4 ) 
Cost 1 (50.0 ) 9 (22.0 ) 3 (60.0 ) 6 (9.7%) 2 (100.0 ) 17 (31.5 ) 38 (22.9 ) 
Exercise Monitoring 
Bo g percei ed exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 (100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 22 (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0%) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 (0.0%) 1 (20.0%) 6 (9.7%) 0 (0.0%) 9 (16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 38 (61.3%) 1 (50.0%) 37 (68.5%) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0%) 12 (22.2%) 58 (34.9%) 
= 4.0
3.0–6.3
3.0 ± 0 0
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Table 1. Ch racteristics of Home-Based Programs by W rld Health Organization Region. 
n (%)/  
Mean ± Standard Deviation 
Afric n  
(n = 2) 
A ericas  
(n = 41) 
EMR  
(n = 5) 
urope  
(n = 62) 
SEAR  
(n = 2) 
Western Pacific  
(n  4) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 2014 979 201  1986 20 5 1980 1979 
% pts served 
20.0 ± 0.0  
x ̃ = 20.0  
Q25–Q 5 = 20.0–20.0 
18.7 ± 18.3  
x ̃ = 1 .   
Q25–Q75 = 5.0–34.8 
12.5 ± 1 .7  
x ̃ = 7.5
Q25–Q 5 = 2.5–25.0 
12.9 ± 11.8  
x ̃ = 1 .  
Q25–Q75 = 5.0–25.0 
5.0 ± 35.4  
x ̃ = 55.0
Q25–Q75 = 30.0–55.0 
35.6 ± 0.8  
x ̃ = 22.5  
25– 75 = 1 .0–6 .0 
21.4 ± 22.  
x ̃ = 1 .  
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (5 . ) 19 (46.3 ) 3 (60.0%) 36 (58.1 ) 1 (5 . ) 28 (51 9 88 (53 )
Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 1  (24.3%) 1 (50.0 ) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (4 .0%) 13 (21.0%) 1 (50.0%) 8 (14.8 ) 31 (18.7%) 
Pts too high-risk 0 (0.0%)  (4.9%) 1 (20.0%)  (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8.0 ± 0.0  
x ̃ = 8.0  
Q25–Q75 = 8.0–8.0 
3.2 ± 2.7  
x ̃ = 3.0  
Q25–Q75 = 1.0–4.0 
6.2 ± 4.6 
x ̃ = 5.0 
Q25– 75 = 2.0–11.  
4.9 ± 7.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.  
6.5  7.8
x ̃ = 6.5
Q25–Q75 = 1.0–6.5
3.9 ± 4.2  
x ̃ = 2.0  
Q25– 7  = 1.0–4.0 
4.2 ± 5.3 
x ̃ = 3.0 
Q25– 7  = 1.0–4.  
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4.0–4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = 3.0–6.5 
2.5 ± 0.8 
x ̃ = 3.0  
Q25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (1 0.0%) 32 (72.0 ) 0 ( . ) 44 (72. ) 2 100.0 ) 21 (38.9 ) 1 1 (6 .8 ) 
Nurse 0 (0.0%) 12 (29.3%) 3 (6 .0%) 31 (50.0%) 0 (0 0 32 (59.3 ) 78 (47.0%) 
Physician 0 (0.0%)  (24.4%) 5 (100.0%) 14 (22.6%) 0 (0 0 14 (25.9 ) 43 (25.9%) 
Basis for Offering 
Patient choice 0 ( . ) 3  (87.8 ) 3 (60.0 ) 45 (72.6 ) 2 1 0.0%) 35 (64.8 ) 12  (72.9 ) 
Transportation barriers 1 (50.0%) 34 (82.9%) 5 (100.0%) 39 (62.9%) 2 100.0%) 29 ( 3.7 ) 110 (66.3 ) 
Distance 1 (50.0%) 35 (85.4 ) 5 (1 .0%) 33 (53.2 ) 1 0.0%) 32 ( . ) 108 (6 .1 ) 
Time or work constraints 0 ( .0%) 29 (70.7%) 2 (40.0%) 26 (41.9%) 2 100.0%) 25 46.3%) 84 (50.6%) 
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 2  (40.3%) 1 (50.0 ) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0%) 20 (48.8%) 1 (20.0%) 22 (35.5%) 1 (50.0 ) 23 (42.6%) 67 (40.4%) 
Cost 1 (50.0%) 9 (22.0%) 3 (60.0%) 6 (9.7%) 2 100.0%) 17 (31.5 ) 38 (22.9%) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 2  (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0 ) 14 (25.9%) 65 (39.2%) 
Telemetry  (0.0%) 0 ( .0%) 1 (20.0%) 6 (9.7%) 0 (0.0 ) 9 16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 38 (61.3%) 1 (50.0 ) 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0 ) 12 (22.2%) 58 (34.9%) 
= 3.0
3.0–3.0
.9 ± 3.4
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Table 1. Ch ract ristics of Home-Bas d Programs by W rld Health Organization Region. 
n (%)/  
Mean ± Standard Deviation 
Afric n  
(n = 2) 
A ericas  
(n = 41) 
EMR  
(n = 5) 
urope 
(n = 62) 
SEAR  
(n = 2) 
Western Pacific  
(n  4) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 014 979 2010 986 0 5 1980 1979 
% pts served 
2 .0 ± 0.0  
x ̃ = 20.0  
Q 5–Q75 = 0. –20.0 
8.7 ± 18.3  
x ̃ = 1 .   
Q25–Q75 = 5.0–34.8 
12.  ± 1 .7  
x ̃ = 7.5  
25–Q 5 = 2. –25.0 
12.9 ± 1.8  
x ̃ = 1 .   
Q25–Q75 = 5.0–25.0 
.0 ± 35.  
x ̃ = 55.0
Q25–Q7  = 30.0–55.0 
35.6 ± 30.8  
x ̃ = 22.5  
25– 75 = 1 .0–6 .0 
21.4 ± 22.8
x ̃ = 1 .  
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (5 . ) 19 6.3 ) 3 (6 6 58.1 ) 1 (5 . ) 28 9 88 ( 3 )
Not enough staff 0 (0.0%) 11 (26.9%) 1 ( 0.0%) 1  (24.3%) 1 (50.0 ) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (4 .0%) 3 (21.0%) 1 (50.0%) 8 (14.8 ) 31 (18.7%) 
Pts too high-risk 0 (0.0%)  (4.9%) 1 (20.0%)  (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8
̃ 8
8 8
3 2 2 7
̃ 3
1 4 0
6 2 4 6
̃ 5
25– 75 = 2.0–11.0 
4 9 7 1
̃ 3
4
6.5  7.
x ̃ = 6.5
Q25– 7  = 1.0–6.5 
3 9 4 2
̃ 2 0
1 0 4
4 2 5 3
̃
1
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4. –4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = . –6.5 
2.5 ± 0.8 
x ̃ = 3.0  
Q25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise phys ologist or 
physiotherapist 
2 (1 0.0%) 32 (72.0 ) 0 ( . ) 44 (72.1 ) 2 100.0 ) 21 (38.9 ) 1 1 (6 .8 ) 
Nurse 0 (0.0 ) 12 (29.3 ) 3 (6 .0 ) 31 (50.0 ) 0 (0 0 32 (59.3 ) 78 (47.0 ) 
Physician 0 (0.0 )  (24.4 ) 5 (100.0 ) 14 (22.6 ) 0 (0 0 14 (25.9 ) 43 (25.9 ) 
Basis for Offering 
Patient ch ice ) 3 87 8 3 6 45 72 6 3 (64 8 ) 12  (72.9 ) 
Tran portation barriers 1 (50.0 ) 3 82 9 5 (100.0 ) 39 62 9 2 100.0 ) 9 53 7 110 (66.3 ) 
Distance 1 (50.0%) 35 85 4 5 (1 .0%) 33 53 2 1 0. ) 32 ( ) 108 (6 .1 ) 
Time or work constraints 0 (0.0 ) 29 (70.7 ) 2 4 2 41.9%) 25 46 3 84 50 6
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 2  (40.3%) 1 (50.0 ) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0 ) 20 (48.8 ) 1 (20.0 ) 22 (35.5 ) 1 (50.0 ) 23 (42.6 ) 67 (40.4 ) 
Cost 1 (50.0 ) 9 (22.0 ) 3 (60.0 ) 6 (9.7%) 2 100.0 ) 17 (31.5 ) 38 (22.9 ) 
Exercise Monitoring 
Bo g percei ed exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 2  (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0 ) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 ( .0%) 1 (20.0%)  (9.7%) 0 (0.0 ) 9 16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 38 (61.3%) 1 (50.0%) 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0 ) 12 (22.2%) 58 (34.9%) 
= 2.0
2.0–
7.5 ± 0.
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Table 1. Ch ract ristics of Home-Bas d Programs by W rld Health Organization Region. 
n (%)/  
Mean ± Standard Deviation 
Afric n  
(n = 2) 
Americ s  
(n = 41) 
EMR
(n = 5) 
urope 
(n = 62) 
SEAR  
(n = 2) 
Western Pacific  
(n  4) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 2014 979 2 1 1986 20 5 1980 1979 
% pts served 
20.0 ± 0.0  
x ̃ = 20.0  
Q25–Q 5 = . –20.0 
8 7 ± 18.3  
x ̃ = 1 .   
Q25–Q75 = 5.0–34.8 
12.  ± 15 7  
x ̃ = 7.5  
2 –Q 5 = 2 –25.0 
12.9 ± 1.8  
x ̃ = 1 .   
Q25–Q 5 = 5.0–25.0 
5.0 ± 35 4  
x ̃ = 55.
Q25–Q7  = 3 –55.0 
35.6 ± 30.8  
x ̃ = 2 .5  
25– 75 = 1 .0–6 .0 
21.4 ± 22.8
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (5 . ) 19 6.3 ) 3 (6 6 58.1 ) 1 (5 . ) 28 1 9 88 ( 3 )
Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 1  (24.3%) 1 (50.0 ) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (4 .0%) 3 (21.0%) 1 (50.0%) 8 (14.8 ) 31 (18.7%) 
Pts too high-risk 0 (0.0%)  (4.9%) 1 (20.0%)  (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8
̃ 8
8 8
3 2 2 7
̃ 3
1 4 0
6 4 6  
̃ 5
25– 75 = 2.0–11.0 
4 9 7 1
̃ 3
4
6.   7.8  
x ̃ = 6.5  
Q25–Q75 = 1.0–6.5 
3 9 4 2
̃ 2 0
1 0 4
4 2 5 3
̃
1
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4. –4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = . –6.5 
2.5 ± 0.8 
x ̃ = 3.0  
2 –Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2. –3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise phys ologist or 
physiotherapist 
2 (1 0.0%) 32 (72.0 ) 0 ( . ) 44 (72.1 ) 2 100.0 ) 21 (38.9 ) 1 1 (6 .8 ) 
Nurse 0 (0.0 ) 12 (29.3 ) 3 (6 .0 ) 31 (50.0 ) 0 (0 0 32 (59.3 ) 78 (47.0 ) 
Physician 0 (0.0 )  (24.4 ) 5 (100.0 ) 14 (22.6 ) 0 (0 0 14 (25.9 ) 43 (25.9 ) 
Basis for Offering 
Patient ch ice ) 3 87 8 3 6 45 72 6 3 (64 8 ) 121 (72.9 ) 
Tran portation barriers 1 (50.0 ) 3 82 9 5 (100.0 ) 39 62 9 2 100.0%) 9 3 7 110 66 3
Distance 1 (50.0%) 35 85 4 5 (1 0. %) 33 53 2 1 0. ) 32 ( 3 ) 108 (65 1 )
Time or work constraints 0 ( .0 ) 29 (70.7 ) 2 4 2 41.9%) 25 46 3 84 5 6
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 2  (40.3%) 1 (50.0 ) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0 ) 20 (48.8 ) 1 (20.0 ) 22 (35.5 ) 1 (50.0 ) 23 (42.6 ) 67 (40.4 ) 
Cost 1 (50.0 ) 9 (22.0 ) 3 (60.0 ) 6 (9.7%) 2 100.0%) 17 (31.5 ) 38 (22.9 ) 
Exercise Monitoring 
Bo g percei ed exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 2  (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0 ) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 ( .0%) 1 (20.0%)  (9.7%) 0 (0.0 ) 9 16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 3  (61.3%) 1 (50.0%) 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0 ) 12 (22.2%) 58 (34.9%) 
= 7.5
7.5–7.5
3.4 ± 3 6
J. Clin. Med. 018, 7, x FOR PEER REVIEW  5 of 13 
 
Table 1. Ch ract ristics of Home-Bas d Programs by W rld Health Organization Region. 
n (%)/  
Mean ± Standard Deviation 
African  
(n = 2) 
Americas  
(n  41) 
EMR
(n  5) 
urope 
(n = 62) 
SEAR  
(n  2) 
Western Pacific  
(n = 4) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 014 979 201 986 20 5 1980 1979 
% pts served 
2 .0 ± 0.0  
x ̃ = 20.0  
Q 5–Q = . –20.0 
8 7 ± 18.3  
x ̃ = 10.0  
Q25–Q75 = 5.0–34.8 
1 ± 15.7 
x ̃ = 7.5  
25–Q75 = 2. –25.0 
12.9 ± 1.8  
x ̃ = 10.0  
Q25–Q75 = 5.0–25.0 
.0 ± 35.4
x ̃ = 55 0
Q25–Q7 = 3 .0–55.0 
35.6 ± 30.8  
x ̃ = 22.5 
25– 7  = 1 .0–6 .0 
1.4 ± 22.8
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (5 . ) 19 6 3 (6 6 58.1 ) 1 (5 . ) 28 1.9%) 88 ( 3.0 ) 
Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 1  (24.3%) 1 (50.0 ) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (4 .0%) 3 (21.0%) 1 (50.0%) 8 (14.8 ) 31 (18.7%) 
Pts too high-risk 0 (0.0%)  (4.9%) 1 (20.0%)  (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8
̃ 8
8 8
3 2 2 7
̃ 3
1 4 0
6 4 6
̃ 5
25– 75 = 2.0–11.0 
4 9 7 1
̃ 3
4
6.5  7.8
x ̃ = 6.5
Q25–Q75 = 1.0–6.5 
3 9 4 2
̃ 2 0
1 0 4
4 2 5 3
̃
1
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q7  = 4. –4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = . –6.5 
2.5 ± 0.8 
x ̃ = 3.0  
2 –Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2. –3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise phys ologist or 
physiotherapist 
2 (1 0.0%) 32 (72. ) 0 ( . ) 44 (72.1 ) 2 100.0 ) 21 (38.9 ) 1 (60.8%) 
Nurse 0 (0.0 ) 12 (29.3 ) 3 (6 .0 ) 31 (50.0 ) 0 (0 0 32 (59.3 ) 78 (47.0 ) 
Physician 0 (0.0 )  (24.4 ) 5 (100.0 ) 14 (22.6 ) 0 (0 0 14 (25.9 ) 43 (25.9 ) 
Basis for Offering 
Patient ch ice ) 3 (87 8 ) 6 45 (72 6 ) 3 64 8 121 (72.9 ) 
Tran portation barriers 1 (50.0 ) 3 82 9 5 (100.0 ) 39 62 9 2 100.0%) 9 3 7 110 (66.3 ) 
Distance 1 (50.0%) 35 85 4% 5 (1 0.0 ) 33 (53 2 ) 1 0.0 ) 32 5 3 08 (65.1 ) 
Time or work constraints 0 ( .0 ) 29 (70.7 ) 2 4 2 41.9 ) 5 46 3 84 50 6
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 2  (40.3%) 1 (50.0 ) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0 ) 20 (48.8 ) 1 (20.0 ) 22 (35.5 ) 1 (50.0 ) 23 (42.6 ) 67 (40.4 ) 
Cost 1 (50.0 ) 9 (22.0 ) 3 (60.0 ) 6 (9.7%) 2 100.0%) 17 (31.5 ) 38 (22.9 ) 
Exercise Monitoring 
Bo g percei ed exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 2  (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0 ) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 ( .0%) 1 (20.0%)  (9.7%) 0 (0.0 ) 9 16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 3  (61.3%) 1 (50.0%) 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0 ) 12 (22.2%) 58 (34.9%) 
=
1 5
7 3.7
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Table 1. Characteris ics of Home-Based Programs by World Health Organization Region. 
n (%)/  
Mean ± Sta dard Deviation 
Af n
(n = 2) 
Americas  
(n = 41) 
EMR
(n = 5) 
Europe  
(n = 62) 
SEAR  
(n = 2)
Western Pacific  
(n = 54) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 2 14 1979 2 1  1986 2005 80 1979 
% pts served 
20.0 ± 0.0  
x ̃ = 20.0  
2 – 75 = 2 .0–20.0 
.7 ± 18.3  
x ̃ = 10.0  
Q25–Q7  = . –34.8 
1 .5 ± 5.7  
x ̃ = 7.5 
2 –Q75 = 2.5–25.0 
12.9 ± 1.8  
x ̃ = 10.0  
Q25–Q7 = 5. –25.0 
5 0 5 4
̃ 5 0
3 55
35 6 30  
̃ 22 5  
25– 75 = 10.0–60.0 
21.4 ± 22.8
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § (5 . ) 19 6.3 ) 3 (6 36 58.1 )  (5 . ) 2 1 9 88 ( 3.0 ) 
Not enough staff (0 0 11 (26.9%) 1 (20.0 ) 1  (24.3%) 1 (50.0 ) 14 9 42 (25.3%) 
Not enough funding (0.0 ) 7 (17.1%) 2 (40.0 ) 3 (21.0%) 1 50 0 8 (14.8 ) 31 (18.7%) 
Pts too high-risk  (0.0%) 2 (4.9 ) 1 (2 .0%) 0 (0.0%) 0 0 0 3 6 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8
̃ 8
8 8
3 2 7
̃ 3
1 4 0
6 2 4 6  
̃ 5
25– 75 = 2. –11.0 
4 9 7 1
̃ 3
4
6 5 7
̃ 6
6 5
9 4 2
̃ 2
4 2 5 3
̃
1
Program duration (months) 
4.  ± 0.0  
x ̃ = 4.0  
2 –Q75 = 4.0–4 0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = 3.0–6.5 
2.5 ± 0.8
x ̃ = 3.0  
2 –Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2 3 1 8  
̃ 1 5  
0 9 3
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
roviders Interacting with Pts ‖ 
Exercise phys ologist or 
physiotherapist 
1 0.0%) 3  (72.0 )  ( 4 (72.1 )  (100 0% 21 (38.9 ) 1 1 (60.8%) 
Nurse  (0 0 12 (29.3 ) 3 (60.0 ) 31 (50.0 ) 0 0 32 59 3 78 (47.0 ) 
Physician  (0 0 10 (24.4 ) 5 100.0 ) 14 (22.6 ) 0 0 0 14 43 (25.9 ) 
Basis for Offering 
Patient ch ice 3 87 8 3 6 4 72 6 ( 3 ( 4 8 ) 121 (72.9 ) 
Tran portation barriers 1 (50.0 ) 3 82 9 1 0.0%) 39 62 9 100 0 9 53 7 110 (66.3 ) 
Distance 1 (50.0 ) 85 4% 1 0.0 ) 3 53 2 (1 0 0% 32 59 3 108 (65.1%) 
Time or work constraints  ( 0 29 (7 .7 ) 2 4 41.9%) 25 46 3 84 50 6
Risk stratification (0 0 24 (58.5%) 1 (20.0 ) 2  (4 .3%) 1 (50.0 ) 25 6 3 76 (45.8%) 
Patient indication (0 0 20 (48.8 ) 1 (20.0 ) 22 (35.5 ) 1 (50.0 ) 23 2 6 67 (40.4 ) 
Cost 1 (50.0 )  (22.0 ) 3 (60.0 ) 6 (9 7 2 100 0 17 31 5 38 (22.9 ) 
Exercise Monitoring 
Bo g percei ed exertion [34] 1 (50.0 ) 2  (48.8%) 2 (40.0 ) 28 (45.2%) 2 100 0 17 31 5 70 (42.2%) 
Heart rate 1 (50.0 ) 22 (53.7%) 1 (20.0 ) 26 (41.9%) 1 (50.0 ) 14 25 9 65 (39.2%) 
Telemetry  (0.0%) 0 (0.0 ) 1 (20.0%) 6 (9.7%) 0 (0.0 ) 9 (16 7 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0 ) 34 (82.9%) 3 (60.0 ) 38 (61.3%) 1 50 0 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
(0 0 4 (58.5%) 1 (20.0 ) 20 (32.3%) 1 (50.0 ) 12 22 2 58 (34.9%) 
= 2.5
= 1.0–3.0
Provider most responsible to supervise exercise sessions
Exercise physiologist or physiotherapist - 10 (4 .6%) 1 (100.0%) 0 (3 . %) 0 (0.0%) 9 (29. %) 40 (36.7%)
Nurse - 3 (14.3%) 0 (0.0%) 16 (29.6%) 1 (100.0%) 8 (25.8%) 28 (25.7%)
Physician - 2 (9.5%) 0 (0.0%) 6 (11.1%) 0 (0.0%) 5 (16.1%) 13 (11.9%)
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Table 2. Cont.
n (%)/Mean± Standard Deviation African (n = 1) Americas (n = 21) EMR (n = 1) European (n = 54) SEAR (n = 1) Western Pacific(n = 31)
Global (n = 109;
10.1% of Total)
Basis for Offering
Patient choice - 15 (71.4%) 0 (0.0%) 38 (70.4%) 1 (100.0%) 19 (61.3%) 73 (67.0%)
Risk stratification - 13 (61.9%) 0 (0.0%) 26 (48.1%) 1 (100.0%) 11 (35.5%) 51 (46.8%)
Distance to main CR centre - 16 (76.2%) 1 (100.0%) 18 (33.3%) 1 (100.0%) 13 (41.9%) 49 (45.0%)
Patient indication - 8 (38.1%) 0 (0.0%) 24 (44.4%) 1 (100.0%) 13 (41.9%) 46 (42.2%)
Transportation barriers - 14 (66.7%) 1 (100.0%) 17 (31.5%) 0 (0.0%) 11 (35.5%) 43 (39.4%)
Time or work constraints - 15 (71.4%) 1 (100.0%) 13 (24.1%) 0 (0.0%) 11 (35.5%) 40 (36.7%)
Cost - 3 (14.3%) 0 (0.0%) 6 (11.1%) 0 (0.0%) 2 (6.5%) 11 (10.1%)
Not having a main centre in a clinical setting - 1 (4.8%) 0 (0.0%) 5 (9.6%) 0 (0.0%) 2 (6.5%) 8 (7.3%)
Capacity Indicators
Number sessions offered per week -
5.7 ± 8.1
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Table 1. Characteristics of Home-Based Programs by World Health Organization Region. 
n (%)/  
Mean ± Standard Deviation 
African  
(n = 2) 
Americas  
(n = 41) 
EMR  
(n = 5) 
Europe  
(n = 62) 
SEAR  
(n = 2) 
Western Pacific  
(n = 54) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 2014 1979 2010 1986 2005 1980 1979 
% pts served 
20.0 ± 0.0  
x ̃ = 20.0  
Q25–Q75 = 20.0–20.0 
18.7 ± 18.3  
x ̃ = 10.0  
Q25–Q75 = 5.0–34.8 
12.5 ± 15.7  
x ̃ = 7.5  
Q25–Q75 = 2.5–25.0 
12.9 ± 11.8  
x ̃ = 10.0  
Q25–Q75 = 5.0–25.0 
55.0 ± 35.4  
x ̃ = 55.0  
Q25–Q75 = 30.0–55.0 
35.6 ± 30.8  
x ̃ = 22.5  
Q25–Q75 = 10.0–60.0 
21.4 ± 22.8 
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (50.0%) 19 (46.3%) 3 (60.0%) 36 (58.1%) 1 (50.0%) 28 (51.9%) 88 (53.0%) 
Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 15 (24.3%) 1 (50.0%) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (40.0%) 13 (21.0%) 1 (50.0%) 8 (14.8%) 31 (18.7%) 
Pts too high-risk 0 (0.0%) 2 (4.9%) 1 (20.0%) 0 (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8.0 ± 0.0  
x ̃ = 8.0  
Q25–Q75 = 8.0–8.0 
3.2 ± 2.7  
x ̃ = 3.0  
Q25–Q75 = 1.0–4.0 
6.2 ± 4.6  
x ̃ = 5.0  
Q25–Q75 = 2.0–11.0 
4.9 ± 7.1  
x ̃ = 3.0  
Q25–Q75 = 2.0–4.0 
6.5  7.8  
x ̃ = 6.5  
Q25–Q75 = 1.0–6.5 
3.9 ± 4.2  
x ̃ = 2.0  
Q25–Q75 = 1.0–4.0 
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4.0–4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = 3.0–6.5 
2.5 ± 0.8 
x ̃ = 3.0  
Q25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (100.0%) 32 (72.0%) 0 (0.0%) 44 (72.1%) 2 (100.0%) 21 (38.9%) 101 (60.8%) 
Nurse 0 (0.0%) 12 (29.3%) 3 (60.0%) 31 (50.0%) 0 (0.0%) 32 (59.3%) 78 (47.0%) 
Physician 0 (0.0%) 10 (24.4%) 5 (100.0%) 14 (22.6%) 0 (0.0%) 14 (25.9%) 43 (25.9%) 
Basis for Offering 
Patient choice 0 (0.0%) 36 (87.8%) 3 (60.0%) 45 (72.6%) 2 (100.0%) 35 (64.8%) 121 (72.9%) 
Transportation barriers 1 (50.0%) 34 (82.9%) 5 (100.0%) 39 (62.9%) 2 (100.0%) 29 (53.7%) 110 (66.3%) 
Distance 1 (50.0%) 35 (85.4%) 5 (100.0%) 33 (53.2%) 2 (100.0%) 32 (59.3%) 108 (65.1%) 
Time or work constraints 0 (0.0%) 29 (70.7%) 2 (40.0%) 26 (41.9%) 2 (100.0%) 25 (46.3%) 84 (50.6%) 
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 25 (40.3%) 1 (50.0%) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0%) 20 (48.8%) 1 (20.0%) 22 (35.5%) 1 (50.0%) 23 (42.6%) 67 (40.4%) 
Cost 1 (50.0%) 9 (22.0%) 3 (60.0%) 6 (9.7%) 2 (100.0%) 17 (31.5%) 38 (22.9%) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 (100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 22 (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0%) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 (0.0%) 1 (20.0%) 6 (9.7%) 0 (0.0%) 9 (16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 38 (61.3%) 1 (50.0%) 37 (68.5%) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0%) 12 (22.2%) 58 (34.9%) 
= 3.0
1.8–6.3
-
4.7 ± 6.1
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(n = 54) 
Global  
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Not enough funding 0 (0.0%) 7 (17.1%) 2 (40.0%) 3 (21.0%) 1 (50.0%) 8 (14.8%) 31 (18.7%) 
Pts too high-risk 0 (0.0%) 2 (4.9%) 1 (20.0%) 0 (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8.0 ± 0.0  
x ̃ = 8.0  
25–Q75 = 8. –8.0 
3.2 ± 2.7  
x ̃ = 3.0  
Q25–Q75 = 1. –4.0 
6.2 ± 4.6  
x ̃ = 5.0  
Q25–Q75 = 2.0–11.0 
4.9 ± 7.1  
x ̃ = 3.0  
Q25–Q75 = 2.0–4.0 
6.5  7.8  
x ̃ = 6.5  
Q25–Q75 = 1.0–6.5 
3.9 ± 4.2  
x ̃ = 2.0  
Q25–Q75 = 1.0–4.0 
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4. –4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = . –6.5 
2.5 ± 0.8 
x ̃ = 3.0  
Q25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (100.0%) 32 (72.0%) 0 (0.0%) 44 (72.1%) 2 (100.0%) 21 (38.9%) 101 (60.8%) 
Nurse 0 (0.0%) 12 (29.3%) 3 (60.0%) 31 (50.0%) 0 (0.0%) 32 (59.3%) 78 (47.0%) 
Physician 0 (0.0%) 10 (24.4%) 5 (100.0%) 14 (22.6%) 0 (0.0%) 14 (25.9%) 43 (25.9%) 
Basis for Offering 
Patient choice 0 (0.0%) 36 (87.8%) 3 (60.0%) 45 (72.6%) 2 (100.0%) 35 (64.8%) 121 (72.9%) 
Transportation barriers 1 (50.0%) 34 (82.9%) 5 (100.0%) 39 (62.9%) 2 (100.0%) 29 (53.7%) 110 (66.3%) 
Distance 1 (50.0%) 35 (85.4%) 5 (100.0%) 33 (53.2%) 2 (100.0%) 32 (59.3%) 108 (65.1%) 
Time or work constraints 0 (0.0%) 29 (70.7%) 2 (40.0%) 26 (41.9%) 2 (100.0%) 25 (46.3%) 84 (50.6%) 
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 25 (40.3%) 1 (50.0%) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0%) 20 (48.8%) 1 (20.0%) 22 (35.5%) 1 (50.0%) 23 (42.6%) 67 (40.4%) 
Cost 1 (50.0%) 9 (22.0%) 3 (60.0%) 6 (9.7%) 2 (100.0%) 17 (31.5%) 38 (22.9%) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 (100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 22 (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0%) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 (0.0%) 1 (20.0%)  (9.7%) 0 (0.0%) 9 (16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 38 (61.3%) 1 (50.0%) 37 (68.5%) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0%) 12 (22.2%) 58 (34.9%) 
= 3.0
2.0–5.0
2.0 ± 0.0
J. Clin. Med. 2018, 7, x FOR PEER REVIEW  5 of 13 
 
Table 1. Ch racteristics of Home-Based Programs by W rld Health Organization Region. 
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12.9 ± 11.8  
x ̃ = 10.0  
Q25–Q75 = 5.0–25.0 
5.0 ± 35.4  
x ̃ = 55.0  
Q25–Q75 = 30.0–55.0 
35.6 ± 30.8  
x ̃ = 22.5  
25– 75 = 1 .0–6 .0 
21.4 ± 22.8 
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (50.0%) 19 (46.3%) 3 (60.0%) 36 (58.1%) 1 (50.0 ) 28 (51.9%) 88 (53.0%) 
Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 1  (24.3%) 1 (50.0 ) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (4 .0%) 13 (21.0%) 1 (50.0%) 8 (14.8 ) 31 (18.7%) 
Pts too high-risk 0 (0.0%)  (4.9%) 1 (20.0%)  (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8.0 ± 0.0  
x ̃ = 8.0  
Q25–Q75 = 8.0–8.0 
3.2 ± 2.7  
x ̃ = 3.0  
Q25–Q75 = 1.0–4.0 
6.  ± 4.6  
x ̃ = 5.0  
25–Q75 = 2.0–11.0 
4.9 ± 7.1  
x ̃ = 3.0  
Q25–Q75 = 2. –4.0 
6.5  7.8  
x ̃ = 6.5  
Q25–Q75 = 1.0–6.5 
3.9 ± 4.2  
x ̃ = 2.0  
Q25–Q75 = 1.0–4.0 
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4.0–4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = 3.0–6.5 
2.5 ± 0.8 
x ̃ = 3.0  
2 –Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2. –3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (100.0%) 32 (72.0%) 0 (0.0%) 44 (72.1%) 2 100.0%) 21 (38.9 ) 101 (60.8%) 
Nurse 0 (0.0%) 12 (29.3%) 3 (6 .0%) 31 (50.0%) 0 (0 0 32 (59.3%) 78 (47.0%) 
Physician 0 (0.0%)  (24.4%) 5 (100.0%) 14 (22.6%) 0 (0 0 14 (25.9%) 43 (25.9%) 
Basis for Offering 
Patient choice 0 (0.0%) 3  (87.8%) 3 (60.0%) 45 (72.6%) 2 100.0%) 35 (64.8 ) 121 (72.9%) 
Transportation barriers 1 (50.0%) 34 (82.9%) 5 (100.0%) 39 (62.9%) 2 100.0%) 29 (53.7 ) 110 (66.3%) 
Distance 1 (50.0%) 35 (85.4%) 5 (100.0%) 33 (53.2%) 100.0%) 32 (59.3 ) 108 (65.1%) 
Time or work constraints 0 (0.0%) 29 (70.7%) 2 (40.0%) 26 (41.9%) 2 100.0%) 25 (46.3%) 84 (50.6%) 
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 2  (40.3%) 1 (50.0 ) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0%) 20 (48.8%) 1 (20.0%) 22 (35.5%) 1 (50.0 ) 23 (42.6%) 67 (40.4%) 
Cost 1 (50.0%) 9 (22.0%) 3 (60.0%) 6 (9.7%) 2 100.0%) 17 (31.5%) 38 (22.9%) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 2  (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0 ) 14 (25.9%) 65 (39.2%) 
Telemetry  (0.0%) 0 ( .0%) 1 (20.0%) 6 (9.7%) 0 (0.0 ) 9 16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 3  (61.3%) 1 (50.0 ) 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0 ) 12 (22.2%) 58 (34.9%) 
= 2.0
2.0–0.0
3.8 ± 3.4
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35.6 ± 30.8  
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Pts too high-risk 0 (0.0%)  (4.9%) 1 (20.0%)  (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8.0 ± 0.0  
x ̃ = 8.0  
25–Q75 = 8. –8.0 
3.2 ± 2.7  
x ̃ = 3.0  
Q25–Q75 = 1. –4.0 
6.2 ± 4.6  
x ̃ = 5.0  
Q25–Q75 = 2.0–11.0 
4.9 ± 7.1  
x ̃ = 3.0  
Q25–Q75 = 2.0–4.0 
6.5  7.8  
x ̃ = 6.5  
Q25–Q75 = 1.0–6.5 
3.9 ± 4.2  
x ̃ = 2.0  
Q25–Q75 = 1.0–4.0 
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4. –4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = . –6.5 
2.5 ± 0.8 
x ̃ = 3.0  
Q25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
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2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (100.0%) 32 (72.0%) 0 (0.0%) 44 (72.1%) 2 100.0%) 21 (38.9 ) 101 (60.8%) 
Nurse 0 (0.0%) 12 (29.3%) 3 (6 .0%) 31 (50.0%) 0 (0 0 32 (59.3%) 78 (47.0%) 
Physician 0 (0.0%)  (24.4%) 5 (100.0%) 14 (22.6%) 0 (0 0 14 (25.9%) 43 (25.9%) 
Basis for Offering 
Patient choice 0 (0.0%) 3  (87.8%) 3 (60.0%) 45 (72.6%) 2 100.0%) 35 (64.8 ) 121 (72.9%) 
Transportation barriers 1 (50.0%) 34 (82.9%) 5 (100.0%) 39 (62.9%) 2 100.0%) 29 (53.7 ) 110 (66.3%) 
Distance 1 (50.0%) 35 (85.4%) 5 (100.0%) 33 (53.2%) 100.0%) 32 (59.3 ) 108 (65.1%) 
Time or work constraints 0 (0.0%) 29 (70.7%) 2 (40.0%) 26 (41.9%) 2 100.0%) 25 (46.3%) 84 (50.6%) 
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 2  (40.3%) 1 (50.0 ) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0%) 20 (48.8%) 1 (20.0%) 22 (35.5%) 1 (50.0 ) 23 (42.6%) 67 (40.4%) 
Cost 1 (50.0%) 9 (22.0%) 3 (60.0%) 6 (9.7%) 2 100.0%) 17 (31.5%) 38 (22.9%) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 2  (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0 ) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 ( .0%) 1 (20.0%)  (9.7%) 0 (0.0 ) 9 16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 38 (61.3%) 1 (50.0%) 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0 ) 12 (22.2%) 58 (34.9%) 
= 2.0
1.0–6.0
4.6 6.0
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x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.  ± 0.0  
x ̃ = 4.0  
2 –Q75 = 4.0–4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = 3.0–6.5 
2.5 ± 0.8
x ̃ = 3.0  
Q25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2 3 1 8  
̃ 1 5  
0 9 3
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
roviders Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
100.0%) 3  (72.0%)  (0 0 44 (72.1%)  (100 0 21 (38.9 ) 101 (60.8%) 
Nurse  (0 0 12 (29.3%) 3 (60.0 ) 31 (50.0%) 0 0 32 59 3 78 (47.0%) 
Physician  (0 0 10 (24.4%) 5 100.0%) 14 (22.6%) 0 0 0 14 43 (25.9%) 
Basis for Offering 
Patient choice  (0 0 36 (87.8%) 3 (60.0 ) 45 (72.6%) 2 (100 0 35 (64.8 ) 121 (72.9%) 
Transportation barriers 1 (50.0 ) 34 (82.9%) 5 100.0%) 39 (62.9%)  (100 0 29 (53.7 ) 110 (66.3%) 
Distance 1 (50.0 ) 35 (85.4%) 5 100.0%) 33 (53.2%) 2 (100 0 32 (59.3 ) 108 (65.1%) 
Time or work constraints  ( 0 29 (7 .7%) 2 (40.0 ) 26 (41.9%) 1 0 0 25 46 3 84 (50.6%) 
Risk stratification  (0 0 24 (58.5%) 1 (20.0 ) 2  (4 .3%) 1 (50.0 ) 25 6 3 76 (45.8%) 
Patient indication  (0 0 20 (48.8%) 1 (20.0 ) 22 (35.5%) 1 (50.0 ) 23 2 6 67 (40.4%) 
Cost 1 (50.0%)  (22.0%) 3 (60.0%) 6 (9 7 2 100 0 17 31 5 38 (22.9%) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0 ) 2  (48.8%) 2 (40.0 ) 28 (45.2%) 2 100 0 17 31 5 70 (42.2%) 
Heart rate 1 (50.0 ) 22 (53.7%) 1 (20.0 ) 26 (41.9%) 1 (50.0 ) 14 25 9 65 (39.2%) 
Telemetry  (0.0%) 0 (0.0 ) 1 (20.0%) 6 (9.7%) 0 (0.0 ) 9 (16 7 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0 ) 34 (82.9%) 3 (60.0 ) 38 (61.3%) 1 50 0 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
 (0 0 24 (58.5%) 1 (20.0 ) 20 (32.3%) 1 (50.0 ) 12 22 2 58 (34.9%) 
= 3.0
= 2.0–6.0
Pts per session -
16.9 ± 19.5
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Table 1. Characteristics of Home-Based Programs by World Health Organization Region. 
n (%)/  
Mean ± Standard Deviation 
African  
(n = 2) 
Americas  
(n  41) 
EMR  
(n  5) 
Europe  
(n  62) 
SEAR  
(n = 2) 
Western Pacific  
(n  54) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 2014 1979 2010 1986 2005 1980 1979 
% pts served 
20.0 ± .0  
x ̃ = 2 .0 
Q25–Q75 = 20.0–20.0 
18.7 ± 18.3  
x ̃ = 10.0  
Q25–Q75 = 5.0–34.8 
12.5 ± 15.7  
x ̃ = 7.5  
Q25–Q75 = 2.5–25.0 
12.9 ± 1 .8  
x ̃ = 0.0  
Q25–Q75 = 5.0–25.0 
55.0 ± 35.4  
x ̃ = 55.0  
Q25–Q75 = 30. –55  
35.6 ± 0.8  
x ̃ = 22.5  
Q25–Q75 = 10.0–6 .  
21.4 ± 22.8 
x ̃ = 0.0
Q25–Q75 = 5 –30.0 
% perceive sufficient capacity § 1 (5 19 (46.3 ) 3 (60. ) 36 (58.1 ) 1 (5 28 (51.9 ) 88 (53. )
Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 15 (24.3%) 1 (50.0%) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (40.0%) 13 (21.0%) 1 (50.0%) 8 (14.8%) 31 (18.7%) 
Pts too high-risk 0 (0.0%) 2 (4.9%) 1 (20.0%) 0 (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8.0 ± 0.0  
x ̃ = 8.0  
Q25–Q75 = 8.0–8.0 
3.2 ± 2.7  
x ̃ = 3.0  
Q25–Q75 = 1.0–4.0 
6.2 ± .6  
x ̃ = 5.0  
Q25– 7  = 2.0–11
4.9 ± 7.1  
x ̃ = 3.0  
Q25– 7  = 2.0–4.0 
6.5 ± 7.8  
x ̃ = 6.5  
Q25– 7  = 1.0–6.
3.9 ± 4.2 
x ̃ = 2.0  
Q25–Q75 = 1.0–4
4.2 ± 5.3 
x ̃ = 3.0
Q25– 7  = 1.0–4.0 
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4.0–4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = 3.0–6.5 
2.5 ± 0.8 
x ̃ = 3.0  
Q25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (100.0%) 32 (72.0%) 0 (0.0%) 44 (72.1%) 2 (100.0%) 21 (38.9%) 101 (60.8%) 
Nurse 0 (0.0 ) 12 (29.3 ) 3 (60.0 ) 31 (50.0 ) 0 (0.0%) 32 (59.3 ) 78 (47.0%) 
Physician 0 (0.0%) 10 (24.4 ) 5 (100.0 ) 14 (22.6 ) 0 (0.0%) 14 (25.9 ) 43 (25.9%) 
Basis for Offering 
Patient ch ice 0 (0.0 ) 36 (87.8 ) 3 (60. ) 45 (7 .6 ) 2 (100.0 ) 35 (64.8 ) 121 72 9
Transpor ation barriers 1 (5 34 (82.9%) 5 (10 39 (6 .9%) 2 (10 29 (53.7%) 110 66 3
Distance 1 (5 35 (85.4 ) 5 (10 33 (53.2 ) 2 (10 32 (59.3 ) 108 65 1
Time or work constraints 0 0.0%) 2 70 7 2 (40.0 ) 26 (41.9 ) 2 (100.0 ) 25 (4 . ) 84 (50.6 ) 
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 25 (40.3%) 1 (50.0%) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0%) 20 (48.8%) 1 (20.0%) 22 (35.5%) 1 (50.0%) 23 (42.6 ) 67 (40.4 ) 
Cost 1 (50.0 ) 9 (22.0%) 3 (60.0 ) 6 (9.7%) 2 (100.0 ) 17 (31.5 ) 38 (22.9 ) 
Exercise Monitoring 
Borg percei e  exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 (100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 22 (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0%) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 (0.0%) 1 (20.0%) 6 (9.7%) 0 (0.0%) 9 (16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 38 (61.3%) 1 (50.0%) 37 (68.5%) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0%) 12 (22.2%) 58 (34.9%) 
= 10.0
5 7.5– 5.
-
15.3 ± 14.8
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Table 1. Charact ristics of Home-Bas d Programs by World Health Organization Region. 
n (%)/  
Mean ± Standard Deviation 
African  
(n = 2) 
Americas  
(n  41) 
EMR  
(n  5) 
Europe 
(n  62) 
SEAR  
(n = 2) 
Western Pacific  
(n  54) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 2014 1979 2 10 1986 00 1980 1979
% pts served 
20.0 ± .0  
x ̃ = 2 .0 
Q 5–Q75 = 0. –20.0 
1 7 ± 18.3  
x ̃ = 1 .   
Q25–Q75 = 5.0–34.8 
12.  ± 15 7
x ̃ = 7.5  
2 –Q75 = 2 –25.0 
12.9 ± .8  
x ̃ = 0.0  
Q25–Q75 = 5 –25.0 
55.0 ± 35 4  
x ̃ = 55.0  
Q25–Q75 = 30 –55.0 
35.6 ± 3 .8 
x ̃ = 22 5  
Q25–Q75 = 1 . –60.0 
21.4 ± 22.8 
x ̃ = 10.0 
Q25–Q75 = 5 –30.0 
% perceive sufficient capacity § 1 (5 19 (46.3 ) 3 (60. ) 36 (58.1 ) 1 (5 28 (51.9 ) 88 (53. ) 
Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 15 (24.3%) 1 (50.0%) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (40.0%) 3 (21.0%) 1 (50.0%) 8 (14.8%) 31 (18.7%) 
Pts too high-risk 0 (0.0%) 2 (4.9%) 1 (20.0%) 0 (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8.  ± 0.0  
x ̃ = 8.0  
Q25–Q75 = 8. –8.0 
3.  ± 2.7  
x ̃ = 3.0  
Q25–Q75 = 1. –4.0 
6.2 ± .6  
x ̃ = 5.0  
Q25– 7  = 2.0–11
4.9 ± 7.1 
x ̃ = 3.0 
Q25– 7  = 2.0–4.0 
.5 ± 7.8 
x ̃ = 6.5 
Q25– 7  = 1.0–6.5 
3.9 ± 4 2  
x ̃ = 2.0  
Q25– 7  = 1.0–4  
4.  ± 5.3 
x ̃ = 3.0
Q25–Q75 = 1. –4  
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4. –4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = . –6.5 
2.5 ± 0.8 
x ̃ = 3.0  
Q25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (100.0%) 32 (72.0%) 0 (0.0%) 44 (72.1%) 2 (100.0%) 21 (38.9%) 101 (60.8%) 
Nurse 0 (0.0 ) 12 (29.3 ) 3 (60.0 ) 31 (50.0 ) 0 (0.0 ) 32 (59.3 ) 78 (47.0%) 
Physician 0 (0.0%) 10 (24.4 ) 5 (100.0 ) 14 (22.6 ) 0 (0.0 ) 14 (25.9 ) 43 (25.9%) 
Basis for Offering 
Patient ch ice 0 (0.0 ) 36 (87.8 ) 3 (60. ) 45 (7 .6 ) 2 (1 0.0 ) 35 (64.8 ) 121 72 9
Transpor ation barriers 1 (5 34 (82.9%) 5 (10 39 (6 .9%) 2 (10 29 (53.7%) 110 66 3
Distance 1 (5  (85.4 ) 5 (1 33 (53.2 ) 2 (1 32 (59.3 ) 108 65 1
Time or work constraints 0 0.0%) 2 70 7 2 (40.0 ) 26 (41.9 ) 2 (100.0 ) 25 (4 .3 ) 84 (50.6 ) 
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 25 (40.3%) 1 (50.0%) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0%) 20 (48.8%) 1 (20.0%) 22 (35.5%) 1 (50.0%) 23 (42.6 ) 67 (40.4 ) 
Cost 1 (50.0 ) 9 (22.0%) 3 (60.0 ) 6 (9.7%) 2 (100.0 ) 17 (31.5 ) 38 (22.9 ) 
Exercise Monitoring 
Borg percei e  exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 (100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 22 (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0%) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 (0.0%) 1 (20.0%)  (9.7%) 0 (0.0%) 9 (16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 38 (61.3%) 1 (50.0%) 37 (68.5%) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0%) 12 (22.2%) 58 (34.9%) 
= 12.0
5 9.3– 5
10.0 ± 0.
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Table 1. Ch racteristics of Home-Based Programs by W rld Health Organization Region. 
n (%)/  
Mean ± Standard Deviation 
African  
(n = 2) 
Americas  
(n  41) 
EMR
(n  5) 
urope  
(n  62) 
SEAR  
(n = 2) 
Western Pacific  
(n  54) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 2014 979 2010 1986 20 1980 1979
% pts served 
20.0 ± .0  
x ̃ = 2 .0
Q25–Q75 = 2 .0–20.0 
18 7 ± 18.3  
x ̃ = 1 .   
Q25–Q75 = 5.0–34.8 
2.5 ± 15 7  
x ̃ = 7.5  
Q25–Q75 = 2 5–25.0 
12 9 ± 1 .8  
x ̃ = 0.0  
Q25–Q75 = 5 –25.0 
5.0 ± 35 4  
x ̃ = 55.
Q25–Q75 = 30 –55.0 
35.6 ± 3 8 
x ̃ = 22 5 
25– 75 = 1 –6 .0 
21.4 ± 22.8 
x ̃ = 1  
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (5 19 (46.3 ) 3 (6 .0 ) 36 (58.1 ) 1 28 (51.9 ) 88 (53.0 ) 
Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 1  (24.3%) 1 (50.0 ) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (4 .0%) 13 (21.0%) 1 (50.0%) 8 (14.8 ) 31 (18.7%) 
Pts too high-risk 0 (0.0%)  (4.9%) 1 (20.0%)  (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
.0 ± 0.0  
x ̃ = 8.0  
25–Q75 = 8.0–8.0 
3.2 ± 2.7  
x ̃ = 3.0  
Q25–Q7  = 1 0–4.0 
6. ± 4.6  
x ̃ = 5.0  
25–Q75 = 2 –11
4.9 ± 7.1  
x ̃ = 3   
Q25–Q75 = 2. –4  
6.5 ± 7.8  
x ̃ = 6.5  
25– 75 = 1.0–6 5 
3.9 ± 4.2  
x ̃ = 2.0  
25– 75 = 1.0–4.0 
4.  ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1. –4.0 
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4.0–4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = 3.0–6.5 
2.5 ± 0.8 
x ̃ = 3.0  
2 –Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2. –3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (100.0%) 32 (72.0%) 0 (0.0%) 44 (72.1%) 2 100.0%) 21 (38.9 ) 101 (60.8%) 
Nurse 0 (0.0 ) 12 (29.3 ) 3 (6 .0 ) 31 (50.0 ) 0 (0 0% 32 (59.3 ) 78 (47.0%) 
Physician 0 (0.0 )  (24.4 ) 5 (100.0 ) 14 (22.6 ) 0 (0 0% 14 (25.9 ) 43 (25.9%) 
Basis for Offering 
Patient ch ice 0 ( .0 ) 3  (87.8 ) 3 (60.0 ) 45 (72.6 ) 2 100.0 ) 35 ( 4.8 ) 121 72 9
Transpor ation barriers 1 (5 34 (82.9%)  (1 39 (62.9%) 10 29 (53.7 ) 110 66 3
Distance 1 (5 35 (85.4 ) 5 (1 33 (53.2 ) 10 32 (59. ) 108 65 1
Time or work constraints 0 0.0%) 2 70 7 2 (40.0 ) 6 (41.9 ) 2 100.0 ) 25 (46.3 ) 84 (50.6 ) 
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 2  (40.3%) 1 (50.0 ) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0 ) 20 (48.8%) 1 (20.0%) 22 (35.5%) 1 (50.0 ) 23 (42.6 ) 67 (40.4 ) 
Cost 1 (50.0 ) 9 (22.0%) 3 (60.0 ) 6 (9.7%) 2 100.0 ) 17 (31.5 ) 38 (22.9 ) 
Exercise Monitoring 
Borg percei e  exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 2  (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0 ) 14 (25.9%) 65 (39.2%) 
Telemetry  (0.0%) 0 ( .0%) 1 (20.0%) 6 (9.7%) 0 (0.0 ) 9 16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 3  (61.3%) 1 (50.0 ) 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0 ) 12 (22.2%) 58 (34.9%) 
= 10.0
.0–10.0
11.4 8.1
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Table 1. Ch ract ristics of Home-Bas d Programs by W rld Health Organization Region. 
n (%)/  
Mean ± Standard Deviation 
African  
(n = 2) 
Americas  
(n  41) 
EMR  
(n  5) 
urope 
(n  62) 
SEAR  
(n  2) 
Western Pacific  
(n  4) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 2014 979 2 1  1986 20 5 1980 1979 
% pts served 
20.0 ± .0  
x ̃ = 2 .0
Q 5–Q7 = 0. –20.0 
1 7 ± 18.3  
x ̃ = 10.0  
Q25–Q75 = 5.0–34.8 
1 ± 15.7  
x ̃ = 7.5  
2 –Q 5 = 2. –25.0 
12.9 ± 1 .8  
x ̃ = 1   
Q25–Q75 = 5.0–25.0 
5.0 ± 35.4  
x ̃ = 55.0
Q25–Q75 = 30.0–55.0 
35.6 ± 30.8  
x ̃ = 22.5 
25– 75 = 1 .0–6 .0 
21.4 ± 22.8 
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 (5 19 (46.3 ) 3 (6 .0 ) 36 (58.1 ) 1 28 (51.9 ) 88 (53.0 ) 
Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 1  (24.3%) 1 (50.0 ) 14 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (4 .0%) 3 (21.0%) 1 (50.0%) 8 (14.8 ) 31 (18.7%) 
Pts too high-risk 0 (0.0%)  (4.9%) 1 (20.0%)  (0.0%) 0 (0.0%) 3 (5.6%) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
.  ± 0.0  
x ̃ = 8.0  
Q25–Q75 = 8. –8.0 
3.  ± 2.7  
x ̃ = 3.0  
Q25–Q75 = 1. –4.0 
6.2 ± 4.6  
x ̃ = 5.0  
2 –Q75 = 2.0–11
4.9 ± 7.1  
x ̃ = 3   
Q25–Q75 = 2.0 4.0 
.5 ± 7.8  
x ̃ = 6.5  
25– 75 = 1.0–6.5 
3.9 ± 4.2  
x ̃ = 2.0  
25– 75 = 1.0–4.0 
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4. –4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = . –6.5 
2.5 ± 0.8 
x ̃ = 3.0  
Q25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (100.0%) 32 (72.0%) 0 (0.0%) 44 (72.1%) 2 100.0%) 21 (38.9 ) 101 (60.8%) 
Nurse 0 (0.0 ) 12 (29.3 ) 3 (6 .0 ) 31 (50.0 ) 0 (0 0 32 (59.3 ) 78 (47.0%) 
Physician 0 (0.0 )  (24.4 ) 5 (100.0 ) 14 (22.6 ) 0 (0 0 14 (25.9 ) 43 (25.9%) 
Basis for Offering 
Patient ch ice 0 ( .0 )  (87.8 ) 3 (60.0 ) 45 (72.6 ) 2 1 0.0 ) 35 (64.8 ) 1 1 72 9
Transpor ation barriers 1 (5 4 (82.9%) 5 (1 39 (6 .9%) 10 29 3 7 110 6
Distance 1 (5  (85.4 ) 5 (10 33 (53.2 ) 1 32 9 3 108 65 1
Time or work constraints 0 0.0%) 2 70 7 2 (40.0 ) 26 (41.9 ) 2 100.0 ) 25 (46.3 ) 84 (50.6 ) 
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 2  (40.3%) 1 (50.0 ) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0 ) 20 (48.8%) 1 (20.0%) 22 (35.5%) 1 (50.0 ) 23 (42.6 ) 67 (40.4 ) 
Cost 1 (50.0 ) 9 (22.0%) 3 (60.0 ) 6 (9.7%) 2 100.0 ) 17 (31.5 ) 38 (22.9 ) 
Exercise Monitoring 
Borg percei e  exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 2  (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0 ) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 ( .0%) 1 (20.0%)  (9.7%) 0 (0.0 ) 9 16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 38 (61.3%) 1 (50.0%) 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0 ) 12 (22.2%) 58 (34.9%) 
= 10.0
8.0–15.0
14 6 14.5
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Table 1. Characteris ics of Home-Based Programs by World Health Organization Region. 
n (%)/  
Mean ± Sta dard Deviation 
Af n
(n = 2) 
Americas  
(n  41) 
EMR
(n  5) 
Europe  
(n  62) 
SEAR  
(n = )
Western Pacific  
(n  54) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 2 14 1979 2 1  1986 200 80 1979 
% pts served 
2 ± .0  
x ̃ = 2 .0
2 – 75 = 2 .0–20.0 
18.7 ± 18.3  
x ̃ = 10.0  
Q2 –Q7  = . –34.8 
12  ± 5.7  
x ̃ = 7.5  
2 –Q75 = 2.5–25.0 
2.9 ± 1 .8  
x ̃ = 10.0  
Q25–Q7 = 5. –25.0 
5 0 5 4
̃ 55 0
3 55
35 6 30  
̃ 22 5  
25– 75 = 10.0–60.0 
21.4 ± 22.8 
x ̃ = 10.0 
Q25–Q75 = 5.0–30.0 
% perceive sufficient capacity § 1 5 9 (46.3%) 3 60.0 ) 36 (58.1 ) 1 2 1 9 88 (53.0 ) 
Not enough staff  (0 0 11 (26.9%) 1 (20.0 ) 1  (24.3%) 1 (50.0 ) 14 9 42 (25.3%) 
Not enough funding  (0.0 ) 7 (17.1%) 2 (40.0 ) 3 (21.0%) 1 50 0 8 (14.8 ) 31 (18.7%) 
Pts too high-risk  (0.0%) 2 (4.9 ) 1 (2 .0%) 0 (0.0%) 0 0 0 3 6 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8.  ± 0.0  
x ̃ = 8.0  
25– 75 = 8.0–8.0 
3.2 ± 2.7  
x ̃ = 3.0  
2 – 75 = 1.0–4.0 
6.2 ± 4.6  
x ̃ = 5.0  
11
4.9 ± 7.1  
x ̃ = 3.0  
Q25–Q75 = 2 4.0 
6 5 7 8
̃ 6 5
6 5
3 9 4 2  
̃ 2  
4.2 ± 5.3 
x ̃ = 3.0 
Q25–Q75 = 1.0–4.0 
Program duration (months) 
4.  ± 0.0  
x ̃ = 4.0  
2 –Q75 = 4.0–4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = 3.0–6.5 
2.5 ± 0.8
x ̃ = 3.0  
Q25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2.0–3.0 
- 
2 3 1 8  
̃ 1 5  
0 9 3
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
roviders Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
100.0%) 3  (72.0%)  (0 0 44 (72.1%)  (100 0 21 (38.9 ) 101 (60.8%) 
Nurse  (0 0 12 (29.3 ) 3 (60.0 ) 31 (50.0 ) 0 0 32 59 3 78 (47.0%) 
Physician  (0 0 10 (24.4 ) 5 100.0 ) 14 (22.6 ) 0 0 0 14 43 (25.9%) 
Basis for Offering 
Patient ch ice ( 0 36 (87.8 ) 3 6 0 4  (72.6 ) 2 (100 0 35 (64.8 ) 121 72 9
Transpor ation barriers 1 3  (82.9%) 5 1 39 ( 2.9%)  (10 29 (53.7 ) 110 66 3
Distance 1 5 35 (85.4 ) 10 33 (53.2 ) 2 (10 32 (59.3 ) 108 65 1
Time or work constraints 2 7 7 2 4 .0 ) 26 (41.9 ) 1 0 0 25 46 3 84 (50.6 ) 
Risk stratification  (0 0 24 (58.5%) 1 (20.0 ) 2  (4 .3%) 1 (50.0 ) 25 6 3 76 (45.8%) 
Patient indication  (0 0 20 (48.8%) 1 (20.0 ) 22 (35.5 ) 1 (50.0 ) 23 2 6 67 (40.4 ) 
Cost 1 (50.0 )  (22.0 ) 3 (60.0 ) 6 (9 7 2 100 0 17 31 5 38 (22.9 ) 
Exercise Monitoring 
Borg percei e  exertion [34] 1 (50.0 ) 2  (48.8%) 2 (40.0 ) 28 (45.2%) 2 100 0 17 31 5 70 (42.2%) 
Heart rate 1 (50.0 ) 22 (53.7%) 1 (20.0 ) 26 (41.9%) 1 (50.0 ) 14 25 9 65 (39.2%) 
Telemetry  (0.0%) 0 (0.0 ) 1 (20.0%) 6 (9.7%) 0 (0.0 ) 9 (16 7 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0 ) 34 (82.9%) 3 (60.0 ) 38 (61.3%) 1 50 0 37 (68.5 ) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
 (0 0 24 (58.5%) 1 (20.0 ) 20 (32.3%) 1 (50.0 ) 12 22 2 58 (34.9%) 
0.0
9.0–15.0
Exercise Monitoring
Heart rate - 10 (47.6%) 0 (0. %) 23 (42.6%) 0 (0. %) 14 (45.2%) 4 (43.1%)
Borg perceived exertion [34] - 8 (38.1%) 1 (100.0%) 23 (42.6%) 0 (0.0%) 14 (45.2%) 46 (42.2%)
Telemetry - 0 (0.0%) 0 (0.0%) 5 (9.6%) 0 (0.0%) 4 (12.9%) 9 (8.3%)
Level of Risk Accepted
High - 4 (19.0%) 0 (0.0%) 22 (40.7%) 0 (0.0%) 7 (22.6%) 33 (30.3%)
Moderate - 13 (61.9%) 0 (0.0%) 37 (68.5%) 1 (100.0%) 18 (58.1%) 69 (63.3%)
Low - 17 (81.0%) 1 (100.0%) 42 (77.8%) 1 (100.0%) 16 (51.6%) 77 (70.6%)
Do not risk stratify - 2 (9.5%) 0 (0.0%) 2 (3.7%) 0 (0.0%) 5 (16.1%) 9 (8.3%)
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Table 1. Characteristics of Home-Based Programs by World Health Organization Region. 
n (%)/  
Mean ± Standard Deviation 
African  
(n = 2) 
Americas  
(n = 41) 
EMR  
(n = 5) 
Euro   
(n = 62) 
SEAR  
(n = 2) 
Western Pacific  
(n = 54) 
Global  
(n = 166; 15.3% Total) 
Year 1st program opened 2014 1979 2010 1986 2005 198  1979 
% pts served 
20.0 ± 0.0  
x ̃ = 20.0  
Q25–Q75 = 20.0–20.0 
18.7 ± 18.3  
x ̃ = 10.0  
Q25–Q75 = 5.0–34.8 
12.5 ± 15.7  
x ̃ = 7.5  
Q25–Q75 = 2.5–2 .0 
12.9 ± 11.8  
x ̃ = 10.0  
Q25–Q75 = .0–25.0 
55.0 ± 35.4  
x ̃ = 55.0  
Q25–Q75 = 30 0 55.0 
35.6 ± 30.8  
x ̃ = 22.5  
Q 75 1 0–60.0 
21.4 ± 22.8 
x ̃ = 10.0 
Q2 –Q75 = 5.0 3 .
% perceive sufficient capacity § 1 (50.0%) 19 (46.3%) 3 (60.0%) 36 (58.1%) 1 (50. %) 8 (51.9%) 88 (53.0%) 
Not enough staff 0 (0.0%) 11 (26.9%) 1 (20.0%) 15 (24.3%) 1 (50. ) 4 (25.9%) 42 (25.3%) 
Not enough funding 0 (0.0%) 7 (17.1%) 2 (40.0%) 13 (21.0%) 1 (50.0%) 8 (14.8%) 31 (18.7%) 
Pts too high-risk 0 (0.0%) 2 (4.9%) 1 (20.0%) 0 (0.0%) 0 (0. %) 3 (5.6 ) 6 (5.2%) 
Dose 
Number sessions pts prescribed 
per month a 
8.0 ± 0.0  
x ̃ = 8.0  
Q25–Q75 = 8.0–8.0 
3.2 ± 2.7  
x ̃ = 3.0  
Q25–Q75 = 1.0–4.0 
6.2 ± 4.6  
x ̃ = 5.0  
Q25–Q75 = 2.0–11.0 
4.9 ± 7.1  
x ̃ = 3.0  
Q25–Q75 = 2.0–4.0 
6.5 ± 7.8  
x ̃ = 6.5  
Q25–Q75 = 1. –6.5 
3.9 ± 4.2  
x ̃ = 2.0  
Q25–Q75 = 1.0–4.0 
4.2 ± 5.3 
x ̃ = 3.0 
Q 5–Q75 = 1.0–4.0 
Program duration (months) 
4.0 ± 0.0  
x ̃ = 4.0  
Q25–Q75 = 4.0–4.0 
5.8 ± 3.9  
x ̃ = 4.0  
Q25–Q75 = 3.0–6.5 
2.5 ± 0.8 
x ̃ = 3.0  
Q25–Q75 = 1.6–3.0 
2.7 ± 2.0  
x ̃ = 2.0  
Q25–Q75 = 2. –3.0 
- 
2.3 ± 1.8  
x ̃ = 1.5  
Q25–Q75 = 0.9–3.0 
3.6 ± 3.1 
x ̃ = 3.0 
Q25–Q75 = 2.0–4.0 
Providers Interacting with Pts ‖ 
Exercise physiologist or 
physiotherapist 
2 (100.0%) 32 (72.0%) 0 (0.0%) 44 (72.1%) 2 (100.0%) 21 (38.9%) 101 (60.8%) 
Nurse 0 (0.0%) 12 (29.3%) 3 (60.0%) 31 (50.0%) 0 (0.0%) 32 (59.3%) 78 (47.0%) 
Physician 0 (0.0%) 10 (24.4%) 5 (100.0%) 14 (22.6%) 0 (0.0%) 14 (25.9%) 43 (25.9%) 
Basis for Offering 
Patient choice 0 (0.0%) 36 (87.8%) 3 (60.0%) 45 (72.6%) 2 (100.0%) 35 (64.8%) 121 (72.9%) 
Transportation barriers 1 (50.0%) 34 (82.9%) 5 (100.0%) 39 (62.9%) 2 (100.0%) 29 (53.7%) 110 (66.3%) 
Distance 1 (50.0%) 35 (85.4%) 5 (100.0%) 33 (53.2%) 2 (100.0%) 32 (59.3%) 108 (65.1%) 
Time or work constraints 0 (0.0%) 29 (70.7%) 2 (40.0%) 26 (41.9%) 2 (100.0%) 25 (46.3%) 84 (50.6%) 
Risk stratification 0 (0.0%) 24 (58.5%) 1 (20.0%) 25 (40.3%) 1 (50.0%) 25 (46.3%) 76 (45.8%) 
Patient indication 0 (0.0%) 20 (48.8%) 1 (20.0%) 22 (35.5%) 1 (50.0%) 23 (42.6%) 67 (40.4%) 
Cost 1 (50.0%) 9 (22.0%) 3 (60.0%) 6 (9.7%) 2 (100.0%) 17 (31.5%) 38 (22.9%) 
Exercise Monitoring 
Borg perceived exertion [34] 1 (50.0%) 20 (48.8%) 2 (40.0%) 28 (45.2%) 2 (100.0%) 17 (31.5%) 70 (42.2%) 
Heart rate 1 (50.0%) 22 (53.7%) 1 (20.0%) 26 (41.9%) 1 (50.0%) 14 (25.9%) 65 (39.2%) 
Telemetry 0 (0.0%) 0 (0.0%) 1 (20.0%) 6 (9.7%) 0 (0.0%) 9 (16.7%) 16 (9.6%) 
Materials Provided 
Education materials (workbook, 
DVD, website) 
1 (50.0%) 34 (82.9%) 3 (60.0%) 38 (61.3%) 1 (50.0%) 37 (68.5%) 114 (68.7%) 
Activity tracker (accelerometer, 
pedometer) 
0 (0.0%) 24 (58.5%) 1 (20.0%) 20 (32.3%) 1 (50.0%) 12 (22.2%) 58 (34.9%) 
median; - no response; Abbreviations: p s = patients; Acronyms: SEAR = South-East Asia region; EMR = Eastern Mediterranean region.
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Figure 2 displays the forms of communication with patients in home-based programs, along
with frequency. This is shown by WHO region in Supplemental Figures S1–S6. No other forms of
communication were reported. Barriers to using these communication tools are shown in Table 1, with
one respondent also noting institutional policies restricted electronic communication with patients.
Figure 2. Forms of Communication in Home-Based Programs and Their Mean Frequency of Use
Globally, n = 166.
Overall, 106 (63.9%) responding programs reported using at least one form of information and
communication technology (i.e., eCR) at least once per program with patients, and this was most
commonly smartphone, email, and text messages (Figure 2). By WHO region, this was 2 (100.0%) for
the Eastern Mediterranean Region, 34 (82.9%) for the Americas, 39 (62.9%) for Europe, 28 (51.9%) for
the Western-Pacific, and 1 (50.0%) for Africa.
3.3. Community-Based CR
The nature of the community-based CR programs delivered in the 25 countries where it is offered
is shown by WHO region in Table 2. Median dose globally was 20 sessions (Q25–Q75 = 9.6–36.0).
Providers responsible for supervising exercise sessions are also shown (most commonly exercise
physiologist/physiotherapist). Where involved, physician type was most often cardiologists (n = 14,
1.3%), physiatrists (n = 6, 0.6%), and “other” provider types included dietitians (n = 6, 0.6%) and
occupational therapists (n = 4, 0.4%). As also shown, programs most often offered patients a
community-based program on the basis of choice, risk / indication, and distance/transportation.
3.4. Increasing Capacity of Alternative Models
As shown in Table 1, almost 40% of programs did not perceive they had sufficient capacity to
meet demand in their home-based program, most commonly due to insufficient staff and funding.
Respondents perceived they would need to increase their capacity to deliver home and community-based
CR included staff, facilities/space, financial resources and equipment (Figure 3a,b respectively).
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Figure 3. Needed elements to increase capacity of alternative model delivery. (a) home-based;
(b) community-based.
4. Discussion
Approximately half of countries in the world offer supervised CR, with alternative models of
CR available in only one-quarter (or just less than half of those with any CR), despite the first such
program starting 50 years ago. This is problematic given the grossly insufficient global CR capacity to
meet the demand—capacity that could be drastically increased with broader provision of alternative
models [7]. In the 15% of programs that even offered it, the median dose for home-based CR was a mere
3 sessions—a dose which is insufficient to achieve the reductions in morbidity and mortality associated
with CR [35,36]. One-fifth of patients in CR are treated in unsupervised settings (but two-thirds in
community-based, where available in the 10% of programs), yet there is no evidentiary basis on
which to allocate patients to such models. So while appropriateness of this cannot be established, it is
assumed that this is greatly constraining CR reach as only 5% of programs reported patient risk as the
limiting factor.
The most-commonly used forms of communication in non-clinical CR settings were
non-technological forms such as landlines, and paper logs/diaries, although in well over half of
the programs patients came on site monthly. This is likely to ensure rapport and check clinical
status for safety assurance. eCR has been introduced in about two-thirds of the programs. Similar to
supervised programs [30], exercise physiologists/physiotherapists were commonly delivering services.
Two-thirds of patients received patient education materials, and one-third a device to track physical
activity. Use of telemetry was infrequent, which may be appropriate as there is no evidence it improves
safety, and it comes with significant cost.
Given (a) it is expensive and often unnecessary to treat CVD patients in a hospital setting (and
could expose patients to nosocomial infections), (b) that CR delivered in alternative setting is shown
to be equivalent in benefit to supervised programs [9], and (c) that more patients can be treated in
alternative settings, the clinical and policy implications of this first ever global survey on alternative
CR delivery models are many. First, the capacity for alternative model delivery is very low, and this
is likely limiting the reach of CR. The Western Pacific region appears to be the leader in delivering
alternative models (followed by the Americas for home-based and Europe for community-based);
we need to learn more about how these regions have achieved these heights, and apply their lessons
in other jurisdictions. Where community-based services are offered, it appears that the programs
are generally headquartered in the community and offer sufficient dose; more programs should be
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encouraged to establish community satellite centers. Barriers to greater provision were most often
human resource-related. Funding and training (e.g., ICCPR Cardiovascular Rehabilitation Foundation
Certifications [37]) for CR staff should be promoted.
Second, allocation to program model is currently haphazard, and again it would be useful for the
global CR community to review available evidence and achieve consensus on a triage algorithm, taking
into consideration the factors shown to be commonly-considered herein (i.e., patient preference, clinical
considerations, logistical factors). For example, there was quite a bit of variation in terms of level of risk
accepted to these models offered outside of clinical centers. It is assumed that most indicated patients
(likely well more than the approximately 20% getting home-based) would be moderate or low-risk (i.e.,
only 5% of responding programs reported patient risk was a barrier to delivery of home-based CR; and
a quarter of programs offering home-based could safely accept high-risk patients), and hence could
safely receive CR services outside a clinical setting (including in the community—a setting that was
not commonly exploited; this too warrants further investigation). The proportion of patients served in
alternative models is not based on evidence but likely policy, given that a mere 12% of countries that
offer CR reimburse alternative models. With an evidence-based allocation algorithm for alternative CR
models established, programs could be encouraged to ascertain the proportion of indicated patients
in their referral catchment appropriate for such models, and then work to ensure capacity meets this
need. This would be facilitated by sharing of previously-developed and validated eCR models open
source, successful advocacy for reimbursement of alternative models [38] (it is encouraging to note
that there appears to be movement in this direction in the United States), as well as the development of
‘communities of practice’ to increase provider competence in delivering CR in non-traditional settings.
Third, while the survey failed to explicitly assess core components delivered in alternative
models [31] (but only two-thirds of home-based patients received education materials), clearly
the dose of three home-based CR sessions (although these were over 3 months, and this may not
capture asynchronous communication between patients and program staff) is grossly insufficient.
This would not ensure comprehensive delivery of all secondary prevention recommendations, to
promote long-term patient adoption of a heart-healthy lifestyle and the achievement of all CVD
risk factor targets [39], and hence the morbidity and mortality reductions associated with CR
participation [1]. The global CR community should come together to agree on minimum standards for
these models—standards which should then be tested empirically in various settings with regard to
safety and efficacy.
Caution is necessary when interpreting the findings, particularly due to limits on generalizability.
Firstly, response rates to online surveys are notoriously low. Second, it may not have been possible to
identify all programs. For instance, smaller, community-based centers may have been missed if they
did not have a website or engage with the CR community in their country. Thirdly and on a related
note, programs affiliated with prominent academic centers may have been more readily identified for
surveying. These centers may be more likely to offer alternative models than an average CR program,
and therefore results may reflect somewhat greater provision of alternative models than reality.
Fourth, there are measurement issues. Items were self-reported, and a random subsample of
programs were not audited to corroborate reporting. Moreover, many respondents did not complete
all survey items, even in cases where they were applicable. This missing data may have introduced
additional bias, such that results could reflect better delivery than reality if respondents did not
respond if responses did not reflect guideline-based care. Finally, cell sizes were quite small regarding
the nature of alternative models delivered. Therefore, proportions may not be reliable.
The limitations of alternative models of CR should also be considered. Some patients may prefer
going to a hospital setting to exercise, for concerns over safety (which may or may not be valid) or for
needed motivation [40]. With regard to the latter, for some patients, having less in-person contact with
healthcare providers may result in less engagement in the program, and ultimately less heart-healthy
behavior change. Some patients should also potentially only be treated in a supervised setting, not only
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for reasons of risk of an acute event during exercise, but for instance if they have clinical depression,
communication barriers, or are at risk of falling during exercise.
5. Conclusions
In conclusion, through this first-ever global survey of CR programs, the fact that three-quarters of
countries with CR offer supervised models, and almost one-half offer alternative models (38 countries
offer home-based and 25 offer community) has been characterized for the first time around the world.
Home-based models were least-frequently available in Europe and Western-Pacific regions, but where
offered; 15% of programs in these countries offered the model, treating 21% of their total yearly patients.
The scant number of home-based sessions were most commonly delivered by an exercise professional
or physiotherapist, on a landline. The basis for offering alternative models was most-commonly
patient choice, while model capacity was considered insufficient to meet patient need almost half the
time. The CR community needs to develop evidence-based standards on which to allocate patients to
alternative models, and then ensure sufficient capacity in such models, and that they are delivered in
accordance with CR standards.
Supplementary Materials: The following are available online at http://www.mdpi.com/2077-0383/7/9/260/s1,
Figure S1: Forms of Communication in Home-Based Programs and Their Frequency of Use in the African region,
Figure S2: Forms of Communication in Home-Based Programs and Their Frequency of Use in the Americas,
Figure S3: Forms of Communication in Home-Based Programs and Their Frequency of Use in the Eastern
Mediterranean Region, Figure S4: Forms of Communication in Home-Based Programs and Their Frequency of
Use in Europe, Figure S5: Forms of Communication in Home-Based Programs and Their Frequency of Use in
the South-East Asia Region, Figure S6: Forms of Communication in Home-Based Programs and Their Frequency
of Use in the Western Pacific region, Table S1: Delivery of alternative cardiac rehabilitation models by country,
Table S2: Patient Education in Supervised Cardiac Rehabilitation by country.
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